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Abstract
Protein-protein interactions play a crucial role in all biological system s and 
an increasing em phasis has been placed on identifying the full repertoire of 
interacting proteins in cellular systems. Recent developm ents have enabled 
large-scale screening of protein interactions, which has yielded extensive 
inform ation on protein-protein interactions. These efforts have been com ­
plem ented by a num ber of m ethods aim ed at predicting interactions in silico, 
based on a variety of factors, ranging from sequence to structural features.
This work explores the them e of protein-protein interactions, starting 
with the molecular aspect of proteins, leading on to predicting interaction 
partners and, at the top level, exam ining genome-scale protein-protein in­
teraction networks. On the m olecular level, the sequence and structural 
details of proteins were exam ined, particularly focusing on the location 
of intron-exon boundaries in relation to protein interfaces. In addition, a 
homology-based m ethod for predicting protein-protein interactions was de­
veloped, along w ith a scoring function for estim ating the confidence of the 
prediction. Large-scale protein netw orks or 'interactom es' for key species 
were constructed, followed by a validation of the scoring function which 
confirmed its usefulness as an indicator of prediction reliability.
The value of the predicted interactom es was dem onstrated by two sep­
arate studies. First, the overall topology of the hum an interactome w as ex­
am ined and the netw ork properties of cancer-related proteins com pared to 
non-cancer proteins. Cancer-related proteins were shown to display net­
work characteristics that differed m arkedly from non-cancer proteins. The 
second study was aimed at identified key proteins likely to be im plicated 
in cancer metastasis. This was done by m apping gene expression data from 
highly metastatic rat cell-lines onto the rat interactome. A cluster analysis of 
the data revealed distinct, tightly interconnected protein com m unities that 
play a role in metastasis.
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Chapter 1 
Introduction
The world of proteins w ith its fascinating diversity and functionality has 
been the source of m uch interest over the decades. Proteins, whose nam e 
originates from the Greek protas m eaning 'of prim ary im portance', are the 
building blocks of life. They are polym ers of am ino acids and serve in a 
variety of ways, ranging from having structural and mechanical roles in 
the cell, to catalysing chemical reactions and transporting cellular signals. 
Proteins are therefore essential to all living cells.
In most organisms, proteins are encoded in strands of deoxyribonucleic 
acid, or DNA. This forms the basis of the 'central dogm a' in biology, pro­
posed by Francis Crick (1970), which states that inform ation is transferred 
from DNA to proteins in an irreversible process. The 'sequence hypothe­
sis' that is derived from the central dogm a outlines the information transfer 
of coded genetic information: from DNA that is transcribed to ribonucleic 
acid, RNA, and in turn  translated to proteins (see Figure 1.1).
Transcription Translation
DNA  ->  RNA ► PROTEIN
O
Replication
Figure 1.1: The sequence hypothesis that is derived from the central dogma of biology 
represents the general flow of information that is coded in DNA. The pathway can be 
summarised in a simplified manner, with the genetic information originating in DNA, 
which is then transcribed to RNA, from which proteins are translated.
15
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Since the idea was first p u t forw ard, it has developed to reflect the added 
knowledge of biological system s that has accum ulated over the years. For 
instance, it has become apparent that the DNA —> RNA transfer can be re­
versed in a process that makes use of reverse transcriptase, and that some 
RNA is non-coding, and can be spliced out via constitutive or alternative 
splicing. Nevertheless the underlying idea of the sequence hypothesis is 
still valid and is the foundation on which our understanding  of m olecular 
biology is built.
1.1 The systems view  of biology
The recent developm ents in genom e sequencing have resulted in an extraor­
dinary  am ount of genomic data that provides a w ealth of information; cur­
rently, just under 370 prokaryotic and 22 eukaryotic genom es have been 
com pletely sequenced (NCBI Genome Project, 2006). The sequence data has 
enabled gene prediction for m ost of the genomes and this, in turn, allows 
scientists to interpret this data in terms of the gene products—the proteins.
Even with the genes and the corresponding proteins established, there is 
still a long way to go until a full understanding of the functional aspects of 
the proteins in a given organism  is achieved. A great em phasis has therefore 
been put on unravelling the functional features of proteins through large- 
scale screenings of protein interactions, building on the idea that a protein 's 
function can be inferred by looking at the proteins w ith which it interacts. 
Moreover, protein-protein interactions are crucial for m ediating most bio­
logical processes: tens of thousands of proteins and other macromolecules 
are, at any given time, expressed in a typical cell, and each will participate in 
a num ber of interactions w ith other proteins (Alberts et al., 2002). A com pre­
hensive determ ination of all protein-protein interactions that take place in 
an organism is therefore needed to provide an understanding of the molec­
ular basis of the cellular function.
As technology advances, the em phasis of research efforts has moved 
from genomics to proteomics. The term proteomics refers to the study of the 
complete set of proteins that is expressed by the entire genome in a cell. 
The advances in proteomic study were largely driven by methods for large- 
scale protein separation and identification (such the combination of chro­
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Genomes ----------» Proteomes  * Interactomes
Figure 1.2: The advances in genome sequencing have brought research emphasis from 
genomics to proteomics, which focuses on identification of the entire set of expressed 
proteins under a given cellular condition. More recently, system wide approach for ex­
amining the complex networks of protein interactions, or interactomics, has gained mo­
mentum as a way towards understanding biological systems.
matography with mass spectrometry, see Lee and Lee (2004) for a review). 
Once the participating proteins have been identified, the next logical step 
is to examine the context in which the protein exists. This is the subject of 
protein interactomics, the study of the complete set of physical interactions 
m ediated by all proteins of an organism (see Figure 1.2). The emergence of 
interactomics has been facilitated by another technological leap which has 
enabled large-scale and high-throughput m apping of protein interactions, 
where yeast two-hybrid (Y2H) is one of the major m ethods (see Section 1.3). 
As this has progressed, scientists are increasingly examining cellular p ro ­
cesses in terms of networks of protein-protein interactions, rather than fol­
lowing the more traditional reductionist view of functions brought about 
through simple molecular pathways. This approach is especially appro­
priate when complicated diseases, such as cancer, are being investigated. 
As more and more signalling pathways are being identified, it has become 
apparent that cellular regulation is achieved through networks of signals, 
rather than simple linear pathw ays (Weng et a l, 1999; Hom berg et a l, 2006).
In spite of ever increasing data on protein interactions, there are still
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X-ray
structureHomology
model
r yf  X-ray 1  
■  structure «-*
Homology
model
Figure 1.3: An example of an interaction map of known and potential interactions. Pro­
teins are shown in a linear manner, split into domains separated by spacers for clarity. 
Domains are further split into exons and alternatively spliced exons are shown with a 
darker shade of domain colour. Proteins, whose structures have not been solved but for 
which interaction data exists (e.g. from Y2H studies), are labelled as "models", whereas 
proteins of known structure are labelled "X-ray". The strength of association is repre­
sented by the arrow width; crystallographic data having the strongest association and 
data involving protein models weaker association.
gaps in our knowledge of genome-wide interactome maps, partially due 
to lack of coverage, and also as a result of the experimental errors associ­
ated with some of the high-throughput screening methods. Empirical data 
m ust therefore be integrated w ith comparative and predictive bioinformat­
ics analyses.
Towards this end, much effort is being channelled into firstly, expressing 
known protein-protein interaction information in a form that is useful for 
interpretation and, secondly, filling in as many gaps in our knowledge as 
possible, by considering the evolutionary aspects of proteins, sequence and 
function. Figure 1.3 shows the principle of one interpretation of the idea, 
depicting a hypothetical contact map between a few proteins in a eukaryotic 
genome. It shows a mixture of known and predicted data, the ratio of which 
will continually change as experimental data accumulates.
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1.2 Biological databases
The num ber of biological databases is constantly increasing. This trend is 
fuelled in particular by advances in biological and biochemical research that 
produce diverse types of data in an ever increasing volume. Not only is the 
availability of new data increasing, but advances in bioinformatics in the 
last decade have also enabled scientists to re-examine old data, for exam ­
ple using data mining techniques, which allows fresh interpretation of old 
discoveries.
Undoubtedly, the plethora of biological data has enhanced our under­
standing of biological systems. Most biological databases available to the 
public are accessible on the Internet and they cover aspects such as DNA, 
RNA and protein sequences, gene m utation and disease inform ation, pro­
tein structures, enzymatic activity and ligand binding, to nam e a few. Before 
proceeding further it is appropriate to introduce the data sources that were 
particularly valuable in this work.
1.2.1 Protein sequence depositories
The am ount of sequence data has expanded enorm ously in the last decade. 
The largest am ount of am ino acid data is now produced by translation of 
nucleic acid sequences, w hose num bers have been on the increase as ever 
more genomic sequencing projects are completed. Presently, sequence data 
and associated annotations are stored in several databases run by separate 
organisations. The Swiss Institute of Bioinformatics has collaborated with 
the European Bioinformatics Institute (EBI) to construct a database of anno­
tated protein sequences, nam ed Swiss-Prot (Boeckmann et al., 2003). Swiss- 
Prot is a curated protein sequence database of low redundancy that includes 
diverse information associated w ith its sequences (such as description of 
protein functions, dom ain structure, post-translational modification, alter­
native splicing, etc.). TrEMBL is the nam e of a com puter-annotated supple­
m ent to Swiss-Prot and it contains sequences not yet ready to be included 
in the m ain database. The Protein Inform ation Resource, or PIR, (Wu et al., 
2003) is another high-quality database established by the National Biomed­
ical Research Foundation in 1984. These three databases have now joined 
forces under the name UniProt (Wu et a l, 2006), and function as a central
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repository of protein sequence and function.
A nother im portant source for protein sequence inform ation, and one 
that is prim arily used in this thesis, is the RefSeq database (Pruitt et al., 
2005) which is m aintained by the N ational Center for Biotechnology Infor­
m ation (NCBI). RefSeq provides annotated sequence inform ation on both 
nucleotide and protein sequences. Its m ain strength lies in the em phasis on 
data validation, format consistency and non-redundancy. This m eans that 
it is smaller in size than many other databases; however, the data integrity 
makes it a good source for genom e-w ide protein studies.
1.2.2 The Protein Data Bank
The Research Collaboratory for Structural Bioinformatics m aintains the Pro­
tein Data Bank (PDB) (Berman et al., 2000). The PDB is the prim ary repos­
itory of three-dim ensional protein structures in the scientific community. 
The database was constructed by Bernstein et al. (1977). Initially the rate 
of subm itted structures was very low, which reflects the lim itations of the 
experim ental m ethods that were used at the time. By 1986 the num ber of 
protein structures had reached 214, w ith an average of 23 structures being 
added to the database yearly. With advances in technology, the rate of sub­
mission has increased exponentially, as can be seen in Figure 1.4, and in July 
2006 the PDB contained 37,873 structures in total. This trend is expected 
to continue, boosted by the efforts of the Structural Genomics Consortium  
(SGC) (Williamson, 2000), which is filling in the gaps of the protein struc­
ture space by targeting a large num ber of proteins relevant to hum an health 
and disease. The PDB contains structures solved prim arily by two m eth­
ods: X-ray crystallography and Nucleic Magnetic Resonance. Lately there 
has been an addition of another m ethod, electron microscopy, which has to 
date yielded 127 structures, particularly large m acromolecular structures.
1.2.3 Structural classification
The Structural Classification of Proteins (SCOP) database is a m anually cu­
rated database that orders proteins of known structure according to their 
evolutionary and structural relationships (Murzin et al., 1995). SCOP de­
scribes protein structures in the basic units of domains, which are evolution-
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Figure 1.4: The num ber of structures in the Protein Data Bank over the last twenty years. 
The structures are divided into the two main experimental methods by which they are 
solved: X-ray crystallography and NMR. The third method (electron microscopy) has 
yielded limited number of data to date (127 structures in 2006).
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ary units of protein structure and can exist either on their ow n or as building 
blocks in m ulti-dom ain proteins. The dom ains in SCOP are hierarchically 
classified into increasingly descriptive groups, starting w ith the most gen­
eral class description (ft-helix proteins, /3-sheet proteins, etc.) and further 
subclassifications into folds, superfam ilies and finally into families. The 
first official SCOP release in 1995 com prised 3,179 protein  dom ains grouped 
into 498 families, 366 superfam ilies and 279 folds. The latest version of the 
database (release 1.69, July 2005) contains 2,845 families, 1,539 superfam ilies 
and 945 folds.
As the rate of newly deposited structures increases, m anual assignm ent 
becomes less feasible and autom ated m ethods for analysing and classifying 
structures becomes a key requirem ent. A nother key database, CATH Pro­
tein Structure Classification (Orengo et al., 1997), is perhaps better suited to 
m eet the dem ands of the increased supply of structures, as it utilises au to ­
m ated methods to a greater degree for its classifications. Like SCOP, CATH 
is a hierarchical classification of protein dom ain structures, which clusters 
proteins at four major levels, Class (C), Architecture (A), Topology (T) and 
Hom ologous superfam ily (H). A protein 's class is determ ined according to 
the secondary structure and packing, w ith the prim ary groups being alpha, 
beta and alpha-beta proteins. The architecture indicates the general shape of 
the dom ain based on internal orientation of secondary structures. The topol­
ogy describes the fold that is based on overall connectivity and shape of the 
secondary structures. Furtherm ore, hom ologous superfam ilies, which con­
tain proteins thought to share a common ancestor, get their classification 
based on sequence and structural similarity. Dom ains w ithin each hom olo­
gous superfamily are further classified into sequence families based on their 
sequence identity overlap. In July 2006 CATH contained 40 individual ar­
chitecture types, 1,110 types of topology, 2,147 hom ologous superfamilies 
and 7,841 sequence families.
Another database that docum ents protein families and domains is Pfam 
(Bateman et al., 2004). This database contains m ultiple sequence alignm ents 
representing each family, along with dom ain architecture, functional anno­
tation, literature reference and database links for each family. Each family 
is assigned two sets of m ultiple alignments. One is the seed alignment that 
contains a small num ber of representative sequences and the other is the
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full alignm ent that contains all m em bers in the database that can be de­
tected. In addition, each family contains profile h idden  Markov m odels 
(profile HMMs) (see e.g. Eddy (1996)) for detecting dom ains in sequences 
not already covered in its alignm ents.
An offshoot of Pfam is the iPfam database, which is a resource that 
describes dom ain-dom ain interactions that are observed in PDB entries. 
It m aps the parent's database dom ain definitions onto protein structures. 
W hen m ultiple dom ains occur in a single structure, the dom ains are anal­
ysed to see if they form interactions. Version 20.0 of iPfam contains 3,019 
dom ain-dom ain interactions of which 25% are intrachain and 75% are inter­
chain interactions.
1.2.4 ASTRAL
The ASTRAL database (Chandonia et a l, 2004a) com plem ents and is par­
tially derived from the SCOP database. The database provides sequence- 
level information on the structures in the PDB by incorporating dom ain 
inform ation from SCOP. PDB files were prim arily designed for containing 
structural detail of proteins. The implications are that extracting sequence 
details of dom ains from PDB files is often cum bersom e and autom atic se­
quence retrieval from these files can be inaccurate. ASTRAL was provided 
as a solution to these problems. Another feature of ASTRAL, and per­
haps the most useful one, is the classification of proteins into groups of 
hom ologues, which brings together structures that share similarity at the 
sequence level.
1.2.5 OMIM
Of particular interest to scientists involved in cancer research is OMIM— 
'O nline M endelian Inheritance in M an'—which is compiled by Johns H op­
kins University (Hamosh et al., 2005). OMIM is a catalogue of hum an genes 
and genetic disorders with links to both literature and sequences. It first ap ­
peared in a printed form in 1966 and has since been curated by physicians 
and scientists and this m ixture of contributors makes it a valuable source 
for unravelling the complex relationship between genes and disease.
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1.2.6 Gene Ontology
The Gene Ontology (GO) project is a collaborative effort to define a set of 
controlled and unified vocabulary for genes and gene products in a w ide 
variety of organisms (Gene Ontology Consortium , 2006). The project was 
initiated in 1998 and initially included data on Drosophila melanogaster, Sac- 
charomyces cerevisiae and the m ouse genomes. Since then several plant, ani­
mal and microbial genomes have been added. The structure of the ontolo­
gies is hierarchical; the top level contains general descriptions of the gene 
products in terms of their associated properties, i.e. 'biological processes', 
'cellular com ponents' and 'm olecular functions'. These ontologies succes­
sively branch to form a complex web of descriptions, which have been used 
by scientists to help interpret com plicated genome-size data sets.
1.2.7 Interaction data
Currently, there are num erous sources for direct experim ental evidence 
of protein-protein interactions. M any cover single-species experim ental 
data, such as the Hum an Protein Reference Database, HPRD (Peri et al., 
2003), the M unich Information Center for Protein Sequences yeast database, 
MIPS CYGT (Guldener et al., 2005) and the CuraGen database for Drosophila 
melanogaster (Giot et al., 2002), to nam e a few. M ultiple genom e databases 
are, however, progressively covering m ost single-gene data sources. An 
exam ple of the available multi-species databases are BIND (Biomolecular 
Interaction N etwork Database) (Bader et al., 2003) which, in addition to 
inform ation on interactions, contains details on molecular complexes and 
pathw ays from various sources; BioGRID (Stark et al., 2006), which includes 
interactions prim arily from Saccharomyces cerevisiae, Caenorhabditis elegans, 
Drosophila melanogaster and Homo sapiens; MINT (Molecular INTeraction 
Database) (Zanzoni et al., 2002), which data is m ined from the scientific 
literature; and DIP, Database of Interacting Proteins (Xenarios et al., 2002), 
which includes both high-throughput data from m ultiple sources as well 
as sm aller high quality data sets. In June 2006 DIP contained over 55,755 
interactions in 110 species, many of which were from high-throughput ex­
perim ents. In spite of being some of the most com prehensive interaction 
databases available, the above databases contain relatively little protein-
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protein interaction data from m am m als. Saccharomyces cerevisiae, or b u d ­
ding yeast, was am ong the first species to be extensively studied for protein- 
protein interactions (Uetz et al., 2000; Ho et al., 2002), and although useful 
as a model organism, medical and therapeutic research often requires m am ­
malian m odels for optimal results. The MIPS M ammalian Protein-Protein 
Interaction Database (Pagel et al., 2005) addresses this need and provides 
well-curated interaction data from m am m alian species, however it is still 
quite limited in size (about 1,800 interactions am ong 900 proteins from 10 
m am m alian species in June 2005).
The advances in experim ental techniques have m eant that it has become 
cheaper and quicker to perform  protein-protein interaction surveys. Ac­
cordingly, data has been m ade available for a diverse range of species, and 
is often produced by individual laboratories who collect data into their ow n 
local databases. The current situation therefore calls for a com prehensive 
and unified data depository for experim ental results that confirm to stan­
dards for experim ental procedures agreed by the scientific community. The 
Proteomic Standards Initiative, or PSI (Hermjakob et al., 2004a), has been 
formed as a step in that direction. The PSI has proposed a standardised 
data format w ith the M olecular Interaction (MI) Extensible M arkup Lan­
guage (XML) w ith the aim of facilitating data integration. Moreover, the 
PSI MI makes use of controlled vocabularies or ontologies to standardise 
the contents of data attributes. Com bined, these approaches will m ake com ­
parative analyses of protein interaction data more streamlined and prom ote 
data integration. The scientific com m unity is already seeing the results of 
this effort in the IntAct database, developed by the European Bioinformatics 
Institute, which is effectively a m eta-database, containing inform ation from 
many of the above mentioned data sources (Hermjakob et al., 2004b).
1.3 Methods for detecting protein interactions
Experimental m ethods for detecting protein-protein interactions are m any 
and varied. In general, they can be classified into two categories: structure- 
based m ethods and biochemical m ethods.
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1.3.1 Structure-based methods
In the first category are m ethods that aim to elucidate the physical structure 
of the proteins and the complexes they make. The m ethods in this first cat­
egory are X-ray crystallography, Nuclear M agnetic Resonance (NMR) and 
Electron M icroscopy Used in combination w ith protein sequencing they 
can be used to identify the actual physical interaction, including the protein 
interfaces and their makeup. An interaction docum ented by structural ev­
idence obtained by one of these m ethods can be considered proved to the 
highest standard possible—the physical aspects of the interaction can be 
seen and interpreted by the images they provide. These m ethods form the 
backbone of structural biology studies, but as a form of surveying a large 
am ount of data they are very limited. X-ray crystallography, which to date 
has yielded m ost structures (see Section 1.2.2), relies on the proteins u n ­
der study being highly purified, folded correctly under conditions close to 
physiological and subsequently crystallised. For some proteins this process 
can take m onths and others have proved very difficult to crystallise.
1.3.2 Biochemical methods
The second category encompasses a variety of biochemical and genetic 
m ethods, which lend themselves better to extensive screening of interac­
tions. Biochemical m ethods particularly successful for detecting protein- 
protein interactions include genom e-wide assays by yeast tw o-hybrid 
technology (Y2H), im m unoprecipitation (IP), tandem  affinity purification 
(TAP), mass spectrom etry (MS), and protein chips (see Piehler (2005) for an 
overview of these methods).
The yeast tw o-hybrid approach is of particular interest, as it has been the 
m ethod that has produced by far the m ost interactome data and, indeed is 
the method that yielded 70% of the experim ental data used in the netw ork 
studies in this thesis (see Table 3.1 in Chapter 3). The assay was inspired by 
the m odular structure of transcription factors in yeast, Sncchnromi/ccs cere­
visiae. The transcription factors contain a DNA-binding dom ain (DBD) and 
a transcription activation dom ain (AD) and in order for transcription to take 
place both dom ains m ust be in close proximity. The two genes coding for 
the proteins to be tested for interactions are fused to transcription factor do­
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mains, one to the AD (the 'prey ') and the other to the DBD (the 'bait'). If 
the bait and prey interact the transcription factor activity is reconstituted 
and reporter genes that have upstream  binding sites for the DBD get acti­
vated. The expression of the reporter gene allows the diploid yeast cells to 
grow on selective m edia and the interaction is thereby detected. In large- 
scale surveys, the DBD and AD expression vectors are placed initially into 
different haploid yeast strains of opposite m ating types. Pairs of BD and 
AD fused proteins can then be tested for interaction by mating the appro ­
priate pair of yeast strains and assaying reporter activity in the resulting 
diploid cells (Finley and Brent, 1994; Uetz, 2002; Stanyon et a l, 2004; Piehler,
2005). In addition to the above approach, several im provem ents and vari­
ations have been reported, see for instance a review by Toby and Golemis 
(2001). The simplicity and relatively inexpensive nature of the technology, 
and the fact that the m ethod is easily scalable for large studies, has m ade 
yeast two hybrid extremely popular. The m ethod is not w ithout negative 
aspects though, as it has relatively high false-positive and false-negative 
rates (Titz et al., 2004). This is often attributed to m isfolding of the fusion 
proteins; the interaction betw een the bait and prey has to take place in the 
yeast nucleus, where m any proteins are not in their native physiological en­
vironment. Moreover, the m ethod is only suitable for binary protein-protein 
association and cannot autom atically detect m ulti-protein complexes.
1.4 Global experimental analyses
1.4.1 Genome screening by yeast two-hybrid
Most large-scale protein-protein interaction screens have, to date, been per­
formed using the yeast tw o-hybrid method. The first genome-wide inter­
action m ap generated by the tw o-hybrid approach w as for Escherichia coli 
bacteriophage T7 (Bartel et a l, 1996). This screen was later followed by 
comprehensive surveys of the budding  yeast Saccharomyces cerevisae (Uetz 
et al., 2000; I to et a l, 2001 ) which paved the way for subsequent genome- 
w ide screens in a variety of species (Parrish et a l, 2006). The most prom i­
nent and extensive screening efforts to date are listed in Table 1.1. Initially 
the yeast protein m aps m ade up the majority of data available to the sci­
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entific community, however, a few years later an extensive survey of the 
first metazoan proteome— the fruit fly—was published by Giot et al. (2002). 
Com bined with the two subsequent Drosophila melanogaster surveys listed in 
Table 1.1 over 50% of the fruit fly proteome has been m apped (Pacifico et al.,
2006). The generation of this m ap is of particular interest to those studying 
hum an disease as over half of the hum an disease-associated genes in the 
OMIM database have orthologues in Drosophila (Parrish et al., 2006).
Table 1.1: A comparison of 12 of the most prominent large-scale Y2H maps to date, 
showing the relative number of proteins and interactions detected for each study. * A 
subset of highly confident interactions. ** Study focusing only on the Smad signalling 
system.
Total num ber
Species P ub lished  by  P roteins In teractions
B acteriophage T7 Bartel et al. (1996) 55 25
Vaccinia virus M cC raith  et al. (2000) 266 37
H erpes virus VZV U etz et al. (2006) 69 173
H. pylori Rain et al. (2001) 261 1,280
S. cerevisiae U etz et al. (2000) 1,005 905
S. cerevisiae Ito et al. (2001) 797 754
C. elegans Li et al. (2004) 1,415 2,082
D. melanogaster G iot et al. (2002) 7,048 (4,679*) 20,405 (4,780’
D. melanogaster Stanyon et al. (2004) 488 1,814
D. melanogaster Form stecher et al. (2005) 102 2,338 (710*)
P. falciparum L aC ount et al. (2005) 1,308 2,846
H. sapiens Stelzl et al. (2005) 1,705 3,186
H. sapiens Rual et al. (2005) 1,549 2,754
H. sapiens ** C olland  et al. (2004) 591 755
A lthough m ulticellular m odel organisms have been helpful as tools for 
studying hum an disease, a com plete interaction map based on hum an pro­
teins would be enorm ously beneficial. Until recently m ost Y2H screens in­
volving hum an proteins were focused on specific diseases or pathw ays and 
the first large-scale hum an m aps were published by Stelzl et al. (2005) and 
Rual et al. (2005). The two hum an studies have a low level of overlap (Par­
rish et al., 2006) m aking up a total of about 5900 protein interactions. This, 
however, is only a small a fraction of the interactions thought to take place 
in the hum an cell, as the num ber of genes in the hum an genome is cur­
rently estimated at about 20,000-25,000 (International H um an Genome Se­
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quencing Consortium, 2004). Ramani et al. (2005), for instance, combined 
available experimental data w ith literature m ining and estim ated that each 
hum an protein is involved in approxim ately 15 interactions, w hich implies 
m ore than 375,000 interactions in the complete hum an protein interaction 
network. This figure is very likely an underestim ate, ow ing to a num ber of 
protein products that are produced by alternative splicing, which may affect 
up to 40-50% of all genes (M odrek et al., 2001).
1.4.2 Quality assessment of high-throughput data
False-positive results from high-throughput Y2H studies have been a con­
siderable problem when it comes to interpreting the results of these large- 
scale experiments. The size of the problem  has been assessed in several pub­
lications and it has even been suggested that as m uch as 50% of the interac­
tions in some earlier h igh-throughput surveys were false-positive (Sprinzak 
et al., 2003; Deane et al., 2002). The problem  w ith false-positive results can 
be defined as two fold: Firstly, the false-positive interaction can be a result 
of a non-specific binding in the yeast two-hybrid assay. Duplicate assays 
and orthogonal experimental approaches can help to determ ine this class 
of true positives. The second issue, and one that is m uch harder to tackle, 
is the question of biological significance— i.e. in the case of a true specific 
binding, is the interaction likely to exist in vivo and contribute to a cellular 
function?
In order to be considered reliable, interactions have to be detected by 
m ultiple screens and, ideally, by com plem entary experim ental m ethods 
(Bader and Hogue, 2002). For large genomes, the situation is not likely 
to im prove considerably in the im m ediate future, particularly given the 
com position of the data available in some of the larger databases. For ex­
am ple, by pooling the protein-protein interaction data from both DIP and 
MIPS M ammalian databases and examining the underlying experimental 
evidence it becomes apparent that m ost interactions are docum ented by one 
piece of experimental evidence only (see Figure 1.5). Together the databases 
contained about 45,200 interactions that originated from 51,200 experim en­
tal m easurements. This equates to 1.13 experiments per interaction, where 
93% of interactions are supported by one experim ental detail only.
The two-hybrid approach is increasingly com plem ented by alternative
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Figure 1.5: The frequency distribution of the experimental data behind documented 
protein-protein interactions. The abscissa shows the number of separate experiments 
for each documented interaction in the DIP and MIPS Mammalian Databases as at March 
2005.
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methods, such as mass spectroscopy, w ith the aim of validating the results 
(Bork et a l, 2004). Independent coim m unoprecipitation and pull-dow n as­
says, to nam e a few, have also been used in conjunction with yeast two- 
hybrid screening. These techniques are norm ally perform ed on a sm aller 
scale, w ith the aim of identifying a high-confidence core set w ithin the re­
sults. Validation of larger datasets, however, requires a bioinform atics ap ­
proach for validation owing to the expensive and time consum ing nature of 
the com plem entary experimental techniques.
For this purpose, several groups have proposed different m ethods for 
interaction confidence scoring, which aim to estimate more accurately the 
likelihood that an interaction occurs in vivo, see for instance Bader et al.
(2004); Deane et al. (2002); Deng et al. (2003); Sharan et al. (2005) and  Qi 
et al. (2005). In general, the m ethods take input param eters based on pro ­
tein a n d /o r  netw ork properties and contrast these against biological sig­
nificance to arrive at a statistical score for an interaction. In a com parative 
study by Suthram  et al. (2006) the probability assignm ent m ethod by Deng 
et al. was show n to provide the most accurate assessm ent of these m ethods, 
in spite of being the simplest one. This implies that there is still scope for im ­
proving our understanding of which factors can be used as good indicators 
of valid protein-protein interaction data.
1.5 Properties of networks
Within complex systems there are num erous diverse processes that are 
brought about by carefully coordinated pairw ise interactions. The cell is 
a good example of such a complex system, where functions are driven by 
protein-protein interactions. The increasing complexity of biological obser­
vations has m otivated scientists to use m odels that originate from netw ork 
theories to describe the behaviour of their systems. In the abstract netw ork 
representation of protein behaviour, proteins are reduced to nodes that are 
connected to each other, whereby each connection represents a protein- 
protein interaction.
Network theories have a w ide range of applications and they have been 
used to describe systems as diverse as telecommunications, social and bio­
logical networks. Various netw ork m odels have been proposed and adapted
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throughout the years. N etw ork theories traditionally assum ed that net­
works were either completely regular or com pletely random , w ith m ost 
complex physical netw orks being random , i.e. netw orks formed by nodes 
that are connected together by edges in a random  manner. The random - 
netw ork model is often term ed the 'ER-model' as it was proposed by Erdos 
and Renyi who pioneered the study of the m athem atical properties of ran­
dom  networks (Erdos and Renyi, 1959). It later appeared that many techno­
logical, social and biological systems show ed signs of mixed properties and 
other theories were pu t forward, including the small-worlds theory (Watts 
and Strogatz, 1998) and the scale-free m odel (Barabasi and Albert, 1999). 
The small-world theory gets its nam e from the fact that in small-world net­
works it is possible to connect any one node to another node through rela­
tively few interm ediate connecting nodes. Small-world architecture also im ­
plies a highly clustered architecture, such that w hen a node is connected to 
two other nodes, the latter two also tend to have a direct connection to each 
other. The scale-free m odel is a modification of the small-world m odel and 
assumes an inhom ogeneous distribution of connectivity, with most nodes 
having few connections and a small, but significant, fraction of nodes in­
volved in a large num ber of interactions (see Figure 1.6). In scale-free sys­
tems the probability of finding a node that connects to k other nodes follows 
a power law, i.e.
P { k ) ^ k ~ \  ( 1 .1)
where P(k)  represents the connectivity distribution, or the probability that 
a chosen node has exactly k links, and 7  is a degree exponent that charac­
terises the system.
Scale-free netw orks have unique properties that make them robust to 
the random removal of nodes. This feature of robustness seems to describe 
biological networks well, for instance in the situation where a failure of a 
certain protein leads to the activation of an alternative network path to re­
store the original function (Albert et al., 2000; Barabasi and Oltvai, 2004). 
There is increasing evidence that protein-protein interaction networks ex­
hibit scale-free properties. Scale-free topology has been observed in the bi­
ological context, for example in a study of cellular metabolism (Jeong et al., 
2000) and later from a study on the robustness of the p53 network (Dartnell 
et al., 2005). Larger, m ore global proteomic studies on different species have
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Figure 1.6: Comparison between a random (left) and a scale-free (right) network. The 
random network: The model consists of N nodes and connects each pair of nodes 
with probability p, which results in a graph with approximately pN(N — l ) /2  randomly 
placed links. The random network follows a Poisson distribution (shown below the net­
work), which indicates that most nodes have approximately the same number of links. 
The scale-free network: The network has a small number of highly connected nodes 
(shown in blue) and the probability of finding a node that shows a greater-than-average 
connectivity is more significant than in the random graph. The probability that a node 
has k links is expressed by P(k) ~  k~7 , where 7  is the degree exponent. The scale-free 
model is characterised by a power law degree distribution of connectivity as can be seen 
below the network. From Barabasi and Oltvai (2004).
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also shown the same scale-free topological structure, e.g. in fruit fly, w orm  
and yeast (Giot et a l, 2002; Li et a l, 2004; Lee and Megeney, 2005).
The validity of this observation is currently subject to debate. It has been 
suggested (Hakes et al., 2005) that previous topology observations could be 
the results of biases, introduced either through data set selection, experi­
mental m ethodologies or the choice of experim ental methods. This view 
is supported by evidence that the main m ethod for large-scale surveys— 
the yeast two-hybrid m ethod—can produce biased results arising from an 
asymmetry between the connectivity of baits and preys; the mean connec­
tivity of baits is significantly higher than the m ean connectivity of preys 
(Maslov and Sneppen, 2002). Further biases can also be introduced through 
auto activation and presence of sticky proteins (Vidalain et a l, 2004; H an 
et al., 2005). Stum pf et al. (2005) also argue that data sam pling can affect 
assum ptions of the netw ork topology—that is, the scale-free topology of 
an entire netw ork cannot be extrapolated from experim ents that only cover 
part of their entire interactome. Taken together, all the above argum ents in ­
dicate that a conclusive view on the topology of protein networks cannot be 
achieved until we can be certain that the entire interactomes have been sam ­
pled. Experiments m ust therefore be carefully designed such that results are 
not biased by experim ental artefacts.
1.6 Towards predicting interactions
Despite the various research efforts aim ed at describing interactions for 
whole genomes, the available information does not offer complete coverage 
of any one genome, and in addition, owing to the lack of overlapping data 
within the genomes under study, has not been verifiable to a great extent. 
This situation has been the m otivation for developm ent of in silica m ethods 
for predicting individual interactions, w ith the aim  of building com plete 
networks for both m odel species and the hum an. Table 1.2 lists some of the 
databases containing predicted protein interactions. Com putational tech­
niques have been developed to predict gene and protein interactions based 
on a priori biological knowledge. These include m ethods based on gene fu­
sion (Marcotte et a l, 1999), gene neighbourhood (Dandekar et al., 1998) and 
phylogenetic tree similarity profiling (Pellegrini et al., 1999), but the focus of
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the following section is on m ethods that heavily base their predictions on 
experim ental data. The approaches can be broadly divided into the follow­
ing: Firstly, using structural inform ation to infer both interaction sites and 
subsequently binary interactions, and secondly, non-structure based m eth­
ods building on a variety of m ethods and data sources.
Table 1.2: Database servers available on the Internet. These databases contain
protein-protein interaction data, often combining both experimental data and predicted 
interactions.
N am e Species M ethod 
D atabase URL
A uthors
O PH ID
POINT
Prolinks
Visant
STRING
PEP
H um an
H om oM int H um an
H um an  
83 organ ism s 
103 o rgan ism s 
179 o rgan ism s 
105 o rgan ism s
O rthology Brow n an d  Jurisica (2005)
h t t p : / / o p h id .u to r o n to . c a /
O rthology Persico et al. (2005)
h t t p : / / m i n t . b i o .u n iro m a2 . it/HomoMINT/ 
M iscellaneous H u an g  et al. (2004) 
h t t p : / / p o i n t .b i o i n f o r m a t i c s . tw / 
M iscellaneous B ow ers et al. (2004) 
h t t p : / / d i p . d o e -m b i. u c l a . ed u /p ro n a v / 
M iscellaneous H u  et al. (2005) 
h t t p : / / v i s a n t . b u . ed u /
M iscellaneous von  M ering  et al. (2005) 
h t t p : / / s t r i n g . em bl. d e /
M iscellaneous C arter et al. (2003) 
h t t p : / / c u b ic . b i o c . C o lum bia .edu /pep /
1.6.1 Structure-based prediction
The structure-based approach has a longer history than the structure in­
dependent, and has been focused on characterisation of protein interfaces 
(see for example Jones and Thornton (1997), Valdar and Thornton (2001b) 
and Ofran and Rost (2003)), w ith the aim of subsequently using this know l­
edge for predicting interfaces. A large am ount of work has been done to 
this end, particularly m aking use of neural netw orks (Fariselli et al., 2002; 
Keil et al., 2004; Hoskins et al., 2006) and Support Vector Machines (SVM) 
(Yuan et al., 2002; Kim and Park, 2003; Koike and Takagi, 2004; Bordner 
and Abagyan, 2005; Bradford and Westhead, 2005). SVMs (Vapnik, 1995; 
Burges, 1998) are com putational learning systems based on statistical learn-
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ing theories. SVMs have been used for various applications, such as text 
categorisation, hand-w ritten character recognition, image recognition and 
various other analyses (Cristianini and Shawe-Taylor, 2000). They are also 
well suited for the binary task of discrim inating betw een interacting and 
non-interacting protein pairs. SVMs perform  pattern recognition by using 
binary classification. SVMs m ap their non-linear ^-dim ensional input space 
into a high dimensional feature space and seek a separating hyperplane in 
this space. The hyperplane is selected in such a way as to maximise its dis­
tance from the closest training sam ples (see Figure 1.7). In contrast w ith 
the SVM's discriminative nature, the neural netw orks use a probabilistic 
approach for constructing netw orks so that the individual interactions that 
m ake up the network receive a probability based on an assessm ent by a 
probability scoring function.
The machine learning m ethods use a variety of sequence, structure and 
physical properties (e.g. am ino acid propensity, solvent accessibility, elec­
trostatic potential, residue hydrophobicity, sequence conservation, surface 
planarity and protrusion) as inpu t param eters for their predictions. These 
m ethods are designed to identify binding sites but do not indicate which 
proteins are likely to interact. The natural progression for extensive predic­
tion of interactions w ould be to incorporate the interface prediction with 
genom e-wide protein docking. Docking of proteins on a genomic scale is 
a huge challenge with today 's technology and knowledge (Szilagyi et al., 
2005), although small steps have been m ade towards docking approxim ate 
protein structures (Tovchigrechko et al., 2002), but generally, the current 
docking methods would need a substantial im provem ent of com putational 
efficiency and reliability for this to become possible.
1.6.2 Structure-independent prediction
The second approach—using structure-independent based m ethods— is 
more feasible in the im m ediate term. In contrast to the above, these m eth­
ods do not rely on protein structures being available for complete genomes, 
but take advantage of the h igh-throughput data already available and ex­
trapolate to fill in the gaps w here experim ental knowledge is missing. This 
subject has expanded greatly in the last few years, particularly since the first 
genom e-wide screening of Saccharomyces cerevisiae.
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Figure 1.7: The principles of support vector machines. The original objects are trans­
formed from the input space into a multi-dimensional feature space, using a set of math­
ematical functions, known as kernels. The process of rearranging the objects from input 
space to feature space is known as mapping. The SVM finds an optimal hyperplane sepa­
rating the two classes (represented by red and green dots), so that a maximum distance is 
achieved between the hyperplane and the support vectors. Note that in the feature space, 
the classes are linearly separable which facilitates an easy solution for the separation.
Predicting protein-protein interactions based on prim ary sequence prop­
erties is probably one of the earliest m ethods suitable for large-scale pre­
dictions. Sprinzak and Margalit (2001) correlated experimental yeast two- 
hybrid data w ith sequence signatures that corresponded to protein super­
families and used those to predict the interacting partners. A more exten­
sive approach was taken by Bock and Gough (2001). A lthough their m ethod 
used prim ary structure as the input for their predictions, the sequences were 
interpreted in terms of physicochemical properties (charge, hydrophobicity 
and surface tension). These factors were then fed into an SVM learning sys­
tem to identify protein-protein binding interactions from the descriptors. 
The m ethod of Bock and co-workers has since been further developed by 
Martin et al. (2005), who used 'signature products' that combine the se­
quences of both proteins involved in an interaction, w ithout the need to 
transform sequence into the physicochemical attributes.
Gene expression has proved useful for validating high-throughput ex­
perimental data (Deane et a l, 2002; Bader et a l, 2004). Additionally, it has 
been suggested that gene coexpression may be a useful indicator for pre­
dicting interactions. This is based on the observation that interacting pro­
teins appear to be coexpressed to m aintain a correct chemical stoichiometry
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am ong interacting proteins (Fraser et al., 2004).
Several groups have examined the possibility of predicting protein  in­
teractions on the dom ain level (Sprinzak and Margalit, 2001; Deng et a l, 
2002; Nye et a l, 2005), by statistically analysing dom ain com position of in­
teraction data. These m ethods assum e that each dom ain is responsible for 
a specific interaction with another dom ain. By identifying correlated do­
main pairs in a set of known interactions, inform ation is subsequently used 
to predict interacting proteins pair that contain them. These probabilistic 
m ethods show a considerable prom ise as validation tools to filter out false 
positives and false negatives in large-scale data sets and may even be useful 
for inferring interactions based on observation from m ultiple species (Pagel 
et al., 2004; Riley et al., 2005; Liu et al., 2005).
Furtherm ore, gene ontology and functional classification features are 
particularly useful for prediction of protein interactions, as dem onstrated 
by Lin et al. (2004). They used a Bayesian netw ork approach for predic­
tion and exam ined the usefulness of data from different sources, including 
mRNA expression data, Gene Ontology and MIPS functional annotations, 
essentiality data and high-throughput experim ental data. They found that 
annotation data from GO and MIPS (Mewes et al., 2002) were better contrib­
utors for predicting the protein-protein interactions than the others.
Data integration methods
The use of machine learning for predicting protein-protein interactions has 
opened the door for integration of data from diverse sources in an a ttem pt to 
provide more accurate results. Supervised learning m ethods can use both 
direct (experimental) biological data and indirect (e.g. annotation and  on­
tologies) as sources for prediction, often combining fundam entally different 
sets of genomic information. This is done w ith the aim of m inim ising the 
effect of noise that often comes from the error-prone high-throughput data, 
and has resulted in progressively more identifications of protein-protein as­
sociation (Gerstein et al., 2002).
A lthough SVMs have proved useful for predictions based on data in­
tegration, there are several other approaches. Jansen et al. (2003), for in­
stance, used a naive Bayes classifier to predict interactions in yeast. Based 
on high-throughput Y2H data, in addition to mRNA coexpression, colocal­
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isation from ontology and protein essentiality for survival, they predicted 
over 10,000 interactions and subsequently validated a num ber of them  w ith  
tandem  affinity purification. Another probabilistic model, proposed by Ios- 
sifov et al. (2004), used data from literature m ining in com bination w ith  
yeast two-hybrid experim ents to predict specific dom ain-dom ain interac­
tions, for which no experim ental data was available.
Studies focusing on interactions involved in defined aspects of biolog­
ical functions have also been published. G unsalus et al. (2005) took an in­
tegrated approach for an investigation of the molecular machines involved 
in early em bryogenesis in Caenorhabditis elegans, by integrating gene and 
protein netw ork inform ation that was generated from three types of func­
tional relationships, i.e. protein interaction, expression profiling sim ilarity 
and phenotypic profiling expressed as embryonic lethality. A more exten­
sive study on hum an netw orks was done by Rhodes et al. (2005), who used a 
naive Bayes probabilistic classifier to predict 40,000 interactions. The classi­
fier was fed four types of evidence (model organism  interactome data, coex­
pression matrices, gene ontology biological function, and dom ain-dom ain 
enrichment).
With integrative studies on the increase, it is im portant to assess the ef­
fectiveness of data integration and the limits of the current tools. One s tudy  
examining this area was done by Lu et al. (2005). They investigated the effect 
of the num ber of features used for prediction using a naive Bayes classifier, 
and found that including a large num ber of features does not im prove p re­
diction quality; future efforts should therefore be limited to a few (up to 
four) good quality features. Qi et al. (2006) assessed the ability of six differ­
ent classifiers, including Bayes and SVMs, to predict interactions from the 
same data feature set. They found that a classifier nam ed 'Random  Forest' 
consistently ranked as one of the top two classifiers for all com binations 
of feature sets. The Random Forest classifier, developed by Breiman (2001), 
bases its predictions on a collection of decision trees and outputs a classifica­
tion that is based on the mode (the most frequently occurring) of the classes 
output by individual trees. Qi and co-workers also assessed the relative 
importance of each of the data set features that were fed into the Random  
Forest prediction. Gene expression ranked highest in importance followed 
by gene ontology process and com ponent descriptions. Fourth on the list
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was TAP MS data, followed by gene ontology function terms and lastly m u ­
tant phenotype. It is notew orthy that yeast tw o-hybrid does not feature in 
this list of the most im portant prediction factors. Indirect information, such 
as GO annotation, appears to be highly im portant in the decision process, 
which can be attributed to the extensive coverage—direct experim ents only 
covered about 20% of the protein pairs in the study.
The above mentioned studies are only a few of the m any that have been 
published recently, collectively indicating that in silico data integration is a 
m ethod that will continue to grow and establish itself in biological sciences.
The orthology approach
The advantages of integration of orthogonal data sources are evident by the 
rapid evolution of integrative approaches. The benefits also extend to the 
use of experimental data from different species as dem onstrated by Liu et al.
(2005), who confirmed that the integrated approach provides a more reliable 
inference of protein-protein interactions than an analysis from a single or­
ganism.
In a seminal publication, Chothia and Lesk (1986) dem onstrated the re­
lationship between sequence divergence and protein structure (decreasing 
sequence similarity results in structural divergence), which is the basis of 
today's homology m odelling principle. More recently Aloy et al. (2005) 
dem onstrated, in an analogous way, the correlation betw een sequence and 
protein interaction divergence. This means that for two pairs of interacting 
proteins, A B and C <-»■ D, where A shares hom ology w ith C and B w ith 
D, the structural com position of the interfaces is retained for the hom olo­
gous pairs. This was found, in particular, for sequences sharing more than 
30% sequence similarity and indicates that hom ologous proteins interact in 
a physically similar m anner (see Figure 1.8). This observation is in agree­
m ent with the increasing evidence from other sources that protein-protein 
interfaces are conserved through evolution (Wuchty et al., 2003; Pagel et al., 
2004; Rhodes et al., 2005).
The concept of 'in terologs'—conserved protein-protein interactions 
through orthology—was first proposed by W alhout et al. (2000) who were 
investigating a small num ber of proteins associated w ith vulval develop­
m ent in Caenorhabditis elegans. The concept builds on the idea that physically
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Figure 1.8: The relationship between sequence and interaction divergence shown as the 
the structural interaction similarity (iRMSD; interaction Root Mean Square Deviation) 
against sequence identity (%). Above 60% sequence similarity, protein interfaces retain 
similar atomic details, in the range between 30-60% the overall structure of the interface is 
retained, and below 30% only the overall orientation may be conserved. Figure adapted 
from Aloy, Pichaud, and Russell (2005).
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interacting proteins in one organism  have coevolved so that the respective 
orthologues in other related organism s interact in a same manner. The idea 
was developed and scaled up by M atthew s et al. (2001), w ho used the ap­
proach to m ap protein-protein interactions from yeast into Caenorhabditis 
elegans and verified them experim entally by yeast tw o-hybrid. M atthew s 
and co-workers started from a sam ple of 1,195 pairw ise interactions from 
yeast and identified 257 potentially orthologous interactions in the fruit fly. 
They subjected a small subset of the predicted interactions to experim ental 
verification and found that around 30% of the fruit fly interactions could be 
substantiated—an interesting fact given that the yeast and w orm  are distant 
relatives
The m ethod has subsequently been developed by other research groups. 
Lehner and Fraser (2004), for instance, directly translated protein-protein 
interaction data from three species: Saccharomyces cerevisiae, Drosophila 
melanogaster, and Caenorhabditis elegans. They applied an algorithm  which is 
based on clustering of similar sequences, developed by Remm et al. (2001), 
to find hum an homologues to protein-protein interactions in these species 
and no other mechanism was used for the actual prediction. The advantage 
of using this approach is that it distinguishes between 'out-paralogues' (ho­
m ologous genes that appeared by duplication before the speciation event 
and therefore not orthologues by definition) and 'in-paralogues' w hich are 
post-speciation products and genuine orthologues. To estim ate the accu­
racy of the results, they calculated the percentage of interactions that shared 
at least one gene ontology term. The complete netw ork contained 71,496 
interactions between 6,231 hum an proteins. Persico et al. (2005) applied 
the same approach for a construction of a set hum an interactions, bu t they 
utilised a string matching algorithm  to filter out orthologous proteins whose 
dom ain organisation was not conserved and predicted 5,200 interactions, 
substantially fewer than Lehner and Fraser. Brown and Jurisica (2005) 
used similar approach to Lehner and Fraser, but used an alternative ap­
proach for identifying homologues and added more m ethods for the valida­
tion. They m apped Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila 
melanogaster and Mus musculiis to the hum an reference frame by assigning 
a hum an homologue to the experim ental data in the the four m odel species 
via the reciprocal best-hit approach (using Blast homology searches in both
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directions) (Yu et al., 2004), rather than the in-paralogue m ethod used by 
Lehner. In addition, they incorporated tw o m ethods (dom ain-dom ain co­
occurrence and gene coexpression) as well as gene orthology to identify ad ­
ditional evidence for part of the data. Their data contained 4,552 proteins in­
volved in 23,889 interactions, of which 5,483 interactions remain (23%) once 
interactions supported by one of the three m ethods are removed. Brown 
and Jurisica compared their hom ology approach to Lehner and Brown's 
and found theirs marginally better in term s of the extent to which netw orks 
could be validated by GO terms (20.6% com pared with 17.7%).
1.7 Overview of the thesis
The construction of protein-protein netw orks should aid our understanding  
of both norm al and aberrant cellular functions. However, it has been show n 
that the quality of high throughput protein-protein detection m ethods is 
questionable and additionally only a fraction of the interactions have been 
m apped in m any of the key species. This has served as a m otivation for 
the work presented in this thesis. The central them e of the work is protein- 
protein interactions and the thesis explores this theme on different levels, 
starting with the molecular aspect of proteins, progressing on to predicting 
interaction partners and, at the top level, examining genome-scale protein- 
protein interaction networks.
In Chapter 2, the focus is on the m olecular level, where the sequence and 
structural details of proteins are examined. In a eukaryotic genome, such 
as the hum an, the coding regions are interspersed w ith non-coding regions 
called introns. Therefore, as a first step to understanding protein-protein 
interactions, we look at the building blocks of eukaryotic genes and inves­
tigate w hether they affect the overall structure of proteins. Moreover, the 
effect of intron-exon boundaries on the structure of protein interfaces are 
studied with the view of uncovering differences that may aid the validation 
or prediction of binding sites.
Chapter 3 explores the idea of predicting protein-protein interactions by 
expanding the 'interolog' concept. In particular, a novel scoring function to 
estimate the reliability of the prediction is proposed and networks of theo­
retical protein-protein interactions—or interactomes—are created for three
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key species. The chapter investigates w hether the large-scale netw orks that 
were created exhibit the small-world properties often observed in biological 
networks. Furtherm ore, the developm ent of a database to house the inter- 
actome data is described, and an interactive web server to accom pany the 
database is presented.
Chapter 4 contains an analysis of the topological netw ork features of the 
hum an interactome. It asks w hether proteins whose m utation can lead to 
cancer, exhibit a degree of topological difference com pared with proteins 
not associated w ith cancer. To facilitate further the com parative analysis 
between cancer and non-cancer proteins, a clustering technique for h igh­
lighting parts of the netw ork that are involved in distinct cellular processes 
is introduced and subsequently the dom ain com position of both groups are 
examined in an effort to shed light on the findings.
Chapter 5 takes the study to the rat interactom e and explores the possi­
bility w hether the com putationally-constructed interactome netw ork m ight 
be used to help interpret microarray expression data. For this purpose, gene 
expression data from cell-lines that show high levels of metastasis are incor­
porated into the protein network. The analysis that follows explores the 
possibility of identifying novel interactions that may play a key role in can­
cer metastasis.
Chapter 6 contains an overview of the w ork presented in the thesis and 
examines the overall conclusions that can be draw n from the material in the 
previous chapters.
Chapter 2 
Exon arrangement and protein 
structure
Protein networks are m ade up of a w ide variety of individual proteins that 
interact and perform  diverse tasks w ithin the cell. In order to understand 
w hat dictates protein-protein interactions, it is im portant to recognise that 
the overall protein structure affects the physical properties of proteins and 
their functionality. More im portantly, the structure of the interface—the site 
which comes in contact w ith the protein 's binding partner—directly affects 
the function and specificity of the protein. U nderstanding of protein struc­
ture and interfaces is therefore im portant for a greater understanding of 
interactions and subsequently for the verification and even prediction of 
protein-protein interactions.
The following w ork looks at one aspect that m ay affect protein struc­
ture: namely the arrangem ent of exons in the genetic material, from which 
eukaryotic proteins are translated. It examines w hether the area, where two 
exons meet through RNA splicing, has any special features in terms of its 
location in the protein structure, and furtherm ore w hether the intron-exon 
boundaries (IEBs) have any correlation with the highly im portant protein 
interface. This chapter contains the results of an initial analysis on the ar­
rangem ent of introns and exons in relation to protein structure, followed by 
an investigation into the correlation of intron-exon boundaries and protein 
interfaces, and finally concluding by examining the special case of alterna­
tively spliced exons in protein interfaces.
Part of the work in this w ork in this chapter was done in collaboration
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Figure 2.1: A general overview of the processes involved in eukaryotic gene expression. 
The main events that take place in the nucleus are transcription and post-transcriptional 
processes (5'capping, 3'poly-adenylation and splicing of introns). Once these events have 
taken place the mRNA is transported to the cytoplasm where ribosomal complexes trans­
late the mRNA into a protein. Figure based on Alberts et al. (2002, pg. 315).
with Bruno Contreras-Moreira and was published in the Journal of Molec­
ular Biology (Contreras-Moreira, Jonsson, and Bates, 2003). Contreras- 
Moreira and Jonsson were joint first authors of this work; Contreras- 
Moreira's contributions related to the modelling aspects and genetic algo­
rithms for modelling and the author of this thesis performed the work relat­
ing the structural aspect of IEBs.
2.1 Gene expression
Before turning to protein structure, it is im portant to look at the biological 
process involved in eukaryotic gene expression. The main events are tran ­
scription from DNA to RNA, the splicing of RNA and subsequent trans­
lation into the final protein product. Figure 2.1 summarises the processes 
involved in eukaryotic protein expression. Initially, the transcription un it of
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the DNA, containing both coding (exon) and non-coding (intron) regions, 
is transcribed to pre-mRNA. Introns can be inserted either between codons 
(phase 0 ) or w ithin codons, after the first nucleotide (phase 1) and after the 
second (phase 2). The pre-mRNA is then subject to post-transcriptional 
modification to both its ends, involving 5'-end capping with a modified 
guanine nucleotide and poly-adenylation to the 3'-end. The modification 
of both ends is a control m echanism  that allows the cellular m achinery to 
check whether the RNA has been completely transcribed before being ex­
ported to the cytoplasm. At this stage the introns are also removed in a 
process of enzymatically catalysed RNA splicing, at which point the mRNA 
is ready to be transported into the cytoplasm  w here it is translated into a 
protein by ribosomal complexes.
2.2 Origin of introns
The organisation of eukaryotic DNA into exons (expressed sequences) and 
introns (intervening sequences) requires a more com plicated transcriptional 
mechanism than is observed in lower organism s, such as the much sim pler 
prokaryotes, which generally do not have introns. Some exceptions to this 
general observation have, nevertheless, been found in archaebacteria and 
some eubacteria, where introns have been discovered (Marlene Belfort and 
Dalgaard, 1995). In the 30 years since they were discovered by Berget et al. 
(1977) and Chow et al. (1977), introns have been a source of much interest 
in the scientific community. W hat at a first glance appears to be a waste 
of genetic material has subsequently been show n to be a feature that effi­
ciently maximises the coding potentials of genes. The intron-exon arrange­
ments appear to be a way of speeding up evolution, allowing new proteins 
to evolve by combinations of different exons into a new protein product 
(Patthy, 1999a). Furthermore, the cell has a m echanism  that allows alterna­
tive splicing of exons, i.e. allowing different proteins to be produced from 
the same gene under different conditions (Letunic et al., 2002).
Introns are recognised as genomic regions involved in insertion, deletion 
or duplication of new exons, or even in the form ation of chimeric proteins 
(Patthy, 1999b). For this reason, introns are potential places for insertion 
or deletion of fragments in proteins, and therefore possible locations for
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significant changes in protein structure and function. Three theories have 
been pu t forward as an explanation of the existence of introns: the introns- 
early (Gilbert, 1987), introns-late (Palmer and Logsdon, 1991) and synthetic 
(de Souza, 2003) theories. The three theories can be sum m aries as follows 
(Stoltzfus et al.f 1994; Roy, 2003):
Introns early:
1. Exons are the descendants of ancient mini-genes and introns stem 
from the spacers betw een them.
2. Exons were joined together to form larger genes.
3. The splicing m echanism originates from ancient RNA.
4. Introns were lost from bacteria through evolution.
The introns late theory contradicts the above in most aspects:
Introns late:
1. Split genes originate from insertion of introns.
2. Genes encoding m odem  proteins developed w ithout the participation 
of introns.
3. The splicing m echanism developed from fragm ented self-splicing in­
trons.
4. Spliceosomal introns were never present in the ancestors of intron-free 
organisms.
The earlier debate was highly polarised, but more inclusive perspectives 
that allow elements from both theories are now becoming increasingly com ­
mon, for instance in the synthetic theory:
Synthetic theory:
1. A mixed model: some introns are ancient and others new.
2. Most introns, especially phase 1 and phase 2 are recent additions to 
the eukaryotic genomes (agreeing with introns-late theory).
3. Some phase 0 introns are ancient and are correlated with protein m od­
ules (agreeing with introns-early theory).
2.2.1 Splicing
The splicing of most exons takes place in the spliceosome, although some 
introns are capable of self splicing (Cech, 1986). RNA molecules know n as
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Figure 2.2: An overview of the RNA splicing mechanism. In the first step, an adenine 
nucleotide at the branch site, towards the 3'-end of the intron sequence (indicated red in a 
black circle), attacks the 5' splice site and cuts the backbone of the RNA. In the second step 
the cut 5'-end covalently joins the adenine nucleotide and a loop in the RNA is created. 
The final step takes place by the released 3'-OH end of the exon reacts with the start of the 
next exon, joining the two exons together and releasing the intron sequence as a 'lariat'. 
Adapted from Alberts et al. (2002, pg. 318).
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snRNA (small nuclear RNAs) complex w ith  several snRNP (small nuclear 
ribonucleoproteins) to form the core of the spliceosome. The spliceosome 
recognises consensus nucleotide sequences in the pre-mRNA that signal the 
beginning and the end of m ost introns (Padgett et n l, 1986; Alberts et nl., 
2002; Clark and Thanaraj, 2002). The consensus nucleotides depend  on 
the specific splicing mechanism, how ever 95-99% of all m am m alian sites 
are marked by GU and AG nucleotides at 5' and 3'-ends (Burset et a i, 
2000; Black, 2003). In addition to consensus sequences directly at the 5' 
and 3' splice sites, a third branch site region about 20-50 nucleotides u p ­
stream from the 3'-end is required. The branch site contains an adenine n u ­
cleotide that perform s a key role in the splicing m echanism (see Figure 2.2). 
Each splicing event removes one intron, proceeding through two sequential 
phosphoryl-transfer reactions; these join two exons while rem oving the in­
tron in a loop know n as 'lariat'. The lariat intron sequence is subsequently 
degraded in the cell.
Alternative splicing
The sequencing of the hum an genom e revealed that the hum an genom e 
is thought to contain approxim ately 25,000 genes (International H um an 
Genome Sequencing Consortium, 2004), which is much lower than previ­
ously expected. It has become apparent that alternative splicing m echa­
nisms are in place to compensate for the shortage of genes. A lterations in a 
splice site can substantially increase the num ber of protein products stem ­
ming from a single gene and recent studies indicate that up to 74% of h u ­
man proteins may be produced through alternative splicing (Johnson et al., 
2003). Furthermore, alternative splicing is one of the most im portant m ech­
anisms in gene regulation (Stamm et at., 2005), allowing different proteins to 
be produced in response to physiological changes in the cell. Exons that are 
present in all mRNA after processing are term ed constitutive, but those that 
vary are referred to as alternatively spliced exons and they can be formed 
by several distinct splicing patterns (Black, 2003), shown in Figure 2.3.
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Figure 2.3: A schematic interpretation of a pre-mRNA and the possible splicing patterns. 
Constitutive exons present in all final mRNA are shown in blue, alternatively spliced 
exons in brown and introns in white. The lines joining one exon to another indicate 
possible splicing paths: one alternative path shown with a solid line and the other with 
a dotted line. (1) Exon skipping/inclusion; (2) alternative 5' splice sites; (3) alternative 3' 
splice sites; (4) mutually exclusive exons; (5) Intron retention. (Based on Cartegni et al. 
(2002)).
2.3 Protein structure
In the subsequent sections the intron-exon arrangem ent will be exam ined 
in relation to protein structure and therefore a description of the elem ents 
of protein structure is needed. Protein structure is classified into different 
levels: primary, secondary, tertiary and quaternary structure.
2.3.1 Primary structure
The primary protein structure is defined as the one dimensional amino acid 
sequence and is determ ined by the covalently linked amino acids in the 
polypeptide backbone. The structure of a protein determines its function, 
but what determ ines the structure? Anfinsen (1973) first dem onstrated that 
the primary structure—the amino acid sequence—determines the higher 
degree three-dimensional structure. This can be reasoned by understanding 
that the polypeptide seeks to fold into a native structure that is therm ody­
namically the most stable in the intracellular environment (Creighton, 1993).
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Figure 2.4: Structure of /5-strands (left) and a-helices (right). The colour coding of
the atoms is as follows: carbon (black), nitrogen (blue), oxygen (green), hydrogen 
(red) and side-chains (yellow). The polypeptide backbone (black) is formed by pep­
tide bonds between carbon and nitrogen molecules. The structure is supported by hy­
drogen bonds (dotted orange lines) that extend from amine groups (NH) to carbonyl 
groups (CO) of nearby peptides. (From the Department of Biology, Penn State University 
(h ttp : /  /  www. b io . psu . edu)).
2.3.2 Secondary structures
Contrary to primary structures, secondary and higher structures are chiefly 
held together by non-covalent forces such as hydrogen bonds, ionic bonds, 
van der Waals and hydrophobic interactions. Adjacent residues in polypep­
tide chains can form hydrogen bonding interactions between the back­
bone oxygens and am ide hydrogens, facilitating formation of structural 
arrangements that are the protein's essential building elements in three- 
dimensional space.
The a-helices and /5-sheets are the two m ain types of secondary struc­
ture elements (see Figure 2.4). The tf-helix is a spiral-like construction, sta­
bilised by hydrogen bonding between backbone amine and backbone car­
bonyl atoms. One turn  of the most common helix represents 3.6 amino acid 
residues containing 13 atoms, which is why the a-helix is sometimes re­
ferred to as 3 .613-helix. Strands, usually 5 to 10 residue long, make up /5- 
sheets through hydrogen bonding as they are structurally unstable on their 
own. Adjacent /5-strands can be either parallel (running in the same direc­
tion) or antiparallel (running in the opposite direction to each other).
Helices and sheets are frequently joined together by loosely structured
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and flexible peptide loops or m ore structured secondary elem ents that form 
turns. Most proteins are globular structures, which requires the polypeptide 
chain to bend such that it can form the desired overall structure. This is 
frequently done with a sim ple structure termed /5-turn (or /5-bend). The 
turn  is formed with a hydrogen bonding between a carbonyl oxygen of one 
residue and the am ide of a residue three position dow n the chain. The /5- 
turn  allows a tight bend of the polypeptide chain which facilitates a reversal 
of the direction of the chain.
2.3.3 Tertiary and quaternary structure
Protein domains are exam ples of tertiary structure elements. The tertiary 
structure is formed once the secondary structure elem ents fold in order to 
assum e a low energy state and a more compact three-dim ensional shape. 
The tertiary structure is often globular as this allows the form ation of large 
num bers of intramolecular hydrogen bonds, and reduces the solvent acces­
sible surface. Amino acids w ith hydrophobic side-chains are folded in such 
a w ay that they form the core of dom ains whereas residues w ith hydrophilic 
side-chains are exposed to the solvent on the outside of the structure. Fi­
nally, the highest structural form, quaternary structure, is the arrangem ent 
of two or more tertiary structures, often from separate polypeptide chains, 
into larger complex structures.
2.4 Methods
Exons, both constitutively and alternatively spliced, and the intron-exon 
boundaries were examined using the following data and methods:
2.4.1 Data
The protein set used in the study of intron-exon boundaries and protein 
structure was composed of hum an and mouse proteins obtained from the 
Protein Data Bank (PDB), as at 22 January 2003 (Berman et nl., 2000). To 
avoid large multi-dom ain proteins, structures with at least 100 residues but 
no more than 300 were selected. Imm unoglobulins and T-cell receptors were 
identified by sequence sim ilarity and excluded from this data set to avoid
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spliced genes. Chimeric proteins w ere also excluded. After excluding pro­
teins w ith only one exon (about 25% of the original set), this data set con­
tained a total of 684 PDB chains. These proteins contained, on average, 3.2 
introns.
Inform ation on variable sequence splicing in the data set w as obtained 
from release 41.16 of the Swissprot database (Bairoch and Apweiler, 2000). 
Swissprot sequences for which splice variant inform ation w as available 
were m atched against the sequences containing intron-exon boundary  (IEB) 
inform ation (see below). Stringent matching criteria were used, allowing 
two gap regions in the sequence alignm ents, yielding only 24 sequences 
where IEBs could confidently be identified in alternatively spliced areas. 
For the study of hum an-m ouse hom ologues, hum an and m ouse sequence 
pairs of sequence identity >  40% were extracted from the above data set, 
resulting in 118 pairs.
2.4.2 Assignment of introns to protein sequences
Intron-exon boundaries were assigned by m apping protein sequences to 
the hum an and murine genome assemblies (Hum an genom e build  31 from 
the National Center for Biotechnology Information (Lander et ai ,  2001) and 
M ouse genome release 3 from the M ouse Genome Sequencing Consortium  
(Waterston et at., 2002)), using the BLAT server (Kent, 2002). W hen using 
am ino acid sequences in this work, introns are defined as the residues cor­
responding to the left hand side of the boundary at the DNA level. IEBs 
in hom ologous proteins are defined as conserved if they occupy the same 
place in a structural alignment of those proteins. Phases of exons at IEBs 
were obtained by dividing the genomic position of the last DNA base of 
each exon by three and calculating the modulus.
2.4.3 Secondary structure assignment
Secondary-structure of proteins was assigned using the program  DSSP 
(Kabsch and Sander, 1983). Protein structure figures were prepared using 
Rasmol (Sayle and Milner-White, 1995), Molscript (Kraulis, 1991) and VMD 
(H um phrey et at., 1996).
Chapter 2. Exon arrangement and protein structure 55
Interface area = (SASa+SAS B) - SASab
Figure 2.5: A schematic diagram of domain A and domain B forming a complex. Solvent 
accessible surface area is calculated for each domain separately and for the whole com­
plex. A change in the accessible surface area indicates a buried surface area (coloured 
red) and thereby interaction between the domains.
2.4.4 Structural conservation and IEBs
Proteins were aligned by structure using the program  Msuper, which 
was developed for progressive m ultiple structure alignment (Gerstein and 
Levitt, 1996; Russell and Barton, 1992) in the Biomolecular M odelling Lab­
oratory. The level of structural conservation, or variability, was based on 
M super's alignment scores for each column of structurally aligned residues, 
centering on the distance between atoms, ranging from 0 (close structural 
alignment) to 9 (distant alignment) and /-/ where structural alignm ent was 
not possible.
2.4.5 Domain contacts from PDB structures
A database of protein domain interfaces was created by the following ap­
proach: experimentally determ ined structures were retrieved from the PDB 
and each of the structures was split into domains using information from 
SCOP. Domain-domain contacts were detected by systematically rem oving 
one domain at a time from each protein structure. The exposed surface 
area was then calculated using Naccess (h ttp ://w o lf .b m s .u m is t.a c .u k / 
naccess), which estimates the accessible area when a probe with a radius 
of 1.4A (the radius of a H 2O molecule) is rolled around the van der Waals
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Figure 2.6: A schematic figure of two multi-domain proteins (one lilac, the other yellow) 
bound in a complex. The solvent accessible surface area is calculated for the complex 
as a whole and then one domain is removed at a time and the accessible surface area 
recalculated. Removing a domain exposes contact residues on remaining domains and 
these contacts are identified by recalculating the accessible surface area. This process is 
repeated for all domains in both proteins (domain removal is indicated by a star) and 
the domain-domain contacts recorded. Inter-chain contacts are distinguished from intra­
chain contacts (shown as red and blue patches respectively).
surface of the dom ain (see Figure 2.5). Any change in the solvent accessible 
surface area (ASA) of a domain when an adjacent dom ain is rem oved indi­
cates a buried surface area and thereby an interaction between two dom ains. 
Once this has been calculated for a domain, it is replaced on the complex 
and the calculation then proceeds to the next domain, see Figure 2.6 for an 
illustration. Residues participating in a dom ain-dom ain contact were classi­
fied as 'core' if completely buried in the interface or 'peripheral' if partially 
exposed to solvent. All available structures in the PDB were processed in 
this way and stored in a relational database (see Figure 2.7 for an example 
of the information recorded for a complex).
2.4.6 Distinguishing obligomers from transient complexes
When examining PDB files containing more them one polypeptide chain, it 
is not obvious whether chains making contact form obligatory or nonobliga- 
tory complexes. The terms were first defined by Jones and Thornton (1996)
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(A)
T cell p-chain
Superantigen 
Staphylococcus enterotoxm C3
T cell p-chain Superantigen 
Staphylococcus enterotoxin C3
493 A2
2245 AM I  2245 A'
Total interface area: 1248 A
SCOP superfamily domains: 
^  Immunoglobulin 
0  Bacterial enterotoxins 
0  Superantigen toxins
(B)
Header and interaction type
POB SfMCfeS Contact
type
l j c k 4 9 1 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 491 2 8 KXT
l j c k 491 2 8 EXT
l j c k 491 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 491 2 8 EXT
l j c k 491 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 4 91 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 4 9 1 2 8 EXT
l j c k 4 91 2 8 EXT
l j c k 4 91 2 8 EXT
l j c k 4 91 2 8 EXT
Domain Domain Domain Chain
superfamily start end
487 2 6 3 1 17  A
487 2 6 3 1 1 7  A
487 2 6 3 1 1 7  A
4 8 7 2 6 3 1 1 7  A
4 8 7 2 6 3 1 1 7  A
4 8 7 2 6 3 11 7  A
4 8 7 2 6 3 1 1 7  A
4 8 7 2 6 3 11 7  A
4 8726 3 11 7  A
4 8 7 2 6 3 1 1 7  A
4 8 7 2 6 3 1 1 7  A
4 8 7 2 6 3 11 7  A
4 8 7 2 6 3 11 7  A
4 87 2 6 3 1 1 7  A
4 8 7 2 6 3 11 7  A
4 3726 3 11 7  A
Domain
superfamily
Domain
start
Domain
end
Chain
5 0 2 0 3 1 1 21 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 1 2 1 B
502 0 3 1 12 1 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 121 B
5 0 2 0 3 1 12 1 B
5 0 2 0 3 1 1 2 1 B
50203 1 121 B
5 0 2 0 3 1 12 1 B
5 0 2 0 3 1 1 21 B
Contact area on B
Contact
residue
Residue
number
Contact
(A*)
VAL 101 0 .1 3 0
GLY 102 1 8 .6 2 8
LYS 103 3 5 .3 0 4
VAL 104 4 9 .7 3 1
THR 105 4 .3 6 7
SER 106 4 3 .8 3 4
THR 18 1 0 .2 0 9
OLY 19 1 4 .2 9 5
THR 2 0 5 9 .9 7 4
OLY 22 0 .5 3 0
ASN 23 4 8 .9 5 4
TYR 26 3 8 .7 3 7
LEU 58 2 7 .9 5 3
ASN 60 4 2 .3 3 2
TYR 90 3 2 .1 5 6
VAL 91 7 1 .8 6 2
Total domain-domain contact: 498.998
Figure 2.7: (A) The structure of a superantigen-T-cell complex (PDB ID: 1JCK) with the 
atomic details of contacts of both molecules shown (left) and a schematic diagram of the 
same complex (right), showing the domain composition and residue numbers. The ar­
rows represent contacts between domains, showing the exposed surface on the target 
domain (arrow head) when the binding domain (arrow tail) is removed. Intra-chain con­
tact is shown in blue and inter-chain contact in red. (B) An example of the database entry 
for the immunoglobulin-enterotoxin domain interaction. The table shows details such as 
the species (49128=human) and the type of interaction (EXT=inter-chain contact) as well 
as domain information for both interacting domains (SCOP id 48726 for Immunoglobu­
lin and 50203 for Bacterial enterotoxins). Finally, the contact area is shown with residue 
details.
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and refer to whether chains are necessarily and perm anently  bound, to form 
a multimeric complex that functions as a cellular m achine (obligomer), or 
transiently bound w here the proteins are functional on their ow n—and in­
teraction is brought about by tem porary connection (nonobligomer). It was 
therefore necessary to process the PDB files to differentiate between the two 
since the intention here w as to examine nonobligatory complex interfaces. 
The two groups were separated by applying a m ethod proposed by Ofran 
and Rost (2003). Their m ethod builds on the observation that experts exam ­
ining a functional complex tend to submit the sequences of all the polypep­
tide chains that form the complex in a single file to Swiss-Prot. Conversely, 
they proposed that if a single chain is functional on its own, experts tend 
to submit the chain to Swiss-Prot in a separate file. Thus, by com paring the 
PDB against Swiss-Prot, it is possible to distinguish transient interactions 
from perm anent interactions: contacts between chains in a PDB file that 
appear w ith the same Swiss-Prot id were classified as perm anent interac­
tions and omitted and contacts between PDB chains that appear in different 
Swiss-Prot files were classified as transient interactions and taken forward.
Domain information for all chains were obtained from SCOP (v. 1.63), 
and to avoid bias against well studied proteins, close hom ologues (sequence 
similarity > 40%) were rem oved using information from ASTRAL (Chan- 
donia et al., 2004b).
2.4.7 Sequence conservation assessment
PSI-BLAST sequence sim ilarity searches (Altschul et al., 1997) were run 
for each sequence in the hum an, mouse and rat data set against the non- 
redundant NCBI protein sequence database (9 N ovem ber 2003). Hits w ith 
sequence coverage > 80% and sequence similarity >  20 % were taken for­
ward. PSI-BLAST param eters were set to the following values: m axim um  
num ber of passes, j  = 3; Expectation value, e =  1.0; E-value threshold for 
m ultipass, h =  0.0005; and m axim um  num ber of alignm ents, b = 100,000. 
Complete sequences were retrieved for each hit using Fastacmd from the 
BLAST package.
A maximum of 250 sequences, equally distributed through the hom ol­
ogy hits were then aligned by CLUSTAL W (Thompson et al., 1994). Intron- 
exon boundaries were m apped onto the alignm ents and sequence conserva­
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tion scores were calculated for each column, using the sequence w eighted 
matrix method proposed by Valdar and Thornton (2001b) for quantifying 
residue conservation in the m ultiple sequence alignm ent.
A weighted sum of all pairw ise similarities betw een all residues in a 
position, i is given by the Cons(i) equation:
„  , .x E yN E ^ t < v ^ M ( S/( /) ,St(/))
C° ',S(,) =   r N F N ----------- ' (2-D
where M is a normalised substitution matrix w ith a range of [0,1]; M(a,b)  
is the element (a, b) in the matrix M, showing the sim ilarity betw een amino 
acids a and b; N  is the num ber of sequences in the alignm ent; and S j ( i )  
and Sjt(/) are the amino acids at alignm ent position i of sequences Sj and 
respectively. Wj and w% are the w eights of sequence Sj and s*, respectively 
and given by
 ^ N
Wj =  TT— r E Disf(s/ 's*)' (2-2)
k^j
where Dist(sj,sj() is the evolutionary distance between sequences sy and sp.
and Alignedjk is the set of all non-gap positions in sj or s^, and n( Alignedjk)  
is the num ber of such positions.
The matrix used for the above calculations provides inform ation on the 
likelihood of amino acids in aligned positions. Several such m atrices are 
available, for instance PET91, the Pairwise Exchange Table (Jones et al., 
1992), which was used in this work. Gaps in the PET91 substitution m a­
trix were replaced with zeros and the matrix normalised to the range of 0-1 
as described by Karlin and Brocchieri (1996):
M i i ’ k) =  W  {2A)x M '(k ,k )
where M( j ,  k) is the normalised value of M f in position (j, k). The weight of 
each sequence was calculated based on the distribution betw een sequence 
pairs derived from the norm alised substitution matrix and the conservation
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score for each column calculated.
The data pertaining to dom ains and  protein interfaces were retrieved 
from the dom ain contact database described in Section 2.4.5, and m apped 
onto the sequence alignments for further statistical analysis (see A p­
pendix A for a review of some of the statistical m ethods used in this work).
2.5 Results and Discussion
In order to assess the effect of intron-exons boundaries on dom ain structure, 
the set of 684 single-domain hum an and mouse protein structures from the 
PDB was subjected to the following investigation.
2.5.1 Secondary structure at intron-exon boundaries
An analysis was performed to com pare the composition of secondary struc­
tures (1) at intron-exon boundaries and (2) away from boundaries. The re­
sults, shown on the left-hand side of Table 2.1, show a significant preference 
for IEBs to exist in coil regions of proteins and less inside ^-helices and  ex­
tended ^-strand elements. This could indicate that insertion of introns into 
sections of ordered structure, for instance ft-helices and /3-sheets, is likely 
to affect the overall structure and function, which in return affects the fit­
ness of proteins in natural selection terms. Also, even w hen boundaries 
occur w ithin strands and helices, they tend to be close to the end of their 
secondary structure element, as show n in Figure 2.8. This is especially ap­
parent for non-conserved IEBs in extended strands (see Figure 2.8(A)) and 
supports the idea that boundaries occur in less-ordered areas.
The question now arises w hether the observed secondary structure bi­
ases could reflect different types of introns. Introns appearing in proteins 
as a result of late exon duplications and insertions have a phase class that 
is identical w ith that of the recipient intron (Patthy, 1987). An analysis of 
phase classes of exons and their boundaries (see the right-hand side of Ta­
ble 2.1) does not indicate any correlation between the phasing of exons and 
the secondary structure of IEBs. This, however, does not imply that phases 
are not conserved in particular genes, since we are com paring m any dif­
ferent proteins from different genes. Splice variants w ithin proteins could
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Figure 2.8: The probability of intron-exon boundaries appearing at the ends of (A) ex­
tended /5-strands and (B) a-helices. Ends are defined as the first or last 5% of the sec­
ondary structure element length. Red columns show the observed frequency of bound­
aries in ends of secondary structure elements and purple columns show the expected 
frequency. The left-hand side pair of columns in each graph shows statistics for all ex­
ons, whereas the right-hand columns show statistics for a subset of exons that are con­
served between human and mouse. The differences are significant according to ^ 2-test 
(p 0.0001 for all exons in extended strands and helices, N  = 450 and 579, respectively, 
and p < 0.005 for conserved exons in extended strands and helices, N  =  62 and 60, 
respectively).
End-boundaries in helical structures
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Table 2.1: Observed and expected frequencies of IEB within DSSP assigned secondary 
structure elements. Coil, extended strand and helical structures are identified by the 
letters C, E and H, respectively. The total number of intron residues is 2,447, out of a 
total of 116,740 residues. The most significant differences are highlighted in bold. The 
observed differences between the observed frequencies and the expected according to 
the background are highly unlikely to be random, according to a ,y2-test with 7 degrees 
of freedom (p 0.001). The three right columns show the phase of the preceding exon 
for each IEB. We found no overall differential distribution of IEBs with respect to exon 
phases.
Secondary structure f o b s / kxP Difference Phase 0 Phase 1 Phase 2
C - No SSE (loop) 776 544 +43% 279 262 235
C - Isolated /3-bridge 29 31 -6% 10 9 10
C - H-bonded turn 308 288 +7% 106 111 91
C - Bend 260 265 -2% 90 72 98
E - extended /3-strand 430 537 -20% 130 148 152
H - a-helix 570 702 -19% 199 174 197
H - 3io-helix 73 80 -9% 27 22 24
H - 5-helix 1 0 - 0 1 0
potentially show a correlation w ith secondary structure at IEBs—however, 
the data contained only 24 IEBs in alternatively spliced areas, which is in­
sufficient for a thorough statistical analysis.
2.5.2 Local structural variability at intron-exon boundaries
The relationship between conservation of structure and IEBs was studied 
by m apping the boundaries on pairs of hom ologous hum an and m ouse 
PDB structures w ith a pairw ise sequence identity >  40%. These pairs were 
structurally aligned and a w indow  of seven residues was moved along the 
superposition. The fitness of the alignm ent (a score based on the distance 
between atoms) was recorded for each of the seven positions. The sec­
ondary structure of each position was determ ined using DSSP, as before, 
and the window scores for each of the three secondary structure elements 
(ft-helix, /3-strand and coil) were then norm alised and the scores for each 
class of secondary structure elements at boundary positions compared w ith 
the overall expected scores.
The structure conservation of boundaries in coil regions and helices was 
not found to differ significantly from the expected values, see Figure 2.9.
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Figure 2.9: Standardised structural variability scores (standard deviations from the
mean) for windows of seven residues running over the whole length of pairs of struc­
turally aligned sequences. Windows containing IEBs (red columns) and windows not 
containing IEBs (purple columns) were compared, classified by the type of secondary 
structure; coil, a-helix or /5-strand. High scores indicate more variation in structure be­
tween the two structurally aligned sequences and low scores less variation than expected 
in the sequence. The distributions of coils and helices were not significantly different 
according to an independent t-test (p =  0.17 and 0.25 respectively). The distribution of 
strands revealed, on the other hand, a small but significant difference between IEB and 
non-IEB residues (p =  6.0 x 10-6). The standardised deviate (or z-value) is given by 
z  =  where x is the original structural similarity score, p  is the mean and cr is the 
standard deviation.
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There was an increase in the structural variability of strands containing 
intron-exon boundaries (p =  6.0 x 10~6), however, it w as small (0.5 stan­
dard deviations).
The boundaries do not, on the whole, coincide w ith the more structurally 
divergent regions of pairs of hom ologous proteins. Hence, the reason why 
these boundaries are found preferentially in coils and at the ends of a:-helices 
and jS-strands is not clear, bu t it is perceivable that it is to allow variable 
packing of exons. To assess this, the packing of exons was com pared in 
hom ologous proteins.
2.5.3 Packing of exons using structural alignments
A m ethod based on structural alignm ents was used to assess w hether exons 
can have alternative packing arrangem ents w ith 'h inge ' points located at 
intron-exon boundaries. For this study the previously described set of ho­
mologous hum an-m ouse sequence pairs was used. Each pair w as initially 
aligned by sequence and two adjacent windows, representing two exons of 
an average length (43 residues for this sample), were shifted along the se­
quence pairs, and a structural alignm ent then perform ed by superim posing 
the two left-hand exons on each other, carrying over the structure of the 
right-hand exons as rigid bodies.
Flexibility at each position was assessed as the angle betw een vectors 
from the N-terminus to the centre of geometry of each of the right hand 
exons (see inset in Figure 2.10). This angle was used as an indication of the 
structural deviation between the pair at each point. No significant difference 
(p = 0.77) was found in the distribution of angles at IEBs com pared with the 
background distribution as show n in Figure 2.10. This w ould suggest either 
that evolution does not favour increased diversity of packing between ho­
mologous exons, or that the m ethod that was used was not sensitive enough 
to pick up potential hinge points in the boundary locations.
2.5.4 Intron-exon boundaries and their relation to domain 
interfaces
Interaction sites of proteins have been extensively analysed, focusing on 
physicochemical and geometrical properties such as solvation potentials,
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Figure 2.10: Distribution of standardised normal deviates of angles in intron-exon
boundaries (yellow) and the background (grey) with a mean value of 8.1 degrees and 
standard deviation of 6.7 degrees. Greater z-values represent higher degree of variability 
between a homologous pair at a specific position. There is not a significant difference 
between the samples (p  =  0.77 for an independent t-test). The insert shows a schematic 
diagram of the calculation on a pair of proteins consisting of two exons. Centres of geom­
etry are depicted. By superimposing the left-hand exons and carrying over the right-hand 
exons as rigid bodies an angle, <x, can be measured.
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residue propensities, hydrophobicity, solvent accessible surface area and 
protrusion (see e.g. Jones and Thornton (1997); Lo Conte et al. (1999); Ofran 
and Rost (2003); Nooren and Thornton (2003)). A lthough the location of al­
ternatively spliced sequence in relation to protein interaction sites has been 
examined (Offman et al , 2004; Neverov et al., 2005), the arrangem ent of 
intron-exon boundaries in interfaces has, to our knowledge, not been s tu d ­
ied. A further investigation of intron-exon boundaries was therefore car­
ried out, focusing on the IEBs and interfaces of protein complexes. It w ould 
seem feasible that, through evolution, the arrangem ent of introns and  exons 
w ould be affected by evolutionary constraints, particularly at protein  inter­
faces as they are vital for protein function. Figure 2.11 shows one such ex­
ample: a complex between tum our-suppressor p53 and its b inding partner, 
w ith an intron-exon boundary situated in the interface of the p53 binding  
protein highlighted.
For this study a new set of hum an, mouse and rat hetero-com plexes 
(N  = 135, 22 and 13 respectively) w ith know n structures and sequence 
similarity less than 40% was assembled from the ASTRAL database. The 
study was limited to these three species due to limited data on introns and 
exons in the BLAT database. The sequence similarity criterion w as im posed 
to avoid any possible bias in the data, owing to the nature of the PDB, 
where some protein families are underrepresented while others are overrep­
resented. Intron-exon boundaries were m apped onto the structure as before 
(see Section 2.4.2), and this inform ation was related to interface data  by us­
ing the previously constructed database of dom ain-dom ain interactions.
Figures 2.12 and 2.13 show the sequences for the hum an, rat and m ouse 
p53 tum our suppressor and it's binding partner p53BPl. The positions 
of intron-exon boundaries are relatively well conserved for these close ho- 
mologues. Interface residues are indicated above the sequence alignm ent, 
dem onstrating that all species contain one IEB in a protein binding site. This 
intron-exon boundary at residue 120 (hum an sequence num bering) sepa­
rates exon three and four in the p53 binding protein and structurally it ap ­
pears at the edge of the interface, see Figure 2.11.
The initial question to be asked was: Do intron-exon boundaries oc­
cur w ith higher or lower frequency at interfaces than could be expected 
by chance? As shown in Table 2.2, the distribution of IEBs is neither bi-
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BRCT region of 53BP1 Tumor suppressor p53
Figure 2.11: The exon structure of the tumour-suppressor protein p53 and its binding 
partner, 53BP1. Exons participating in the binding are shown with larger structural el­
ements than those not involved in binding. Two exons from p53 (orange and red) and 
one from the BRCT region of 53BP1 (blue) form the protein-protein interface. One in­
tron/exon boundary from 53BP1, depicted as a solid yellow sphere is located at the edge 
of the interface.
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Figure 2.12: p53 Tumour Suppressor alignments for human, rat and mouse. Intron-exon 00
boundaries are highlighted red in the sequences. Protein interface residue ranges (core 
and periphery) are shown in blue above the sequence alignment.
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Human AYQ CLLIA DQH CRT RK YFL CLA SGI PCV SHVW VHDSCHANQLQNYRN YLLPA GYSLE EQRIL DW 0PR ENPFQ NLK 150
R a t  AYQCLLIADQHCR TRK YFL CLA SGI PCV SHV WVHDSCHANQLQNYRNYLLPAGYSLEEQRILDW QPRENPFQNL(3 136
Mouse  AY QCL LI ADQ HCR TRKYFLCLASGI PCV SHVW VHDSCHANQLQNYRN YLLPA GYSLE EQRIL DW 0PR ENPFQ NLK 514
Human VLLVSDQQQNFLELWSEILMTGGAASVKQHHSSAHNKff l lALGVFDVVVTDPSCPASVLKCAEALQLPVVSQEWVI 225
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Human QCLIVGER IGFKQ HPKYKHDYVSH  249
R a t  QCL IVGER IGFQQ HPK YKHDYVSH 235
Mouse  QCLIVGER IGFKQ HPKYKHDYVSH  613
Figure 2.13:
p53 Binding Protein 1 alignments for hum an, rat and mouse. Intron-exon boundaries are highlighted red in the 
sequences. Protein interface residue ranges (core and periphery) are shown in blue above the sequence alignment.
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Table 2.2: Frequencies of IEBs in interfaces vs. outside interfaces for both core interface 
(residues completely buried in the interface) and total interface (core and periphery). 
Observed values are compared with values expected, given a random distribution of 
IEBs. Expected values were calculated by multiplying the total number of IEBs by the 
ratio of amino acids in an interface over the total number of residues.
Core interface Total interface
fobs / e x P Difference / Qbs / Exp Difference
H um an
IEBs in interface 9 13 -30.8% 143 142 +0.7%
IEBs not in interface 627 623 +0.6% 493 494 -0.2%
Mouse
IEBs in interface 1 2 -50.0% 26 23 +13.0%
IEBs not in interface 87 86 +1.1% 62 65 -4.6%
Rat
IEBs in interface 0 1 -100.0% 18 18 0%
IEBs not in interface 91 90 +1.1% 73 73 0%
ased away or towards protein interfaces. This can be seen both for IEBs in 
the total interface, defined as core and  periphery residues, (p =  0.76) and 
core interface (interface consisting of completely buried residues), although 
there appears to be a very slight trend for IEBs to appear away from the 
core, but this observation is not statistically significant (p = 0.25).
2.5.5 Intron-exon boundaries and sequence conservation
In previous studies, residues in protein interfaces have been show n to ex­
hibit a higher degree of conservation com pared w ith those outside the in­
terface (Valdar and Thornton, 2001a; Huan-Xiang and Yibing, 2001). The 
findings described in the previous section indicate that IEBs are statistically 
unbiased towards or away from protein interfaces, bu t how do IEBs relate 
to sequence conservation in general?
To answer this question, the sequence conservation of the hum an, mouse 
and rat functional complexes was calculated as described in the M ethods 
section. A window of 5 colum ns (current position ±2  columns) was shifted 
alongside the multiple alignm ents and average conservation score calcu­
lated alongside the scores at w indow  positions around IEBs. The m ean se­
quence conservation score for IEB w indow s was 0.52 com pared w ith 0.83 
overall, which indicates that intron-exon boundaries have a preference for
Chapter 2. Exon arrangement and protein structure 71
C onserved
Conserved
18%
V ariable
Variable
62%
Figure 2.14: Frequency of intron-exon boundaries classified by the level of conservation 
in a set of homologous sequences. Up to 250 homologous sequences were aligned and 
the placement of IEBs was classified according to the nature of sequence conservation: 
conserved (no gaps in alignment), loop (some gaps) and edge (no gaps, but adjacent to 
gap columns).
less conserved regions of proteins.
The placements of boundaries in relation to conservation were investi­
gated further by studying the sequence alignments. Each colum n in the 
alignments was classified in one of the three following groups: 'conserved ' 
(no gaps in current column and no gaps in the closest two colum ns on ei­
ther side), 'edge' (no gaps, but adjacent (±2  columns) to a colum n w ith one 
or more gaps) and 'variable' (one or more gaps in current column). Using 
these classes, it becomes apparent that the majority of IEBs (62%) reside in 
variable regions of the alignment (see Figure 2.14). A further 20% of IEBs are 
observed in regions close to gaps, which brings the percentage of gap and 
near-gap IEBs to 82%. This high percentage of gap-associated IEBs agrees 
with the overall lower sequence conservation score in IEB locations, and 
also w ith the enrichment of IEBs in structural loops, shown previously in 
Table 2.1, as gap regions in sequence alignments often indicate structurally 
variable loop regions.
The results shown in the previous section indicated that intron-exon 
boundaries have no correlation with protein interfaces. It is therefore inter­
esting to turn  the attention to the exons themselves and the relationship be­
tween exon conservation and interface participation. Focusing specifically 
on a subset of exons that make up the protein interface, the exon interface
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Figure 2.15: Conservation of exons in interfaces of proteins, as a function of interface 
coverage of the exon. Constitutively spliced exons are shown in blue and alternatively 
spliced ones in red. Spearman's rank coefficient for alternatively spliced variants was 
found to be lower than for constitutively spliced ones (ps =  0.57, p — 4.57 x 10~4).
coverage (i.e. the proportion of an exon that forms an interface) was exam ­
ined to establish w hether a correlation to sequence conservation, as calcu­
lated from the sequence alignments, could be observed. A m oderately high 
correlation was found between interface coverage and exon score, m easured 
by Spearman's rank coefficient, ps =  0.81 (see Figure 2.15). This observation 
is significant (p =  6.52 x 10-131) and agrees w ith the general observation 
that conserved residues are more likely to be found at protein interfaces 
(Valdar and Thornton, 2001b; Grishin and Phillips, 1994), although Caffrey 
et al. (2004) more recently showed that this correlation is weaker than previ­
ously thought.
2.5.6 Splice variation in interfaces
Intron-exon boundaries are not only sites for constitutive splicing but also 
alternative splicing. Alternative splicing has been associated w ith an in-
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Table 2.3: The frequencies of splice variants in interfaces. Exons were split into to 
categories; non-interface exons and interface exons with at least one residue involved in 
an interface contact. The observed difference is significantly different (p =  1.03 x 10~4).
Frequency 
in interface not in interface 
Splice variant exons 19 (37.3%) 32 (62.7%)
Non-splice variant exons 523 (63.5%) 300 (36.5%)
creased frequency of exon creation and loss, indicating that alternative splic­
ing is used by nature as a tool for fast-tracking evolution of proteins (Mod- 
rek and Lee, 2003). It can be postulated, because of the im portance of p ro ­
tein interfaces w hen it comes to conserving function, that minimal changes 
would be expected at interfaces of hom ologous proteins. This was indeed 
confirmed by an analysis of the frequency of splice variants in the data. The 
ratio of interface splice variants to non-interface splice variants was found 
to be substantially lower than expected: 37.3% vs. 62.7% com pared w ith  
63.5% and 36.5% for non-splice variant exons (interface and non-interface, 
respectively), see Table 2.3. These results are based on a very limited set of 
protein structures and should be taken w ith some caution until more struc­
tural data becomes available to verify the findings.
2.6 Conclusions
The results presented in this chapter suggest an evolutionary feedback 
mechanism between natural introns and the effect they have on protein 
folds and interaction sites. We observed an enrichm ent of intron-exon 
boundaries in coils and the ends of secondary structure elements. This 
fact suggests an evolutionary model in which the position of introns is 
constrained by protein structure, particularly by tertiary structure contacts. 
W hamond and Thornton (2006) have recently proposed a reversed relation­
ship, i.e. that a nucleotide bias at intron locations produces secondary struc­
ture bias around introns through the coding of residues such as glycine and 
aspartic acid, which are frequently found in coiled regions. It is not possible 
to exclude one or the other based on these findings, and further studies com ­
bining structural, genomic and evolutionary aspects of introns w ould be
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needed to resolve the question. In relation to the introns early /la te  debate, 
the findings cannot rule out either theory. Some results seem to support an 
early origin of introns (such as secondary structure preferences), w hilst o th­
ers could be taken as evidence for their late origin (for example, both pack­
ing and structural variability results). Furtherm ore, older and newer introns 
were not distinguishable in the data set, since only hum an  and m ouse data 
w ere used for the analysis. Overall, the results agree w ith  a model in which 
both theories are compatible (de Souza et al ,  1998; Fedorova and Fedorov, 
2003).
In addition to the structural environm ent of IEBs, intron-exon arrange­
m ent was examined in the context of sequence conservation. Boundaries 
were shown to have a preference to exist in areas of low er conservation and 
therefore have a particular tendency to appear in, or near, gaps in align­
m ents of homologous sequences. Remarkably, the intron-exon boundaries 
studied here do not show a tendency to avoid interfaces, be it core or total 
interface, although sequence conservation is generally a feature of binding 
sites—particularly so in core residues of binding. Indeed, exons in protein 
interfaces seem to be subject to conservational constraints, reflected in the 
observation that the larger the proportion of an exon in an interface the more 
highly it is conserved. Conversely, alternatively spliced exons were found 
to avoid protein interfaces w hen they were com pared w ith constitutively 
spliced exons. This may stem from the deleterious effect alternative splicing 
m ay have on proteins' function, should splicing take place in an interface.
Taking an introns-early view, the arrangem ent of genes into exons is 
a way of facilitating m odulation of protein function. Exons thus pro­
mote functional diversity by allowing recom bination and shuffling of func­
tional m odules—leading to a quicker evolutionary adaptation. Intron- 
exon boundaries, particularly those surrounding alternatively spliced ex­
ons, could then be seen as hot-spots for recom bination and thus less likely 
to appear in protein interfaces. The underrepresentation of alternatively 
spliced exons in interfaces w ould support this view.
The exon arrangem ent should also be looked at in a broader view, since 
m any proteins rely on a precise arrangem ent of m ultiple exons, not just in 
the binding site but also in the vicinity of the interface. Any rearrangem ent 
of exons may dramatically affect protein folds and hence the function. An
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Figure 2.16: The exon structure of the human Trypsin IV (PDB code 1H4W), bound to 
a benzamidine inhibitor in the active site. The four exons that that form the protease 
are shown in different colours. It is evident that the arrangement of all four exons is 
important for forming the active site. Figure created using Molscript (Kraulis, 1991).
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example of this is the hum an Trypsin IV, which specificity is determ ined by 
an extended area of binding, not just the core binding site (Katona et cil, 
2002). The four exons that constitute this enzyme are show n in Figure 2.16 
in different colours. Two of the four IEBs are in close proxim ity (<  7A)  to the 
catalytic site. Clearly, the binding site is the result of the precise packing of at 
least three exons and thus the function of the protein depends on the correct 
m odulation of the exons. Any m odification at the IEBs w ould therefore be 
likely to have a direct effect on the enzym e's function.
One of the questions pu t forw ard at the start of this chapter w as w hether 
the location of intron-exon boundaries could be used to help w ith validating 
or predicting binding sites on proteins. This was proposed on the assum p­
tion that, owing to a relatively high conservation, splicing sites w ould be 
avoided in protein interfaces. IEBs w ould  then be usable to indicate reduced 
probability of binding in their area. In this work, it has been show n that this 
is generally not possible, although inform ation on location of splice variants 
could be used as one com ponent of predictive m ethods using Bayesian or 
SVM analysis for building networks, as they were show n to avoid protein 
interfaces.
Chapter 3
I n  s i l i c o  construction of 
interactomes
3.1 Predicting protein interactions
The analysis of protein netw orks is dependent on a reliable assignm ent 
of protein-protein interactions. Protein-protein interactions are com m only 
studied using biochemical techniques, and several different experim ental 
m ethods are currently in use. Two-hybrid screens have, to date, yielded the 
bulk of available data (Uetz et al ,  2000; Ho et al., 2002); however their level 
of accuracy is not particularly high and  they should be supported by add i­
tional evidence (Sprinzak et al ,  2003; Bader and Hogue, 2002). Advances 
in other techniques, such as tandem -affinity purification and m ass spec­
troscopy, have also m ade large-scale studies increasingly feasible (Gavin 
et al ,  2002; M ann et al ,  2001).
A num ber of com putational m ethods, either based on sequence or 
structural features, have been developed to complement experim ental ap ­
proaches to predicting protein-protein interactions (Park et al ,  2001; Valen­
cia and Pazos, 2002). An increasing em phasis has been on deducing and 
exploring the protein-protein interaction netw orks that are reflected in ex­
pression data; gene networks have been inferred from gene expression data 
using mathematical analysis such as Bayesian regression (Bader et a l ,  2004; 
Brazhnik et al ,  2002; Rogers and Girolami, 2005; Jansen et al ,  2002b). M ore­
over, networks have been derived by com plem enting gene expression data 
with data from different sources, such as gene ontologies, phenotypic p ro ­
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filing and functional similarities (Jansen et al., 2002a; G unsalus et al., 2005; 
Lu et al., 2005; Rhodes et a l ,  2005). Alternative techniques to netw ork con­
struction have also been taken, see for instance Cabusora et al. (2005), w ho 
created a m ap of interacting proteins based upon  the principle that inter­
acting protein m odules in one organism may be fused into a single chain 
in another, and Calvano et al. (2005), w ho constructed the netw ork by liter­
ature searches for inform ation pertaining to interacting protein pairs from 
closely related organisms.
This chapter describes the approaches taken to predict extensive protein- 
protein interaction netw orks in three species. Predicting protein-protein in­
teractions for entire genomes yields a great am ount of data that can only 
be analysed effectively once it has been pu t into a manageable form. An 
efficient way is to store the data in a relational database, and this chap­
ter describes the construction of such a database for three key organism s. 
However, large sets of data are not useful unless there is a way to explore 
and analyse them, and w ith this in m ind an interactive web server w as con­
structed to facilitate a visual exploration of the predicted protein interac­
tions.
3.2 Relational databases
The am ount of biological data scientist have to deal w ith in their studies 
increasingly requires systematic storage and access solutions. Databases 
have therefore become essential tools for biologists and biochemists, as well 
as bioinformaticians, w ho often deal w ith sizable aggregated data. Sev­
eral different commercial Database M anagem ent Systems (DBMS) are avail­
able on the market; nevertheless the scientific com m unity has m ainly m ade 
use of the open source and freely available solutions for data m anagem ent: 
MySQL (www.mysql.com) and PostgreSQL (w w w .postgresql.org). An im ­
portant aspect of these DBMS is that they can be queried through a universal 
standard language (Structured Query Language, or SQL).
A database not only has to store data, but it m ust also contain inform a­
tion about the connection between the various aspects of the data it con­
tains. So before designing a database for any kind of data, the relationship 
between various data items has to be identified. This is often not a trivial
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task as there are usually several ways in which a set of data can be organ­
ised. Well designed databases are fundam ental to efficient and accurate data 
retrieval and care m ust be taken to organise the structure of the database to 
avoid unnecessary duplication of data that can lead to inconsistency w hen 
the data is changed or deleted.
The relational model, proposed by Codd (1970), is the m odel on which 
most current database system s are based. Due to their structure, relational 
databases offer a fast and reliable mechanism for retrieving, updating  and 
inserting data. The relational m odel is based on two m ain elements: the 
relation and the table, which differ in their nature. The tables contain the 
data which is divided into entities and attributes. A protein is an example 
of an entity and its attributes are used to provide description, such as the 
molecular weight, isoelectric point and so on. The attributes make up  the 
colum ns in the entity table and w henever new data is added  to a table (e.g. 
inform ation on a new protein) a new row is inserted.
The concept of relation stem s from a formal m athem atical definition in 
set theory but effectively it describes how data in one table is related to 
another table. It is custom ary to assign an identifying colum n (prim ary key) 
that contains a unique identifier to each row. Relationships are achieved 
through the use of foreign keys that refer, or point, to prim ary keys in a 
different table, and tables are said to be joined w hen a reference between 
keys in separate tables are followed. Relationships can fall into one of the 
following three classifications (Atzeni et a l, 1999):
3.2.1 One-to-one relationships
A One-to-one relationship describes an association betw een two tables that 
are related in such a way that a single row in one table is linked to a single 
row in another table (i.e. a reciprocal relationship). If there are two instances 
of two entities (A and B) called A t and B„ then a one-to-one relationship 
exists if at all times A, is related to no instances of entity B or one instance 
of entity B, and B, is related to no instances of entity A or one instance of 
entity A. One-to-one relationships are infrequently used as they are easily 
incorporated into a single table.
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3.2.2 One-to-many relationships
The m ost common type of relationships is the one-to-m any relationship, 
and as a m atter of fact, m ost databases consist solely of these relations. A 
One-to-m any relationship denotes a link from a prim ary key in a single row 
in one table to many foreign keys (i.e. m any rows) in another table. If we 
have instances of two entities (A and B), then a one-to-m any relationship 
exists betw een two instances (A, and B/) if A, is related to zero, one, or more 
instances of entity B and B/ is related to zero or one instance of entity A. 
These relationships are unidirectional.
3.2.3 Many-to-many relationships
M any-to-many relationships are also very common in real life bu t they pose 
problem s in database design and are usually resolved to one-to-m any re­
lationships through an interm ediary table. A m any-to-m any relationship 
exists between entities A and B if for tw o instances of those entities (A/ and 
B/), A, can be related to zero, one, or more instances of entity B and B/ can 
be related to zero, one or more instances of entity A. In database schemas, 
m any-to-m any relationships are converted by a collection of one to many 
relationships through a third table, often referred to as com posite entity ta­
ble.
3.2.4 Normalisation and table design
The quality of the database design can be assessed by rules, know n as nor­
mal forms. Each normal form represents an increasingly stringent set of 
criteria that aim to eliminate redundancies of data, which can cause unde­
sirable behaviour. By norm alising a database, entities are separated into 
their ow n relations, which allows m odification and deletion of data w ithout 
disturbing entities other than the one being directly modified (Atzeni et al., 
1999).
First Normal Form, INF
First normal form is defined as 'D ata stored in a tw o-dim ensional table 
w ith no repeating groups'. A repeating group is an attribute that has more
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than one value in each row, e.g.:
A  relation with repeating groups
ID Protein name Tumour types
001 KRAS2 pancreatic, colorectal, lung, thyroid
002 BRCA2 breast, ovarian, pancreatic
The above table, once rearranged in first normal form, w ould appear as 
follows:
First normal form
ID Protein name Tumour types
001 KRAS2 pancreatic
001 KRAS2 colorectal
001 KRAS2 lung
001 KRAS2 thyroid
002 BRCA2 breast
002 BRCA2 ovarian
002 BRCA2 pancreatic
Second Normal Form, 2NF
In second normal form, T h e  relation is in first norm al form and all non-key 
attributes are functionally dependent on the entire prim ary key/ i.e. there 
is one relation (or table) for each entity in the INF relation. This can be 
illustrated by the following exam ple where the relation is expressed as: 
relation (table) name, followed by the attributes w ithin parenthesis:
A  relation with mixed dependencies
experiments (first name, last nam e, date, type of experiment, protein 
found, reagent used, reagent's supplier)
Second normal form requires the above to be separated into indepen­
dent tables, such that all the entities are dependent on their prim ary key 
(the prim ary key is shown underlined):
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Second normal form
scientists (scientist id, first name, last name) 
reagents (reagent id, supplier)
experiments (experim ent id, scientist id, reagent id, date, type of 
experiment, protein found)
Third Normal Form, 3NF
Third normal form is defined as 'relation in second normal form and 
no transitive dependencies/ A transitive dependency exists w hen the 
following functional dependency pattern  is observed: A ^ B  and B—>C, 
therefore A ^ C .
A  relation with transitive dependency
reagent (item num ber, reagent nam e, d istribu to r's  name, w arehouse 
phone num ber)
This relation could be normalised in third norm al form as:
Third normal form
items (item num ber, reagent name, distributor id)
distributors (distributor id, d istribu tor's  nam e, warehouse phone
number)
Higher degrees of norm al forms exist, how ever a normalisation to 3NF is 
usually sufficient. Each degree of norm alisation involves the creation of sep­
arate tables w ith matching prim ary key and foreign key. When the database 
is queried, it has to connect these keys up for all relevant tables in an op­
eration called 'join'. As each join takes up  extra time, the querying of a 
highly normalised database slows dow n the perform ance of the database. 
The degree to which a database is norm alised is thus a balancing act be­
tween structural quality of the data and database efficiency.
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3.3 Methods
3.3.1 Prediction of protein-protein interactions
Networks of interacting proteins were constructed for the hum an, brow n rat 
(Rattus norvegicus) and fission yeast (Schizosaccharomyces pombe) genomes. 
These three species are all eukaryotes and are valuable for cancer research. 
The hum an genome is an obvious choice for hum an cancer studies and the 
rat has been chosen as it has been used as a m odel for cancer studies (Kerler 
and Rabes, 1994). The fission yeast is a m odel organism  that is fairly simple 
and contains a small set of genes, but nevertheless proves useful for studies 
into the cell cycle (Hayles and Nurse, 2001).
In an attem pt to make the netw orks as com prehensive as possible, the 
predictions were based on a large am ount of experim ental data from a di­
verse collection of species. The m ethod of prediction was based on the 
principle of orthologous interactions described by W alhout et al. (2000) and 
M atthews et al. (2001), bu t in order to im prove the quality and usefulness of 
the predictions, a procedure for assigning confidence scores to interactions 
was developed and im plem ented.
One of the benefits of the orthologous approach is the reduced noise 
in protein interaction data which allows predictions of interactions that 
would not have been detected in a single organism  (Sharan et al., 2005). 
The method identifies putative interactions based on homology to exper­
imentally determ ined interactions in a range of different species. BLAST 
sequence similarity searches were run for the hum an, rat and fission yeast 
genomes as docum ented in version 9 of the Reference Sequence Database 
(Pruitt et al, 2005) against all proteins in the DIP (Salwinski et al., 2004) 
and MIPS M ammalian Protein-Protein Interaction databases (Pagel et al., 
2005). The data from both databases were sourced from the m ost current 
releases in March 2005. The putative interactions were given confidence 
scores based on two factors: the level of hom ology to proteins found exper­
imentally to interact, and the am ount of experim ental data available. The 
confidence score, S, is given by
N
S =  £ l n ( s a,Sb>  (3.1)
/=!
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where sa/ and Sb( are sequence similarity bit scores to proteins a/ and b /, 
respectively, which have experim entally been show n to interact; n is the 
num ber of experiments linking protein a/ to protein b,-; and N  is the total 
num ber of instances w here the same pair of proteins is identified as inter­
acting through different hom ologues (if in same species) or orthologues (if 
in a different species), see Figure 3.1 for further illustration of the concept. 
As mentioned in Section 1.4.2, tw o-hybrid experim ents are prone to giving 
false-positive results. A lthough m ost of the interactions created here are de­
rived through yeast tw o-hybrid links, it has been show n that confidence is 
higher for interactions detected in m ultiple independent yeast tw o-hybrid 
experiments (Bader and Flogue, 2002; Jansen et a l,  2002a). This fact is re­
flected in the additive nature of the score, where a protein interaction that 
shows up repeatedly in independent two-hybrid experim ents gets a higher 
score.
The experimental data arises from several m ethods and the m ost fre­
quent are listed in Table 3.1. The DIP and MIPS M am m alian Protein-Protein 
Interaction databases w ere selected for the reason that they contain a large 
am ount of manually curated interaction data and do not overlap. This is 
an im portant point, as overlapping data could lead to the false assum p­
tions, for instance im plying that certain protein interactions have m ultiple 
experimental evidences, w here in fact they are the same experim ental ob­
servation, but only docum ented repeatedly in two separate databases. Such 
discrepancies would com prom ise the scoring function as it rates m ultiple 
docum ented interactions higher than single observations.
The interaction data included proteins from an extensive list of species, 
which can be seen in Table 3.2. The majority of the proteins come from three 
m odel organisms (the fruit fly, bakers yeast and worm) in addition to other 
species, mainly mam m als and bacteria.
3.3.2 ROC curve analysis
Receiver operating characteristic (ROC) analysis is frequently used for as­
sessing sensitivity and specificity of prediction methods. The ROC analysis 
builds on the outcome of the prediction, in particular on the rates of true 
and false positive identification of interactions. True positive interactions 
were sourced from the H um an Protein Reference Database (HPRD), Ver-
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Figure 3.1: (A) Each interaction is inferred from homology to experimentally observed 
interactions. In this schematic, proteins a\  and bj have been shown experimentally to 
interact in one organism, here labelled 'species X'. Lists of homologues (rat homologues 
in this example) are generated for both proteins, ranked by their bit score (saj/ Sy,., etc.). 
A protein from one list may interact with a protein from the other (shown by the red 
arrow) and potential pairwise interactions are scored according to Equation 3.1, based on 
homology to the proteins involved in the known interaction. Furthermore, interactions 
receive a higher score if they are derived from multiple experimental sources (n >  1).
(B) The score is additive, for instance, in the example above, the blue and green sequences 
are predicted to interact based on the interactions in 'species X'. If the blue and green 
sequences also share homology with experimentally determined protein interaction in 
'species Y' and 'species Z', the process is repeated and the overall score is the sum of all 
pairwise scores from Equation 3.1. This additive process continues over all experimen­
tally determined protein pairs, N,  for which the rat sequences, labelled blue and green, 
are present.
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Table 3.1: Summary of the experiments used as a foundation for building the interac­
tomes, from most frequent (top) to least frequent (bottom). The percentage of the total is 
listed after each value.
M ethod Frequency (%)
Two-hybrid test 35,759 (69.9)
Imm unoprecipitation 6,290 (12.3)
Tandem Affinity Purification (TAP) 3,503 (6.85)
Affinity chrom atography 1,070 (2.09)
Co-purification 572 (1.12)
Cross-linking 518(1.01)
X-ray crystallography 511 (1.00)
In vitro binding 452 (0.88)
Biochemical/biophysical 327 (0.64)
Gel filtration chrom atography 326 (0.64)
In vivo kinase activity assay 185 (0.36)
Competition binding 185 (0.36)
Im m unoblotting 140 (0.27)
Co-sedimentation 133 (0.26)
Gel retardation assays 106 (0.21)
Native gel electrophoresis 103 (0.20)
Other 973 (1.90)
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Table 3.2: Summary of the model organisms from which experimental data was 
sourced. The number of proteins from each organism is listed in a descending order 
in the right-hand side column (and corresponding percentages within parentheses). 
In addition, the data set included 186 proteins from 77 miscellaneous species, mostly 
bacteria.
Species N um ber of proteins (%)
Drosophila melanogaster 7,052 (39.3)
Saccharomyces cerevisiae 4,751 (26.5)
Caenorhabditis elegans 2,638 (14.7)
Homo sapiens 1,293 (7.2)
Helicobacter pylori 708 (4.0)
Escherichia coli 545 (3.0)
Mus musculus 433 (2.4)
Rattus norvegicus 182 (1.0)
Vaccinia virus 38 (0.2)
Bos Taurus 36 (0.2)
Other (77 entries) 186(1.3)
sion 13 (Peri et al, 2003). The HPRD docum ents protein-protein interactions 
that have been m anually curated from the literature by expert biologists 
which makes it suitable as a gold standard positive set. Selection of neg­
ative examples for the gold standard  negative set is more difficult; unlike 
positive interactions, it is rare to find validated reports of non-interacting 
proteins, especially not on a large scale. Following the approach of Rhodes 
et al. (2005), interactions were classified as false positive if interacting pro­
teins had been docum ented in incompatible cellular com partm ents (plasma 
m em brane proteins interacting w ith nuclear proteins), as annotated in the 
December 2005 release of the Gene Ontology (GO) Consortium  database 
(Ashburner et al., 2000). Ben-Hur and Noble (2006) have highlighted the 
possibility that this approach for selecting negative samples can lead to bi­
ased estimates of accuracy. However, it is unlikely to affect accuracy esti­
mates of the predictions here as they are based on experim ental data, rather 
than being based on machine learning algorithms which rely on accurate 
definitions of true positive and negative samples for their training.
The receiver operating characteristic analysis uses the rates of true and 
false positive identification of interactions (TP and FP, respectively). The
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relationship between these values, along w ith their counterparts, the true 
negatives and false negatives (TN and FN), can be represented by the fol-
True positive fraction (TPF) -  P (1\I+ ) — T P /(T P  +  FN)
True negative fraction (TNF) = P(0| J —) =  T N /(T N  +  FP)
False positive fraction (FPF) = P (l|7  —) =  F P / (FP +  TN)
False negative fraction (FNF) = P (0 |/+ )  =  F N /(F N  +  TP)
In each case the probability of predicted interaction or absence of inter­
action ( 'I ' and '0') is calculated, both for the cases where a real interaction 
has been proved (1+) or disproved (I-). The TPF equals the sensitivity and 
TNF the specificity. Furthermore, the positive predictive value, PPV, where 
PPV =  T P /(T P  +  FP), indicates the likelihood of true interaction, given a 
positive prediction.
The utility of the ROC curve is best appreciated once the area under the 
curve (AUC) is calculated. Hanley and McNeil (1982) dem onstrated  that 
the AUC is a general m easure of the probability that a predicted interaction 
is a genuine interaction and furtherm ore, the quality of the curve can be 
m easured by the curve standard error (SE), which is given by:
where A is the area under the curve; nn and np are the num bers of true 
negatives and true positives respectively; Qi =  A / (2 — A); and  Q2 =  
2A 2/ (1 +  A). The SE is a useful indicator w hether the sam ple size is large 
enough in order for the ROC curve to be accurate—an increased sam ple size 
will yield lower standard error.
3.3.3 PIP database schema
The large am ount of data involved in the project necessitated a structured 
and efficient approach to data managem ent. This was achieved w ith the 
im plem entation of a mySQL relational database which was nam ed TIP: Po­
tential Interactions of Proteins'. The database can be queried in different 
ways: from the command line, by using a scripting language, or through a
lowing:
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Figure 3.2: Database tables used for the PIP database. The relationship between tables 
is shown by conventional symbols: one-to-one (—), one-to-many (—<) and many-to-one 
(>—). Primary and foreign keys (PK and FK, respectively) are also indicated.
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web interface. Most of the data analysis was done w ith Perl scripting after 
im plem entation of a D atabase Interface (DBI) m odule, which provides the 
basic abstraction layer for w orking with databases.
The basic layout of PIP's tables is shown in Figure 3.2. The tables were 
designed to conform to the third normal form in m ost aspects, bu t some 
compromises were m ade to speed up query response time. The database 
comprises 45,154 separate experim ental evidences (edges) based on 59 bio­
chemical m ethods and involving 17,926 proteins (nodes). The num bers of 
homologues to the proteins involved in the experim ental data set differ be­
tween species; the database docum ents 737,000 entries for hum an, 594,000 
for rat and 101,000 for fission yeast homologues.
The following examples outline the sets of queries involved in exploring 
the potential interaction partners of a protein, for exam ple in the rat genome. 
Assum ing the RefSeq identification for the query protein is known, the first 
step is to establish w hether the protein shares hom ology to any of the pro­
teins in the experimental set:
SELECT rat_homolog.bitscr, node.name AS node.name, taxon.name AS node.species, edge.no_expm, 
edge.id AS source, node.id AS nodel FROM rat_homolog, edge, LEFT JOIN link ON (link.edge_id 
= edge.id AND link.node_id = node.id), LEFT JOIN node ON rat_homolog.node_id = node.id,
LEFT JOIN taxon ON node.taxon_id = taxon.id WHERE rat_homolog.name = ’[query sequence id]’ 
ORDER BY rat_homolog.bitscr DESC;
The above query finds the experimental hom ologues along w ith annota­
tions as shown below:
+---------
1 bitscr node.name 1 node.species no_expm source
------ +
nodel 1
1 328.1760 LCK.HUMAN 1 Homo sapiens 3 MIPSM:P30530_P06239 17396 1
1 328.1760 LCK.HUMAN 1 Homo sapiens 2 MIPSM:P28907_P06239 17396 1
1 327.0200 PIR:TVHUA 1 Homo sapiens 1 DIP:25E 5742 1
1 326.6350 ABU. MOUSE 1 Mus musculus 3 MIPSM:P04629_P00520 17907 1
1 322.7830 SR64.DR0ME 1 Drosophila melanogaster 1 DIP:40003E 3428 1
The next step involves an interative query to get the interaction partners 
of the nodes in the experim ental data set and then retrieving their rat ho­
mologues along with associated information and bit scores. The following 
queries are for the first result line in the table above:
SELECT node.id as node2, FROM node, link WHERE node.id = link.node_id AND link.edge_id =
’MIPSM:P30530_P06239’AND link.node_id != ’17396’;
C ha p ter  3. In silico co n s tru c tio n  o f  in tera c to m es  
which gives the interacting node:
91
I nod«2 I
+  +
I 17414 I
and once the interacting node has been found the details of the hom olo­
gous rat sequences to the partner node can be listed (ranked by score):
SELECT node.name AS node.name, sequence.name AS rathomolog.id, rat_homolog.bitscr, 
sequence.desc, rat_gene.name AS gene FROM node LEFT JOIN rathomolog ON node.id = 
rathomolog.node_id, LEFT JOIN ratseq ON ratseq.name = rathomolog.ratseq_name,
LEFT JOIN sequence ON sequence.name = rat_homolog.name, LEFT JOIN rat_gene ON 
rat_gene.rathomol_name = rathomol.name WHERE node.id = *17414’
ORDER BY rathomolog.bitscr DESC;
which yields:
1 node.name rathomolog.id bitscr descr 1 gene 1
1 UFO.HUMAN XP.218346 1483.39 similar to rat Axl shortform [Rattus norvegicus] 1 Axl 1
1 UFO.HUMAN NP.058788 624.39 TYR03 protein tyrosine kinase 3 [Rattus norvegicus] 1 Tyro3 1
1 UFO.HUMAN NP.075232 614.76 MERTK [Rattus norvegicus] 1 Mertk 1
1 UFO.HUMAN NP.113705 235.34 met proto-oncogene [Rattus norvegicus] 1 Met 1
1 UFO.HUMAN XP.347256 235.34 similar to met proto-onco [Rattus norvegicus] 1 L0C368085 1
This process is repeated for all the homologues to the initial query se­
quence, all data collected and  the scores calculated. Once this process is 
completed the results are displayed, ranked by the interaction score, i.e. the 
m ost confident hits listed first.
The interactome data is available though the PIP (Potential Interactions 
of Proteins) web server at h ttp ://b m m .c a n c e rre se a rc h u k .o rg /se rv e rs / 
p ip /. This is an interactive server, allowing scientists to subm it queries for 
the three species. It is built on Perl scripts that access the database and per­
form the necessary task to process the data and finally display the results via 
a Common Gateway Interface (CGI). The combination of CGI and Perl is a 
well established approach for generating web interfaces for num ber crunch­
ing, querying databases, generating customised graphics and perform  any 
other server-side tasks.
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3.3.4 Dynamic interaction maps
In addition to textual inform ation, the web server displays graphs of 
the protein-protein interactions that are predicted for the query sequence. 
G raph draw ing and the study of algorithm s to display graphs is a well es­
tablished field and has been the subject of a num ber of publications, see 
e.g. Di Battista et al. (1994) and K aufm ann and Wagner (2001). G raph draw ­
ing involves m apping the data, usually on a tw o-dim ensional plane util­
ising cost functions to optimise the arrangem ent of edges and nodes such 
that it can more easily be interpreted. The web server utilises the program  
G raphviz (h ttp ://w w w .g rap h v iz .o rg ) for visualisation of the interaction 
networks. G raphviz was originally intended for graph draw ing in telecom­
m unication networks and software engineering. It builds undirected graphs 
by running an iterative solver to find low energy configurations for the ar­
rangem ent of the nodes and edges, and is im plem ented in a plain text graph 
description language nam ed 'DOT' (Gansner et a l,  1993).
3.4 Results and Discussion
3.4.1 PIP server
The server comprises an SQL database and a web interface, allowing the 
user to enter either the sequence or the gene name of the protein of interest 
(see Figure 3.3). The database is then queried and potential b inding part­
ners are listed, ranked by the score as shown in Figures 3.4 and 3.5. The 
results are also presented graphically w ith the aid of the software package 
Graphviz. Further queries can be m ade by clicking on a protein in the map, 
and expanding the network as needed (see Figure 3.6).
To help w ith analysis and validation of the networks, further details on 
each protein are available through external links. Inform ation on the do­
main structure and the facility to build  homology models are also provided, 
with links to the Domain Fishing (Contreras-Moreira and Bates, 2002) and 
3D-JIGSAW (Bates et a l,  2001) m odelling servers. These features have been 
included to assist the user in understanding the structural com positions of 
the proteins involved in the interactions and can be used to confirm associ­
ation or highlight a certain interaction as an unlikely one.
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Figure 3.3: The PIP web interface. This simple form allows the user to enter a sequence 
or a gene name for one of the three species: human, rat and fission yeast. The data are 
submitted to a server which processes the query and returns an interactive results page.
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D e t a i l s  o f  y o u r  q u e r y  p r o t e i n :
G e n e  n a m e : c d c 2
P r o t e i n  I D N P  5 5 5 6 2 9
O r i g i n  o f  s e q u e n c e : S c h i z o s a c c h a r o m y c e s  p o m  b e
98%  of th is  sequence could be modelled. Structural tem p late s  for modelling:
Homology Domain s ta rt Domain en d  Description
66 %  4 2 9 3  Protein kinase domain
Below are  potential interaction partners of your sequence. The potential partn ers  are  derived from homology with docum ented  protein-protein 
interactions. By clicking on a protein in th e  m ap a  new query is execu ted  and th e  graph expanded to  indude th is  information The finks betw een 
proteins a re  coloured according to  th e  confidence score an d  th e  e x te n t, to  which th e  proteins can be structurally modelled is show n a s  a gradient 
of green.
1 7  p o t e n t i a l  i n t e r a c t i o n  p a r t n e r s  f o u n d  t o  y o u r  q u e r y :
c m k l
Confidence score of interaction Structural coverage
Figure 3.4: A view of the top of a PIP results page. Details of the query protein are listed 
and potential interaction partners are shown on a graph below. The confidence of each 
interaction is shown by a colour gradient that ranges from blue (low scoring interactions) 
to red (high scoring interactions). The proteins are also coloured in a shade of green 
according to how much of the sequence can be structurally modelled using homology 
techniques.
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Score Protein 10  Gene nam e Description
8 9 .0 7  HP 59 5 1 7 1  c d c !3  g2/m itotic-specific cydln  (Schizosaccharom yces pom be]
Homologous experim ental in teraction do cu m en ted  in: Species Source Number of experim ents
Schizosaccharom yces pom be DIP;1022£ 1
Mus m u scu lu s D£P:40Q34£ 1
Homo sap ien s D1P:S46E 1
Hom o sap ien s DIP.1121E 1
Homo sap ien s D1P:1119E 1
Hom o sap ien s DIP:1120£ 3
51%  of th is sequence could be modelled. Structural tem plates for modelling:
Homology Domain start Domain end Description
48%  206 4 5 2  CycSn, N-terminal domain plus Cydin, C-terminai domain
su c l
Score Protein ID G ene nam e Description
8 5 .9 6  NP 59 5 4 3 1  s u c l cy d m -d ep en d en t k in ases  regulatory  subun it (Schizosaccharom yces pom be]
Hom ologous experim en ta l in teraction  d o cu m en ted  in : S pecies Source Number of experim ents
H om o sap iens D1P:1010E 1
Hom o sap iens DIP: 1 0 1 2E 1
S accharom yces cerev isiae DIP:1013E 1
S accharom yces cerev isiae DIP:2258E S
72%  of this sequence could be modelled. Structural tem plates for modelling:
Homology Domain start Domain end Description
100%  22 102  Cyclin-dependent kinase regulatory subunit
srw l
Score Protein ID Gene nam e Description
5 9 .3 6  NP 5 9 4674  s rw l WD dom ain  con tain ing  s rw l  pro tein  [Schizosaccharom yces pombe}
H omologous experim ental interaction d o cum en ted  in : Species Source Number of experim ents
Saccharom yces cerev isiae  0IP :1 1 7 2 9 £  S
64%  of th is sequence could be m odelled.  Structural tem plates for modelling:
Homology Domain start Domain end Description
23%  175 531  WD domain, G-beta repeat
rp .W -1
Score Protein ID Gene nam e Description
3 9 .0 3  NP 5 8 7 8 6 9  r p s l2 - l  4 0 s  ribosom ai pro tein  s l 2  [Schizosaccharom yces pombe]
Homologous experim ental interaction d o cum en ted  in: S pecies Source Number of experim ents
Hom o sap ien s DIP:40128E 4
66%  of this sequence could be m odelled. Structural tem plates for modelling:
Homology Domain start Domain end Description
36%  32 126  Ribosomai protein L7Ae/L30e/S12e/Gadd45 family
w e e l
Score Protein ID Gene nam e Description
3 6 .5 2  NP S 8 7 9 3 3  w e e l  m itosis inhibitor protein kinase w e e l (Schizosaccharom yces pom be]
Homologous experim ental interaction do cu m en ted  in : Species Source Number o f experim ents
Schizosaccharom yces pom be DIP: 1 122E 1
Saccharom yces cerev isiae  D1P:44393E 2
35%  of th is sequence could be m odelled. Structural tem plates for modelling:
Homology Domain start Domain end Description
30%  5 6 6  8 6 9  Protein kinase domain
Figure 3.5: Details regarding the interacting partners are displayed further down the 
results page. The confidence score and a brief description for each of the proteins are 
shown. A link to the RefSeq protein record of each protein provides an easy way to 
retrieve further annotations. The experimental data behind each prediction is also shown, 
along with a link to the source (DIP or MIPS). The last bit of detail contains information 
on the domain composition of the proteins.
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Figure 3.6: The interactive protein map. By clicking on a node, a new query is started 
and the protein-protein interaction map is redrawn with the results of the query. The 
top of the illustration shows the interaction partners of cdc2. By clicking on cdcl3 the 
interaction partners of cdcl3 are added to the map (middle) followed by clicking on sucl 
which expands the network even further (bottom).
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3.4.2 Network validation
The interactomes were built from a collection of predicted protein-protein 
interactions. The reliability of these predictions, in terms of sensitivity 
and specificity, was assessed before proceeding to further analyses. Gold- 
standard data containing hum an proteins w as used for this analysis. Each 
interaction received a score according to Equation 3.1, and the scoring func­
tion was assessed by a receiver operating characteristic curve (ROC-curve), 
shown in Figure 3.7. The area under the curve is equal to 0.89, which il­
lustrates that the derived scoring function is a good indicator of prediction 
reliability—an area of 1.0 w ould indicate a zero rate of false negative and 
100% rate of true positive identification. The standard  error for the graph is 
0.00078, which indicates a sufficient sample size.
The trade-off for a high sensitivity is a lower specificity, which means a 
higher fraction of false positives. For a score cut-off of 11.0 we obtained sen­
sitivity of 85% and specificity of 82% (see Table 3.3), which is a reasonable 
balance between the true positive fraction (sensitivity) and the true negative 
fraction (specificity). The hum an interactome consisted of 108,113 binary in­
teractions when a m inim um  score of 11.0 was im plem ented. This com pares 
to 196,213 and 66,944 for cut-off score of 10 and 12 respectively.
Table 3.3: Sensitivity, specificity and positive predictive value (PPV) as a function of 
the cut-off score. The positive predictive value, P P V  =  T P / ( T P  +  FP),  indicates the 
likelihood of a true interaction, given a positive prediction. Also shown is the total 
number of interactions for each score cut-off.
Score cut-off Sensitivity Specificity PPV Interactions
10 0.921 0.639 0.708 196,213
11 0.849 0.816 0.810 108,113
12 0.765 0.887 0.870 66,944
13 0.686 0.908 0.882 53,947
14 0.641 0.915 0.883 51,034
15 0.607 0.916 0.879 50,378
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Figure 3.7: Curve of receiver operating characteristics (ROC) at different cut-off points of 
scores. The area under the curve is 0.89.
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3.4.3 Network properties
The predicted interactomes for the three species consist of individual inter­
actions, each of which has been assigned a confidence score as previously 
described. The size of each interactom e therefore varies as the cut-off for 
the m inim um  confidence score is changed. Table 3.4 illustrates this for the 
three genomes. The selection of a score cut-off involves balancing the num ­
ber of false interactions, which increases as the cut-off is lowered, against 
the num ber of undetected interactions, which increases as the cut-off is set 
higher (see Section 3.4.2 on netw ork validation).
Table 3.4: The number of predicted interactions for the human, mouse and fission yeast 
genomes, as a function of the confidence score cut-off.
N um ber of predicted interactions
Score cut-off H um an Rat Fission yeast
10 196,213 151,905 30,762
11 108,113 82,621 19,314
12 66,944 51,552 12,612
13 53,947 42,179 9,755
14 51,034 40,333 9,256
15 50,378 39,909 9,103
20 38,867 30,348 6,405
30 19,155 14,223 2,978
40 11,228 8,170 1,714
50 7,518 5,442 1,047
As discussed in Chapter 1, there has been a debate regarding the struc­
ture of biological networks. The general consensus seems to be that biologi­
cal networks display scale-free topology, where relatively few proteins have 
a high connectivity (Albert et a l ,  2000), although the subject will rem ain un­
der debate until more complete and reliable interactome data become avail­
able. Of particular concern is the fact that biological data studied to date is 
biased because of the limited sampling, and therefore the topology observa­
tion for the data sets so far cannot be extrapolated to whole genomes (Han 
et al., 2005). It is however of interest to examine the netw ork structure of the 
interactomes that have been constructed by the m ethod described here. As 
can be seen in Figures 3.8 and 3.9 the interactome data for both the m am ­
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malian netw orks and the fission yeast show scale-free properties, i.e. the 
distribution of interaction frequency (degree distribution) can be fitted to a 
power-law curve, P(k) = /c“ 7, where k is the degree of connectivity of a pro­
tein and P(k) is the probability of observing a protein w ith a k connectivity. 
The hum an data shows a least-square fit P 2-value of 0.93 and the rat and 
fission yeast equivalents are 0.91 and 0.94, respectively.
The appearance of scale-free properties in the predicted netw orks is in 
agreem ent w ith the same observation in a num ber of networks (see C hap­
ter 1). Two m ain theories have been pu t forward to explain the scale-free 
nature that is frequently observed in biological networks. The first one is 
based on the com bination of growth and 'preferential attachm ent', which 
stipulates that netw orks are the result of a grow th process, du ring  which 
new nodes join the system over an extended period. In the netw ork grow th, 
nodes prefer to connect to nodes that already have many links in a p ro­
cess term ed 'preferential attachm ent' (Barabasi and Albert, 1999). In biolog­
ical systems this w ould be achieved through gene duplication and  diver­
gence (Pastor-Satorras et a l,  2003; Am outzias et a l,  2004; van N oort et a l,
2004). The second theory, proposed m ore recently by Deeds et a l  (2006), 
is non-evolutionary and suggests that the observed biological interactions 
are influenced by non-specific interactions, e.g. they show that desolvation 
of surface residues is a physical factor in protein-protein interactions and 
can affect the results from yeast tw o-hybrid systems and subsequently in­
fluence the observed topology of the network. As the netw orks described 
here are largely based on experimental data obtained by yeast tw o-hybrid 
techniques, the scale-free properties observed here could therefore be an 
artefact of the hybridisation method. In addition to this, an extra layer of 
uncertainty is encountered as the netw orks are not directly observed but 
inferred by com putational methods. It is therefore not possible to confirm 
the above observation with absolute confidence—until larger portions of 
genomes are surveyed w ith alternative experim ental m ethods the question 
of the scale-free nature of the protein-protein interaction netw orks will re­
main.
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Figure 3.8: The connectivity (degree) distributions for the human (top) and rat (bottom) 
interactomes. Networks were built with interactions with a confidence score of 11.0 or 
above. The node degree k is represented on the x-axis and the probability of observing 
nodes with a particular k is represented on the y-axis. Both axes are logarithmic and the 
data exhibits a power law distribution shown by the fitted lines.
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Figure 3.9: The connectivity (degree) distributions for the Schizosciccharomyces pombe in­
teractome. Refer to Figure 3.8 for further description.
3.5 Conclusions
The m ethod of using hom ologous protein interaction data to infer protein- 
protein information could be particularly useful for proteins for which there 
is no definite binding partner information. By expanding the netw orks 
around the protein of interest one can identify possible binding partners. 
The server has been im plem ented in such a w ay that it can be updated  
as new experimental data becomes available, thereby increasing the con­
fidence in the predicted interactions. Furtherm ore it can be extended to 
include networks for other species, in addition to the hum an, rat and fission 
yeast networks.
The web server allows scientists to explore focused subsets of the 
protein-protein networks, and identify potential targets for further exper­
imental study, but once data has been generated on a genom e-wide level 
perhaps more interesting and revealing questions can be asked. The pos­
sibility of m apping extra attributes—such as gene ontology and expression 
data, to name a few—to the netw ork opens up many interesting avenues
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for network studies. This is the subject of the following two chapters, w here 
firstly the topology of the hum an netw ork is exam ined w ith a special fo­
cus on cancer-related proteins and secondly, w here the rat interactom e is 
explored in com bination w ith microarray data from metastatic cell-lines.
Chapter 4 
Global topological features of 
cancer proteins
4.1 Introduction
The availability of high-throughput experim ental data has allowed con­
struction of increasingly com prehensive protein-protein interaction net­
works (see Chapter 1). The structure, or topology, of such netw orks not 
only sheds light on the complex cellular m echanism s and processes, but 
also gives insight into evolutionary aspects of the proteins involved (Jeong 
et a l,  2001; Fraser et a l ,  2002; Bu et a l ,  2003; W uchty, 2004; Calvano et a l,  
2005). Charting interaction m aps of entire genom es is undoubtedly useful 
for improved understanding of cellular function, especially once they have 
been integrated with a w ider collection of biological data. It is now possible 
to map a num ber of different attributes, or data types, onto interactomes. 
Examples of this are m icroarray expression data (Ideker et al., 2002; Sohler 
et a l,  2004; de Lichtenberg et al., 2005), gene ontology (Formstecher et a l,  
2005), structural inform ation (Dunker et a l ,  2005) and dom ain composition 
(Riley et al, 2005; Wuchty and Almaas, 2005). This chapter continues on this 
theme and investigates how  combining cancer-related information with a 
comprehensive protein netw ork can yield useful inform ation on the general 
nature of cancer proteins in the context of their location in the network. For 
this purpose, the study makes use of the predicted hum an interactome that 
was constructed in the previous chapter.
In a recent publication, Wachi et al. (2005) reported increased interaction
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connectivity of proteins w hich were differentially expressed in lung cancer 
tissues. However, a com prehensive survey of the 'social nature ' or inter­
action characteristics of all know n predisposing hum an cancer genes has 
not previously been attem pted. In this study the netw ork properties of a 
large set of proteins know n to be susceptible to m utations leading to cancer 
(Futreal et al., 2004) was examined. In addition to statistical analysis of the 
netw ork properties of cancer proteins, a clustering m ethod was utilised to 
highlight proteins in centrally connected hubs that form the backbone of the 
interactome.
4.1.1 Community structure in networks
A network can be represented as a set of points (vertices or nodes), joined 
in pairs by lines, or edges. Most networks show some level of inhom o­
geneity, that is, the nodes are not evenly distributed throughout the net­
w ork but form areas w here the density is higher than the average density 
(see Figure 4.1). This forms the basis of the idea of a 'com m unity structure' 
w ithin networks (Newm an, 2004). Strong signs of com m unity structure can 
be found in networks of diverse origin, including com puter netw orks (Al­
bert et a l,  1999), social system s (such as social netw orks (Dodds et al., 2003) 
and scientific collaborations (Newman, 2001)), and biological phenom ena 
(for instance epidemiology (Heath, 2005) and biochemical netw orks (Holme 
et al., 2003; Guimera and N unes Amaral, 2005)). Com m unities are of in­
terest because neighbouring and well-interconnected nodes that make up 
a network community are likely to share some similarity and, in the case 
of protein networks, m ay participate in similar cellular functions (Guimera 
and Nunes Amaral, 2005).
Finding the communities, or the clusters, is im portant in order to u n ­
derstand the netw ork's internal structure. A large num ber of clustering al­
gorithm s have been developed for this purpose, based on m any different 
approaches for distinguishing the clusters. The clustering criteria essen­
tially fit into three categories, based on the netw ork properties they use for 
their task: compactness, connectedness and spatial separation (Handl et al.,
2005). Methods that aim to identify clusters based on their compactedness 
look at the global distribution of nodes and identify those that appear more 
densely located com pared w ith the general distribution (MacQueen, 1976;
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Figure 4.1: Community structure within a network. In many natural networks the nodes 
appear in groups or communities (shown by grey shading). Within a community there 
are many edges, whereas only a small num ber of edges connect nodes of different groups.
McLachlan and Krishnan, 1997; Kohonen, 2001). These m ethods are usu­
ally effective for spherical or w ell-separated clusters, but may not detect 
asymmetric or unusually shaped clusters. Basing clustering on connected­
ness of nodes is particularly suitable for identifying oddly shaped clusters, 
as the clustering is based on m ore local netw ork properties, i.e. distances 
between individual nodes (Griths et a l ,  1984). This approach, however, 
is less practical where there is little separation between the clusters. The 
third methodology, spatial separation, is usually combined with additional 
m ethods as it often fails to find a m eaningful separation in complicated net­
works (Rayward-Smith et a l ,  1996). M ost of these algorithms separate the 
network into non-overlapping clusters, assigning each node to a specific 
cluster, that is they perform  'hard  clustering', although m ethods that allow 
overlapping between clusters are increasingly getting more attention (Re- 
ichardt and Bornholdt, 2004; Gfeller et al., 2005).
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4.2 Methods
4.2.1 Clustering of interconnected proteins
The netw ork of interactions was analysed using clique percolation cluster­
ing (Adamcsek et ah, 2006), which locates maximal complete subgraphs (k- 
cliques) in the netw orks and then identifies 'com m unities' by carrying out 
standard com ponent analysis of the clique-clique overlap. In this context, 
the variable k is defined as the num ber of nodes in the subgraph and a k- 
clique com m unity is defined as the union of all /c-cliques that can be reached 
from each other through a series of adjacent /c-cliques, where cliques sharing 
k — 1 nodes are defined as adjacent. The com m unity definition is based on 
the observation that a typical m em ber in a com m unity is linked to many, bu t 
not necessarily all other nodes in the community. In other w ords, a com m u­
nity can be regarded as a union of smaller, complete, fully-connected sub­
graphs that share nodes. The resulting com m unities are allowed to exhibit a 
degree of overlap, which is particularly useful, as such m ethods have been 
shown to be m ore suitable for identifying nodes of central im portance in 
biological netw orks com pared w ith non-overlapping clustering algorithm s 
(Wuchty and Almaas, 2005; Palla et ah, 2005).
4.2.2 Data sets
Information on cancer genes was obtained from a comprehensive census 
of hum an cancer genes (Futreal et ah, 2004). The data, 346 genes encod­
ing 509 protein isoforms, were m apped on to the protein-protein interaction 
network. For the study of dom ain interactions, statistics relating to the fre­
quency of dom ain-dom ain interactions were obtained from version 19.0 of 
PFAM (Bateman et ah, 2004). And lastly, the analysis of functional aspects 
of the networks involved classification of proteins into cellular processes 
according to inform ation from release 37.0 of the KEGG Pathway Database 
(Kanehisa et ah, 2006) and June 2006 release of the Gene Ontology database.
Chapter 4. Global topological features o f cancer proteins 108
4.3 Results and Discussion
4.3.1 Network properties of cancer proteins
The construction of a validated hum an protein-protein interaction network 
allows an in-depth analysis of individual proteins in the context of their sur­
roundings. Here the netw ork topographies of hum an cancer proteins were 
examined with the aim  of uncovering intrinsic properties that distinguish 
proteins prone to cancerous m utations from those that are not.
Connectivity
The num ber of interaction partners for each protein in the netw ork was cal­
culated, using a cut-off score of 11.0 (see Section 3.4.2). Statistics were ac­
cum ulated for two groups: proteins classified as cancer proteins, and those 
that were not linked to cancer. Cancer proteins were show n to have twice as 
m any interaction partners as non-cancer proteins, w ith 23.4 ± 1 .9  (n =  439) 
and 11.4 ±  0.2 (n = 16,600) interaction partners respectively (mean values 
±  standard error of the mean, see Figure 4.2). Table 4.1 shows a more de­
tailed breakdown of the interaction frequency. Cancer proteins are under­
represented in the category of the least connected proteins, but show the 
reverse trend in all other categories. This trend is highly statistically signifi­
cant (p = 5 x 10-34 for a ^ 2-test).
Table 4.1: The observed interaction frequency distribution of cancer proteins compared 
with the expected distribution in the genome-wide network.
Interactions fobs /E xp Difference (%)
1-10 215 318 -32
11-20 99 69 43
21-30 48 21 134
31-40 12 8 42
> 40 65 23 185
Sum 439 439
Because each interaction in our predicted protein-protein interaction 
m ap receives a confidence score, it is possible to test the robustness of the
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Figure 4.2: The number of interactions in which cancer proteins participate (red), com­
pared with the number of interactions of non-cancer proteins (black). Cancer proteins 
are, on average, involved in 23.4 interactions, whereas non-cancer proteins are involved 
in 11.4. The centre of the box is the median and the box spans from first to third quartiles 
(the inter-quartile range). The whiskers extend to the furthest point within 1.5 times the 
inter-quartile range. Beyond the whiskers, all outliers are shown, in open circles up to a 
distance of 3 times the inter-quartile range and closed beyond that.
Cancer Non-cancer
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above observation. Increasing the cut-off score limits the am ount of inter­
action data, but the confidence of each interaction is increased. Cancer pro­
teins consistently show ed twice as many interaction partners as non-cancer 
proteins, w hen the score cut-off was increased, indicating that the observa­
tion is robust (see Table 4.2).
Table 4.2: The mean connectivity (± standard error of the mean) of cancer and non­
cancer proteins at different cut-off values for interaction scores. The total num ber of 
proteins in both groups at each cut-off value is shown in the last column.
Score Cancer proteins Non-cancer proteins ^cancer/^non-cancer 
“"> 1 2  17.9 ±  1.5 8.1 ± 0 .1  414/14,501
> 13 15.0 ±  1.3 7.1 ±  0.1 402/13,610
> 14 14.3 ±  1.3 6.9 ±  0.1 396/13,369
> 30 8.8 ± 0 .9  4.3 ±0 .1  312/7,829
The discovery of a difference in the num ber of interaction partners be­
tween cancer and non-cancer proteins could suggest a differentiation in the 
evolutionary aspects of these two groups. Indeed, the evolutionary rate and 
age of genes or proteins has been the subject of several publications, show ­
ing increasing evidence for a correlation betw een the age of proteins and the 
num ber of interactions in which they participate (Fraser et al., 2002; Eisen- 
berg and Levanon, 2003; Wuchty, 2004). This correlation has been disputed 
by Jordan et al. (2003), how ever in a recent publication Fraser et al. (2003), 
and subsequently, Saeed and Deane (2006), have stated that a weak correla­
tion does exist, although it is dependent on the completeness and quality of 
the data set under study. W uchty (2004) and Saeed and Deane (2006) have, 
however, found a strong correlation (Spearman's coefficient = 0.97 and 0.98, 
respectively) betw een the age of a protein (calculated as Excess Retention) 
and connectivity. The Excess Retention calculation is based on the observa­
tion of orthologues in related genomes and as such can indicate gene age 
but does not indicate evolutionary rate through changes in the genom es by 
events such as gene loss or horizontal gene transfer. Thus the results p re­
sented here indicate that proteins whose m utation results in a detrim ental 
change of function that leads to cancer may generally be older than the non­
cancer proteins.
Jeong et al. (2001) show ed that the most highly connected proteins in
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yeast are also the ones that are phenotypically m ost im portant, and criti­
cal for the survival of the organism. Furtherm ore, it has been shown that 
toxicity-modulating proteins exhibit a greater num ber of interactions (Said 
et a l,  2004). It follows that the increased connectivity of cancer proteins, 
show n here, suggests that they play a central role in the protein network.
Cancers result from the accum ulation of inherited and somatic m uta­
tions in oncogenes and tum our suppressor genes. With this in m ind, it 
is of interest to distinguish between somatic and germ line m utations that 
result in cancer. Germline m utations can be passed between generations, 
w hereas somatic m utations are not passed on to offspring. This study shows 
a m odest but statistically significant difference (p =  0.002) in the distribu­
tion of interaction partners of somatically m utated vs. germline m utated 
proteins. About tw o-thirds of the proteins show ing somatic m utations in­
teract with a relatively low num ber of proteins (tw enty interaction part­
ners or less), whereas just over half of germ line m utated proteins fell in to 
the same grouping (see Table 4.3). This may indicate som ew hat younger 
m ean evolutionary age of the somatically m utated cancer proteins com­
pared with germline, reflecting the fact that evolutionary selection pressure 
affects germline m utated proteins.
Table 4.3: Connectivity ratio of somatic and germline mutated cancer proteins (number 
of proteins in parentheses). The observed difference is statistically significant according 
to a ^ 2-test (p = 0.002).
Interactions Somatic Germline Difference (%)
T-20 0.68 (175) 0.53 (30) 2^88
> 20 0.32 (83) 0.47 (27) -32.08
Sum 1.00(258) 1.00(57)
Protein domain frequencies
Com paring the structural and dom ain com position of cancer proteins 
against domain propensities of the general netw ork reveals a functional d i­
versity that differs from that of proteins in general. Table 4.4 lists the twenty 
most frequent dom ains found in the cancer protein population. Most of 
those domains appear w ith a higher frequency than expected. Many of the
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proteins, whose frequency is increased compared w ith the expected values, 
appear to be of nuclear origin and have a functionality that particularly fo­
cuses on DNA regulation and repair, such as the Zinc-finger, PHD-finger, 
BRCT and Paired-box dom ains.
The concern that the apparen t increased connectivity of cancer proteins 
is a result of a bias in the protein netw ork needed to be addressed. As de­
scribed, the construction of the hum an interaction netw ork builds on ex­
perim ental data and it could be argued that cancer proteins, having been 
under particular scrutiny by the scientific community, have been studied 
in greater detail which could explain the higher num ber of know n interac­
tion partners for cancer proteins. However, this appears not to be the case 
and is more likely to be a consequence of dom ain usage. By using interac­
tion frequencies for dom ain-dom ain interactions from the PFAM database, 
the propensity of highly-prom iscuous domains, in term s of the variety of 
different domains w ith w hich they interact, was found to be higher in the 
cancer population, w ith 22.2% of dom ains highly prom iscuous compared 
w ith 6.9% of the non-cancer population (the num ber of unique domains, 
n — 212 and n = 4042 respectively).
Some of these dom ains (^promiscuity < 0.005 ) appear in the list of the 
m ost frequently observed cancer dom ains (Table 4.4), and are preceded with 
the symbol V . This is based on a statistical analysis of interaction frequen­
cies of PFAM domains in general, which conform to a Probability Density 
Function:
where x  is the dom ain interaction frequency and A is the rate constant, de­
rived from the mean value of interactions per dom ain (0.56), as observed in 
the PFAM data.
There still remains the argum ent that the PFAM dom ain-dom ain inter­
action data could be biased tow ards cancer protein studies. Since PFAM 
is derived from the Protein Data Bank (PDB) it is im portant to establish 
w hether there is a bias w ithin this prim ary structural database. Less than 
1% of the PDB was found to contain structural information on the cancer 
proteins studied here, or their close homologues (E-value < 1 x 10” 5, se­
quence identity > 70%), thereby indicating no obvious bias tow ards cancer
(4.1)
Table 4.4: The most frequently observed domains in human cancer proteins, listed in a 
descending order. Their frequency is compared against the expected frequency derived 
from a network-wide survey. The Ppromiscuity-value shows the probability of observing a 
domain with higher interaction promiscuity as calculated by a Probability Density Func­
tion based on the PFAM domain population. Domains preceded with ★ show statistically 
higher-than-expected interaction promiscuity (Pprom iscuity <  0 .0 0 5 )  in terms of the num ­
ber of different domains with which they interact. Domains without any documented 
PFAM interactions receive a ppromiscuity_value °f 1-
PFAM id Domain annotation fobs / Exp 72-fold difference /^promiscuity
★ PF00047 Im m unoglobulin dom ain 102 37 2.76 7.93 x 1(T11
PF00096 Zinc-finger, C2H2 type 51 35 1.46 0.0279
* PF00069 Protein kinase dom ain 51 14 3.64 3.70 x 10“ 13
PF00628 PHD-finger 35 4 8.75 1
* PF00097 Zinc-finger, C3HC4 type 28 8 3.50 4.67 x 10“ 3
PF00855 PWWP dom ain 21 1 21.00 1
* PF00046 Homeobox domain 17 7 2.43 7.80 x 10-4
PF00643 Zinc-finger, C3HC4 type plus B-box 16 3 5.33 1
* PF00036 EF hand 16 8 2.00 1.33 x 1 0 -”
* PF00008 EGF-like dom ain 13 20 0.65 1.33 x K T 11
PF00533 BRCA1 C Terminus (BRCT) dom ain 12 1 12.00 0.0279
★ PF00010 Helix-loop-helix DNA-binding dom ain 11 3 3.67 4.67 x 10-3
PF00292 Paired-box dom ain 10 1 10.00 0.167
★ PF00856 SET-domain 10 2 5.00 4.67 x 10-3
★ PF00076 RNA recognition motif. (RRM, RBD, or RNP) 10 9 1.11 4.67 x 10~3
★ PF00020 TNFR/NGFR cysteine-rich region 9 1 9.00 7.80 x 10-4 
6.09 x 10"7* PF00018 SH3-domain 8 7 1.14
PF00439 Bromodomain 8 2 4.00 0.167
PF00531 Death-dom ain 7 1 7.00 0.167
* PF00178 Ets-domain 7 15 0.47 7.80 x 10~4
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proteins.
Cluster analysis of the human interactome
Clustering m ethods have previously been show n to be useful in identifying 
protein interactions that take place w ithin the same cellular process (Palla 
et a l, 2005). This can be attributed to the fact that subnetw orks of proteins 
involved in a defined cellular process are m ore heavily interconnected by 
direct protein interactions than w ould be expected by chance (Jeong et al., 
2001; Gunsalus et al., 2005).
The /;-clique clustering m ethod was applied repeatedly at different k- 
cluster values. Figure 4.3 dem onstrates the concept of clustering, show ­
ing a subsection of the hum an interaction m ap, on which cancer proteins 
have been highlighted. A low k-xalue yields a large num ber of extensive 
communities which overlap to a high degree. Conversely, raising the de­
value results in identification of fewer and m ore distinct protein com m uni­
ties which contain highly interconnected proteins (Table 4.5). Interestingly, 
even though cluster sizes decrease w ith increasing k-x  alue, the proportion 
of cancer genes identified in the protein com m unities increases, indicating 
the enrichment of cancer proteins in the m ost tightly connected com m uni­
ties.
Table 4.5: The number of protein communities in the entire human interactome, 
identified by ^-clique analysis at different A:-values. The number of non-cancer and can­
cer proteins in the communities at each /c-value is listed on the right-hand side of the table
Non-cancer Cancer 
k-x alue Com m unities proteins proteins (%)
3 222 8870 334 (3.6)
4 189 4245 234 (5.2)
5 98 1918 117(5.8)
6 37 764 53 (6.5)
7 19 325 28 (7.9)
8 9 193 14 (6.8)
An example of the protein communities identified by this m ethod is 
shown in Figure 4.4. The communities contain proteins involved in a d i­
verse range of protein functions and are either self contained or connected
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Figure 4.3: A subsection of the human interactome, focusing on protein networks around 
cancer proteins. Each community is shown in a different colour. Cancer proteins are de­
picted as dark triangles and non-cancer proteins as grey circles. Protein communities 
resulting from cluster analyses at different fc-values are shown. Interactions within com­
munities of highly inter-connected proteins are highlighted in different colours.
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to other protein communities. In the latter case, cancer proteins can be seen 
m ediating interactions betw een different pathw ays, such as in the largest 
collection, where four com m unities are linked together, ranging from p ro ­
teins involved in signal transduction to the im m une system, and cell grow th 
and death regulation.
Community size and overlap
On examining the protein com munities, some interesting differences in the 
community size were noticed. Cancer proteins, on average, belonged to 
more highly populated com m unities com pared w ith non-cancer proteins 
(see Figure 4.5). It may be that cancer proteins take part in more complex 
cellular processes than their non-cancer counterparts. It is also conceivable 
that the larger com m unities contain larger or m ore complicated cellular m a­
chinery, where cancer proteins play a role.
Proteins identified as m em bers of m ore than one protein com m unity 
are of particular interest. In general, each protein com m unity represents 
a distinct cellular process; therefore proteins that have multiple com m unity 
membership may be participating in m ultiple processes and can be consid­
ered to be at the 'interface' of distinct but adjacent cellular processes. Com ­
paring the cancer protein population against the non-cancer population re­
veals that cancer proteins reside at com m unity interfaces to a m uch greater 
extent than their non-cancer counterparts, as show n in Table 4.6.
Table 4.6: Percentage of cancer proteins belonging to more than one community (based 
on proteins identified by clustering as belonging to a community). Expected value was 
based on non-cancer proteins.
k-v alue O bserved (%) Expected (%) Fold difference
3 12.67 8.38 1.5
4 21.39 12.38 1.7
5 12.37 9.96 1.2
6 17.07 13.67 1.2
7 17.39 7.26 2.4
8 7.69 2.66 2.9
While connectivity gives an indication of a protein's importance, it is 
possible to further classify the topological role of highly connected proteins
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Figure 4.4: A more detailed description of the protein communities identified by A>clique 
cluster analysis (k =  6) in Figure 4.3. Each community is distinctly coloured, with cancer 
proteins shown as triangles. The main functional classes of each cluster (in bold) and 
individual pathways, as defined in the KEGG database, are listed alongside each com­
munity. Note that proteins can be members of more than one community, but the figure 
shows only one community assignment for each protein. Appendix C lists KEGG path­
way classifications for these communities.
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Figure 4.5: Mean size distribution of protein communities that contain cancer proteins 
compared with those containing non-cancer proteins. Distributions are classified accord­
ing to clustering /c-value, with cancer communities in red and non-cancer in black. The 
difference between cancer and non-cancer groups is statistically significant, according to 
Wilcoxon rank sum tests, for ^-values 3,4, 5 (p <  0.005), and 6 (p  <  0.05).
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Figure 4.6: Local and global centrality of protein hubs is indicated by their network 
neighbourhood: hub proteins can be divided into local hubs (left) and global hubs (right) 
depending on the connectivity of their interaction partners. (Based on Wuchty and Al- 
maas (2005)).
based on their locality. Wuchty and Almaas (2005) used a k-core decom posi­
tion m ethod to distinguish betw een highly connected dom ains in peripheral 
cores (locally central) and highly connected domains in central cores (glob­
ally central). They show that globally central proteins form an evolutionary 
backbone of the proteome, present elevated evolutionary conservation, and 
are essential to the organism.
The protein community identification by the /c-clique clustering used in 
this study allows a similar distinction to be made, owing to the overlapping 
nature of the communities. Proteins in overlapping com m unities can be 
classified as global central cores, and non-overlapping ones as local central 
cores (see Figure 4.6 for illustration of the concept). The results in Table 4.6 
thus emphasise the key role of cancer proteins, which is reflected in their 
protein-network topology. This observation supports and extends the find­
ings of Wachi et al. (2005), w ho showed that differentially expressed proteins 
in squamous cell carcinoma of the lung tend to be global hubs.
Cellular processes
Overall, the above findings reveal a topological distinction of cancer pro­
teins that is primarily displayed in an increased interaction frequency com­
pared with non-cancer proteins. In the light of this, it is interesting to in­
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vestigate w hether this is due to a pronounced increase w ithin a few cellular 
processes, or w hether there is a uniform  distribution of raised connectivity 
of cancer proteins in all aspects of cellular function.
Table 4.7: The connectivity of proteins in primary GO biological process categories. The 
mean connectivity and standard error of the mean for cancer and non-cancer proteins 
in the five most common categories. The total number of observations for each group 
is shown within parentheses. Stars after the percentage difference of the mean values 
indicate statistical significance according to Wilcoxon rank sum tests, p  < 0.05 (★) and 
p < 0.005 (**)•
Connectivity
GO process class Cancer proteins Non-cancer proteins %
Physiological process 
Cellular process 
Development 
Regulation of biol. process 
Response to stimulus
25.4T2.6 (264) 
27.3T2.8 (261) 
14.1T1.9 (73) 
16.1T4.5 (61) 
35.9T8.0 (40)
13.3T0.3 (7657) 
14.0T0.3 (7509) 
12.6T0.7 (1069) 
11.3T0.7 (1018) 
12.2T0.7 (1076)
+91.0 ** 
+94.3 ★★ 
+11.7 ★ 
+43.0 
+193 ★★
Functional description could be assigned to 404 cancer and 10,757 non­
cancer proteins by using Gene Ontology annotation. O w ing to the possibil­
ity of m ultiple annotations for a single protein, the total num ber of func­
tional descriptions was 714 and 18,711 respectively. The m ajority of the 
proteins can be assigned to five key biological processes: response to stim u­
lus, cellular processes, physiological processes, regulation of biological pro­
cesses and development. Cancer proteins are more highly connected in all 
these categories compared w ith non-cancer proteins (see Table 4.7), w ith  the 
stim ulus response groups and cellular processes (encompassing processes 
that are carried out at the cellular level, e.g. cell adhesion, com m unication, 
signal transduction, differentiation, recognition) showing the greatest en­
richment of highly connected cancer proteins.
4.3.2 Conclusions
In summary, the work presented here has shown that hum an proteins in­
volved in cancer exhibit a network topology which is different from that 
of proteins not docum ented as being m utated in cancer. The observation 
is based on the study of a global protein-protein interaction netw ork, con­
structed by a homology-based m ethod, which we have show n to be capa­
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ble of accurately predicting protein-protein interactions. The m ost striking 
property of cancer proteins is the increased frequency of interactions. This 
observation may indicate an underlying evolutionary pressure to w hich 
cancer genes, as genes of central im portance, are subjected.
The C-clique clustering algorithm  allows us to explore protein-protein 
connectivity in a more informative w ay than is possible just by looking at 
the interaction frequency of each protein. Its feature of overlapping protein  
communities allows us to distinguish betw een central and peripheral hubs 
of highly connecting proteins, revealing proteins forming the backbone of 
the proteome. The fact that an enrichm ent of cancer proteins is observed 
in this group indicates the central role of these proteins. The dom ain com ­
position of cancer proteins may indicate w hy this is the case: it appears 
that cancer proteins contain a high ratio of highly prom iscuous dom ains, in 
terms of the num ber of different proteins w ith which they interact.
An example of a protein show ing the above features is the HSPCA 
(Hsp90) heat shock protein 90kDa 1 alpha, which is shown as a w hite trian­
gle with a red border in a central position in Figure 4.7. Heat shock proteins 
are im portant for cellular homeostasis. Their function is prim arily assisting 
protein folding and transport under physiological conditions, bu t du ring  
stress they can prom ote refolding of dam aged proteins. HSPCA has been 
linked to various processes of carcinogenesis, in particular in relation to 
breast cancer (Teng et al., 2004), and the protein has been shown to have 
both prognostic and therapeutic im plications (Romanucci et al., 2006). The 
diverse role of HSPCA is reflected in its netw ork position and num ber of 
interactions. It contains a prom iscuous (^promiscuity =  4-7 x 10~10) ATPase- 
like dom ain that facilitates a num ber of interactions—linking together p ro ­
tein communities involved in signal transduction and apoptosis. O w ing to a 
change in its binding affinity, tum our HSPCA is exclusively found in m ulti­
chaperone complexes w ith high ATPase activity, whereas HSPCA from nor­
mal tissues is in a uncomplexed, latent state (Kamal et al., 2003).
The results presented here provide first insights into the global netw ork 
properties of cancer proteins and can be used to guide experiments tow ards 
regions of the interactome likely to m odulate cellular processes involved in 
cancer. Further studies, however, are required to resolve the evolutionary 
aspect of these findings fully.
Chapter 4. Global topological features o f cancer proteins 122
m
m
•  «
Figure 4.7: A view of a part of the largest network in Figure 4.4, centred around HSPCA 
(Hsp90) heat shock protein 1 alpha. Each community is coloured in a distinct colour 
as per the colour scheme in the previous figure, except for HSPCA, which is shown as 
a white triangle with a red border. Proteins are labelled with gene name and RefSeq 
identifiers. In addition, cancer proteins are shown as triangles and non-cancer as circles. 
Refer to Appendix B for the complete community collection.
Chapter 5 
Clustering of metastasis-related 
proteins
5.1 Introduction
Not only is genome-wide interactome data useful for general topological 
studies, as shown in the previous chapter, bu t large-scale interaction data 
are highly valuable w hen it comes to understanding cellular function. Com ­
bined with microarray expression data they allow insight into im portant as­
pects of the cellular process under study, where the expression data may be 
used to highlight im portant regions of the protein network.
5.1.1 Gene expression analysis
The different physiological states of the cell correlate w ith different gene 
expression, which can be analysed using m icroarray technology. A m icroar­
ray is a glass slide containing up to tens of thousands of probe sequences 
which are attached to the slide. Probes are either single-stranded com ple­
m entary DNA (cDNA) or oligonucleotides ranging from 25-100 base pairs. 
Target RNA is extracted from the samples of interest, reverse transcribed 
into cDNA, labelled with fluorescent dye and then hybridised to the array. 
The fluorescent intensity of a spot indicates the am ount of RNA expressed 
in the sample (see Figure 5.1 for an explanation of the approach). It is there­
fore possible to identify genes involved in a certain disease by com paring 
the expression level of an abnorm al sample to that of a normal cell line. Tens
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of thousands of transcripts can be detected and quantified sim ultaneously 
which makes the technology ideal for large scale analyses.
5.1.2 Network analysis of expression data
Expression patterns can be uncovered from large-scale m icroarray data by 
systematically grouping genes w ith the help of clustering m ethods. Co­
clustering of genes can indicate that the genes in question have a similar 
function or that they participate in the same cellular process (Eisen et al., 
1998; Niehrs and Pollet, 1999). Nevertheless, m icroarray experim ents typi­
cally yield hundreds of significantly differentially-expressed genes, m aking 
it difficult to draw biological conclusions. Furtherm ore, although microar­
ray experiments can show correlations between co-expressed genes, they do 
not reveal the exact protein interaction mechanism.
Previous studies have m apped expression data of different systems onto 
experimentally-based networks. Ideker et al. (2002) used gene expression 
changes in response to perturbation  to highlight clusters w ithin a yeast net­
work, and Sohler et al. (2004) m ade use of statistical analysis to highlight 
significant sub-clusters, also w ithin a yeast network. Moreover, the dy­
namic aspect of yeast netw orks has been highlighted by de Lichtenberg and 
co-workers (de Lichtenberg et al., 2005), who combined tem poral cell cycle 
expression data with protein-protein interaction networks.
Here the multi-genome hom ology approach described in Chapter 3 was 
used to construct an interactom e for Rattus norvegicus, the brow n rat. The 
m ethod, in contrast to the m ethodologies described above, goes beyond 
data integration and is therefore able to create a more extensive protein 
interaction network and has the added benefit of assigning a confidence 
score to each interaction. The scoring function was further validated and 
expression data on tum our progression resulting in rat sarcomas w ith high 
metastatic potential were subsequently m apped onto the interactome, cre­
ating protein networks around key proteins involved in the metastatic pro­
cess.
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Figure 5.1: A schematic overview of the processes involved in the preparation of high- 
density oligonucleotide microarrays, such ash the Affymetrix microarrays. Sequences of 
short oligonucleotides (typically 25 bases) are chosen from the mRNA reference sequence 
of each gene. The sequences are typically selected to represent the most unique part of 
the transcript. From Schulze and Downward (2001).
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5.1.3 Metastasis
Metastasis is a key event that is associated w ith poor prognosis in cancer 
patients. M etastasising cancer cells have the ability to break aw ay from the 
prim ary tum our and move to different organs, m aking the cancer m ore dif­
ficult to treat. M uch is unknow n about the molecular biology of m etastasis, 
as it is a complex process involving series of interactions betw een the cancer 
cell and its surroundings that lead to the cancerous cells acquiring tw o sep­
arate abilities: increased motility and invasiveness (Bogenrieder and  Her- 
lyn, 2003). A w ide variety of proteins take part in the metastasis, reflecting 
the diverse nature of the process. M etastasis requires proteins w ith differ­
ent functions, ranging from cell adhesion molecules (e.g. cadherins, inte- 
grins and immunoglobulins) to proteolytic proteins, such as m atrix metal- 
loproteinases and serine/cysteine proteases, to various angiogenic factors 
involved in angiogenesis and grow th inducing cytokines.
Table 5.1: The metastatic cascade. Only a very small fraction of malignant tum our cells 
that enter the bloodstream will produce a tum our at a new site (Ahmad and Hart, 1997).
Initial transform ing event
i
Growth of neoplastic (physiologically unregulated) cells
i
Angiogenesis of the tum our
I
Detachment of neoplastic cells from prim ary tum our
I
Local invasion of extracellular m atrix by tum our cells
I
Intravasion of tum our cells into lym phatics or vasculature
I
Survival of tum our cells in circulation and avoidance of 
immunological attack
I
Extravasation of tum our cells from vasculature into 
secondary organ tissue
I
Survival and proliferation at a new site
Table 5.1 illustrates the cascading m etastatic process. Metastatic cancer
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cells travel away from the prim ary tum our through the blood vessels. In 
order for metastasis to take place through the blood vessels, cells in the p ri­
mary tum our m ust go though several separate steps: Firstly, they need to 
migrate to a region of capillaries. Then they digest through the basal lam ­
ina surrounding the capillary and slip between the endothelial cells to enter 
the bloodstream; a process know n as intravasion. Once in the blood stream , 
they m ust attach to endothelial cells and then, by the process of extravasa­
tion, move though from the blood vessel though the epithelial cells, d igest­
ing the basal lamina and settle in the extracellular matrix.
5.2 Methods
5.2.1 Validation
The rat interactome was created using the procedure described in C hapter 3. 
As a complementary approach to the ROC-curve validation described there, 
additional tests were conducted to assess the effectiveness of the scoring 
function—this time using data relating to the brow n rat.
For this purpose, a gold standard data set of transient rat protein com ­
plexes from the RCSB Protein Data Bank (Berman et al., 2000) w as con­
structed. The data set was assembled as follows: Protein chains w ith  high 
sequence homology (sequences detected by BLAST searches w ith expecta­
tion value < 1 x 10“ 10) to Rattus norvegicus were considered. Obligomeric 
complexes (where m ultim eric protein chains are perm anently bound and 
essential for the complex function) were distinguished from transient ones 
(where protein chains m ay be bound to a complex but may also act as a sep­
arate functional protein on its own), by applying the m ethod described in 
Section 2.4.6. Only transient complexes were included in the gold data set, 
which was composed of 377 binary chain interactions.
Cellular localisation of proteins was obtained from the Gene O ntology 
Consortium (A shburner et a l,  2000). Each of the proteins identified by the 
cluster analysis was placed in a basic cellular localisation class as per Ta­
ble 5.2. Protein pairs predicted to interact were considered co-localised if 
they were found in com patible cellular com partments.
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Table 5.2 : A simplified representation of gene ontology cellular compartments. Protein 
accessibility between compartments is represented by ones and zeros: the former 
indicates the possibility of interaction between respective compartments and the latter 
excludes any interactions.
Extra­
cellular
Intra­
cellular
Cyto­
plasm
Nuc­
leus
Mitochon­
drion
Membrane
Extracellular 1 0 0 0 0 1
Intracellular 0 1 1 1 1 1
Cytoplasm 0 1 1 0 0 1
Nucleus 0 1 0 1 0 1
Mitochondrion 0 1 0 0 1 0
Membrane 1 1 1 1 0 1
5.2.2 Microarray expression data for metastatic rat cells
All experimental work regarding gene expression on the metastatic rat cell 
lines was carried out by Tamara Cavanna in the Microscopy laboratory at 
Cancer Research UK London Research Institute and she is acknow ledged as 
a contributor to this work.
To investigate genes that may be im portant in the developm ent of 
metastases, a rat sarcoma m odel was used, in which the cell p opu­
lations K2, T15, A297 and A311 have 0, 40, 90 and 100% incidence 
of metastasis, respectively. Affymetrix m icroarray analysis was per­
formed on the four cell populations and the prim ary tum ours that 
formed when the cells were injected subcutaneously into rats. All exper­
iments were performed in triplicate, using Affymetrix rat 230A GeneChip 
oligonucleotide arrays ( h t tp : / / w w w . a f fy m e tr ix . c o m /su p p o rt/te c h n ica l/ 
d a ta sh e e ts /ra t2 3 0 _ d a ta sh e e t.p d f).
Total RNA was extracted from each sample and used to prepare biotiny- 
lated target RNA; 10 //g of RNA was used to generate first-strand cDNA by 
using a T7-linked oligo(dT) primer. After second-strand synthesis, in vitro 
transcription was perform ed with biotinylated UTP and CTP (Enzo Diag­
nostics), resulting in approxim ately 100-fold amplification of RNA. A com­
plete description of the procedures is included in The Paterson Institute's 
Affymetrix GeneChip systems protocols ( h t t p : / / b i o i n f  . p i e r . m a n . ac . uk/ 
m b c f  / d o w n l o a d s / G e n e C h i p _ T a r g e t _ P r e p _ P r o t o c o l - C R - U K _ v 2  . p d f ).
The target cRNA generated from each sam ple was processed as per
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the m anufacturer's recom m endation using an Affymetrix GeneChip Instru­
m ent System (h t t p : / / w w w . a f f y m e t r i x . c o m / s u p p o r t / t e c h n i c a l / m a n u a l /  
e x p r e s s i o n _ m a n u a l . a f  f  x ) .  Briefly, spike controls were added to 10 }ig frag­
m ented cDNA before overnight hybridisation, arrays were w ashed and 
stained w ith streptavidin-phycoerythrin, and scanned on an Affymetrix 
GeneChip scanner. The procedure is further described in The Paterson 
Institute's RNA Hybridisation protocols ( h t t p : / / b i o i n f  . p i e r . m a n . ac .u k /  
m b c f  / d o w n l o a d s / G e n e C h i p _ H y b _ W a s h _ S c a n _ P r o t o c o l - C R - U K _ v 2  . p d f ).
The m edian fluorescence intensity value of each GeneChip was calcu­
lated and used to normalise the chips. Gene expression was considered in 
terms of fold-changes between non-metastatic and the m edian of the three 
metastatic samples.
RNA consensus sequences for each oligonucleotide probe w ere m apped 
to RefSeq rat protein sequences using Blastx, which converts a nucleotide 
query sequence into protein sequences in all six reading frames.
5.2.3 Creation of networks around differentially expressed 
genes
Rat genes that were overexpressed or underexpressed m ore than four-fold 
were used as starting points (n = 100). N etworks were expanded two 
generations out from the starting points using protein-protein interactions 
whose S-score value from Equation 3.1 was 10 or higher (see Section 5.3.1 
for the basis of the score cut-off selection). The resulting 10,628 interactions 
were then analysed using fc-clique clustering.
Table 5.3 shows the num ber of individual protein com m unities for differ­
ent k-values. Thirty-seven com m unities were identified for k =  4, i.e. setting 
the subgraph size threshold to a m inim um  of four. Selecting the /:-value is 
a balancing act; the higher the k-value, the smaller and more internally con­
nected the communities become, bu t less connection is observed betw een 
communities. The k-v alue was selected after observing that at k =  4, rea­
sonably large communities were formed. Proteins which shared sequence 
identity higher than 40% within each com m unity were m erged together 
such that they appeared as single nodes on the protein map. These m erged 
nodes inherited all the interactions from the individual proteins before the
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merging process. This was done to correct for any possible redundancies 
caused by the homology-based m ethod for predicting protein interactions 
and there was negligible change in the protein netw orks as a result of this.
Table 5.3: The number of protein communities vary as the ^-threshold value for cluster­
ing is changed. The table shows the total num ber of separate protein communities for 
each /c-value.
^-threshold N um ber of communities
3 145
4 37
5 12
6 8
7 2
8 1
9 1
10 1
11 1
5.3 Results and Discussion
Networks of interacting proteins were constructed automatically for the en­
tire rat (Rattus norvegicus) genome using the approach described in C hap­
ter 3. The num ber of individual interactions was reduced from 325,087 
to 151,049, w hen the scoring function w as applied to filter out low-quality 
data, and was further cut dow n by a clustering m ethod aimed at identifying 
key interconnected network nodes.
5.3.1 Validation of the scoring function
The scoring function was validated on the hum an data set in C hapter 3, 
however here it is further verified, using structural and biological data that 
is available for the rat system.
Selection of cut-off value for the scoring function
The network construction is based on homology to known interactions 
and it is therefore imperative to ascertain the m inim um  level of hom ology
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whereby the structural and functional sim ilarity of the interacting proteins 
is retained. As m entioned in Chapter 1, pairs of interacting proteins can be 
considered structurally similar if their sequence identity is no low er than 
30% (Aloy et a l ,  2005). The m ethod here utilises Blast bit scores as a com po­
nent in the scoring function and so the relationship between bit scores and 
sequence identity needed to be tested. At the 30% sequence identity level, 
the bit score ranges linearly from 86-177 (see Figure 5.2) which, according 
to Equation 3.1, yields m inim um  interaction scores ranging from 9 to 10. 
The m inim um  score for interactions was set at 10 to minimise possibilities 
of false positive results arising from low homology.
Identification of highly reliable interactions
Many methods for detecting protein-protein interactions can yield either 
false positive or false negative results, nevertheless X-ray crystal structures 
of complexed proteins can be considered to be a gold standard for proof. 
The validity of the scoring of interactions was established by exam ining the 
score distribution of proteins in two separate groups: the rat protein inter­
actions in the gold standard set that have either been crystallised together 
in a complex or have a very high homology to one that has been, and  inter­
actions w ithout any crystallographic evidence, i.e. those that do not interact 
or have not been proved to do so by crystallography.
The interactions in the gold standard data set, identified by X-ray crys­
tallography, were found to score higher than those w ithout crystallographic 
evidence, w ith m edian scores 128 and 16 respectively and m ean scores 
443 ±  34 for the gold standard set and 364 ±  1 for those w ithout crystal­
lographic evidence (see Figure 5.3). This difference was significant (p < 
2.2 x 10“ 16) according to a Wilcoxon rank sum  test, indicating that true in­
teractions score higher than those whose association has not been confirm ed
Table 5.4: Interaction score distribution for complexes confirmed by X-ray crystallogra­
phy (n — 377) compared with the scores of all (genome-wide) predicted interactions.
Interaction score, S X-ray complexes (%) Genome-wide (%) 
0 - 1 0  6A 432
> 10 93.6 56.8
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Figure 5.2: The sequence identity and bit score of each hit when proteins in the interaction 
data were queried against the rat genome. The solid red line shows the best linear fit to 
the data and shown in dotted red is a line, starting at the origin, which contains 97% of 
the data in the area below it. Reading from these lines at 30% sequence identity gives bit 
scores of 86 and 177, respectively, yielding interaction scores of 9 and 10 when inserted 
into Equation 3.1. To ensure a stringent criterion for the minimum interaction score the 
higher value was selected as a cut-off score.
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Figure 5.3: The scoring function was assessed by investigating the scores of binary X-ray 
crystal structure complexes, compared with the distribution of scores for the whole rat 
genome. The X-ray crystal structures received a higher interaction score than expected 
from the genome-wide distribution, with median scores of 128 and 16 respectively, indi­
cating that higher-scoring interactions are less likely to be false.
by crystallography. Moreover, as show n in Table 5.4, about 94% of the in­
teractions confirmed by X-ray crystallography score above 10, reaffirming 
the choice of the cut-off score, whereas just under half of all genome-wide 
predicted interactions score 10 and lower.
Community participation and cellular localisation
Another way of estimating the quality of the scoring function is to look at 
proteins participating in the same cellular process and compare them w ith 
proteins that are not thought to interact directly in a pathway. The clique 
percolation method, which was described in the previous chapter, w as used 
to identify communities within the netw ork that show high interconnec­
tivity. This yielded 37 communities of tightly interconnected proteins that 
will be described later. One can assume that interactions within com m uni­
ties are more likely to be true than interactions between communities, i.e. 
higher scores would be expected for intra-community interactions (Palla 
et a l, 2005). This was found to be true; the mean score for interactions 
within a community was 25.2 ±  0.5 (n =  2038) and the mean score for inter­
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actions between com m unities was 13.5 db 0.4 (n =  502). This is significant 
(p < 2.2 x 10~16) according to a Wilcoxon rank sum  test.
Lastly, the protein interaction scores were exam ined in the context of 
cellular localisation. It can be hypothesized that for true interactions, inter­
acting proteins w ould co-localise in the same cellular com partm ent, at least 
during the time of interaction, and one w ould expect predicted interactions 
between proteins in separate cellular com partm ents to be less reliable and 
receive a lower score. Localisation data from the Gene Ontology Consor­
tium (Ashburner et al., 2000) were used, where available, for proteins w ithin 
the thirty-seven protein communities. Of the protein interactions predicted, 
681 (94%) were considered co-localised, w ith a m ean score of 25.8 ±  1.0; and 
41 (6%) were annotated as not sharing cellular localisation, w ith a m ean 
score of 13.1 ±  1.1. A Wilcoxon test shows that this score difference is statis­
tically significant {p =  4.87 x 10-9 ).
Collectively, the results presented in this section further substantiate the 
validity of the scoring function and indicate that the score cut-off used for 
the generation of the netw orks in this study is appropriate.
5.3.2 Identification of metastatic communities
The metastatic process involves a complex netw ork of cascading protein- 
protein interactions w hich have to be unravelled if an effective treatm ent is 
to be developed. Here an attem pt is m ade to examine these netw orks by 
combining expression data w ith netw ork information. As a starting point, 
data from a m icroarray analysis of cell lines w ith different metastatic poten­
tials was used (see M ethods). The highest up- and dow n-regulated genes (>  
4-fold up- or down-expression) were singled out and protein netw orks con­
structed around these, extending two generations from the starting point, 
i.e. initially including proteins that interact directly w ith the originating pro ­
tein and then going on to include the proteins that interact w ith them. This 
subset of the rat interactom e contained 10,628 interactions.
A cluster analysis w as then perform ed to highlight areas in the protein 
networks that are involved in the metastatic process. The clustering is based 
on the previously described clique percolation m ethod which distinguishes 
communities of highly interconnected proteins that make up the essential 
structural units of the networks. Palla et al. (2005) have shown that clique
Chapter 5. Clustering o f metastasis-related proteins 135
clustering analysis is a pow erful tool to identify com m unities of proteins 
participating in the same cellular processes. Furtherm ore, it has been shown 
that subnetworks of proteins involved in a defined cellular process are more 
heavily interconnected by direct protein interaction than  w ould be expected 
by chance (Gunsalus et al., 2005). Highly connected proteins are also more 
likely to be essential to cellular processes (Jeong et al., 2001).
The clustering m ethod identified 37 highly interconnected communities, 
containing 313 proteins involved in 1,094 interactions (Figure 5.4). The m a­
jority of the communities have been associated w ith cancer and metastasis. 
Some show a degree of overlap and are linked, the m ost prom inent link run­
ning through the centre of the figure and containing 17 com m unities linked 
in a chain-like manner, how ever others are not linked, for example, the tran­
scription regulation, which consists of only four proteins. A more detailed 
description of this graph can be found in A ppendix D and an annotated list 
of all the participants is included in A ppendix E.
An initial analysis of the structural- and functional com position of the 
networks was perform ed using Domain Fishing (Contreras-M oreira and 
Bates, 2002), which assigns structural dom ains to sequences based on ho­
mology to known domains. W hen com paring the dom ain composition of 
the communities to dom ain frequencies of the w hole rat genome a bias 
was observed towards classes of dom ains found in proteins involved in 
cytoskeletal structures, cell m otility and cell-signalling (see Table 5.5). All 
but one of the most frequent dom ains are overrepresented w hen compared 
w ith the genome-wide distribution; only im m unoglobulin dom ains appear 
less frequently. Spectrin repeat domains, which top the table, are found in 
proteins involved in cytoskeletal structure, such as spectrin, ft-actinin and 
dystrophin. They are know n to bind to calponin hom ology domains, which 
are found in both cytoskeletal and signal transduction proteins. The IQ 
calmodulin-binding dom ains w ork as Ca2+ switches for myosin which is 
involved in cell motility and chemotaxis. Furtherm ore, protein kinase do­
mains, SH2 and SH3 dom ains and protein-tyrosine phosphatase dom ains 
participate in signal transduction and are know n to interact. These cate­
gories of domains, and associated functions and interactions, are all of in­
terest in the context of cancer metastasis.
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Figure 5.4: The communities identified by Jr-clique analysis performed on the predicted 
genome-wide rat protein network. The communities are distinguished by different 
colours and labelled by the overall function or the dominating protein class. Note that 
proteins, particularly at community edges, can belong to more than two communities, 
although this is not shown.
Table 5.5: The table shows the most frequently observed domains in the metastasis- 
related cluster communities (observed frequencies) alongside the expected domain fre­
quencies, based on the domain composition of the whole rat genome. The /i-fold differ­
ence was calculated from the frequency percentages (numbers within parentheses).
Domain
Spectrin repeat
IQ calm odulin-binding motif
EGF-like dom ain
Protein kinase dom ain
SH2 dom ain
EF hand
Im m unoglobulin dom ain 
SH3 dom ain
Calponin homology (CH) dom ain 
Proteasome A-type and B-type 
LIM dom ain
Transforming growth factor /Mike dom ain
Observed Expected n-fold
frequency (%) frequency (%) difference
56 (6.9) 6 (0.7) 8.3
54 (6.6) 2 (0.2) 26.5
52 (6.4) 16 (2.0) 2.2
47 (5.8) 12 (1.4) 3.0
27 (3.3) 2 (0.3) 11.7
25 (3.1) 7 (0.8) 2.6
21 (2.6) 35 (4.3) -0.4
20 (2.4) 6 (0.7) 2.6
13(1.6) 2 (0.3) 5.4
12(1.5) 1 (0.1) 20.0
11 (1.3) 3 (0.4) 2.7
10(1.2) 1 (0.1) 11.2
C
hapter 
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lustering 
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proteins 
137
Chapter 5. Clustering o f metastasis-related proteins 138
The intracellular signalling cascade
It is not the aim here to explore every m em ber of each com m unity—the au ­
tomatic identification of m etastatic-related protein communities is the p ri­
mary focus. However, the value of the approach will be illustrated by de­
scribing a key section of the regulation pathway. The intracellular signalling 
cascade constitutes the head of a chain of com m unities (Figure 5.4), and  as 
such w arrants a closer investigation.
Figure 5.5 shows a detailed view of some of the interactions w ithin 
that community, focused on the intersection w ith the vascular endothelial 
growth factors (VEGFs) and the JAK/STAT group. Many of the interactions 
in this network have been established either in rat or in other species; others 
have not been previously dem onstrated and it m ay be proposed that these 
might have a role in the context of the surrounding proteins.
Three separate groups of proteins are distinguishable: vascular endothe­
lial growth factors (Vegfa, Vegfc, Figf) and  the receptor (Kdr), which play a 
principle role in tum our progression and  angiogenesis (Ferrara et al., 2003) 
and which have also been associated w ith tum our metastasis (H irakaw a 
et a l, 2005); insulin-like growth factors and receptors (Igfl, Ig flr and Grb 
7/14); and JAK/STAT proteins (JAK2, STAT5b).
The figure shows the three ligands, Vegfa and Vegfc and Figf, at differ­
ent levels of expression, all of which can bind to the kinase insert dom ain 
protein receptor Kdr, a VEGF receptor, which in turn induces m itogenesis 
and differentiation of vascular endothelial cells (Takahashi et al., 1999).
The interaction between Kdr and Socsl, an SH2 dom ain-containing sup­
pressor of cytokine signalling 1, is plausible as Kdr has a tyrosine protein 
kinase domain which in a mouse hom ologue has been shown to interact 
with Socsl (Bourette et a l, 2001). Furtherm ore, up-regulation of Socsl has 
been linked w ith the suppression of cytokine signalling and the JAK/STAT 
inflammatory signalling pathw ay (Alexander and Hilton, 2004; Park et al., 
2003; Ali et al., 2003), which is show n here further dow n the network; here 
also, Socsl is up-regulated and JAK/STAT down-regulated.
The proposed P tpn ll-L ck  interaction is based on orthology to an interac­
tion between Ptprc and Lck in mouse. P tp n ll  and Ptprc both have tyrosine 
specific protein phosphatase activity. P tp n ll  is phosphorylated by tyrosine 
protein kinases, contains two SH2 dom ains and therefore could be phos-
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Figure 5.5: The figure shows a subsection of the network around the intracellular sig­
nalling cascade where it extends to the VEGFs and JAK/STAT protein communities. The 
confidence of the interactions is shown by colour coding based on the interaction scores 
ranging from low-scoring blue (10 < S < 10.5) to high-scoring red (S >  40.0). The 
metastatic cell line expression levels are also shown; blue for down-regulated genes and 
red for up-regulated ones.
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phorylated by Lck.
Higher up the netw ork are the insulin-like grow th factor 1 and its recep­
tor (Igfl and Igflr, respectively) which are highly im plicated in different 
cancers (Furukawa et a l, 2005; Hofm ann and Garcia-Echeverriaon, 2005; 
All-Ericsson et a l, 2002). The insulin-like grow th factors are involved in 
several cellular processes, such as regulation of proliferation, m igration, 
survival, size control, and differentiation (LeRoith et a l, 1995; Yenush and 
White, 1997; Massague and Czech, 1982; Ullrich et a l , 1986). Ig flr is overex­
pressed in most m alignant tum ours, where it functions as an anti-apoptotic 
agent by enhancing cell survival. Igfl has also been show n to enhance ad­
hesion and motility of cancer cells (Dunn et al., 1998; A ndre et al., 2004); 
however, the exact role of Ig flr in the metastatic process has not been es­
tablished. The netw ork show n here suggests a link betw een the insulin-like 
grow th factor receptor and the vascular endothelial grow th factors through 
the highly up-regulated phospholipase delta 4 (Plcd4) and phospholipase 
gam m a 1/2  (Plcg 1/2). The Plcg 1 /2  and Ig flr interaction is based on the 
fact that the phospholipase has been show n to interact w ith an insulin re­
ceptor, a close hom ologue of the insulin-like receptor.
Another distinguishing feature in the netw ork is the highly down- 
regulated protein tyrosine phosphatase (Ptpnl3). It has been reported that 
a protein tyrosine phosphatase, Ptp61F, negatively regulates the JAK/STAT 
pathw ay in Drosophila melanogaster (Muller et al., 2005). The networks sug­
gest that the signalling protein tyrosine phosphatase, P tpnl3 , may act on 
the JAK/STAT pathw ay similarly, through the dephosphorylation of the 
growth hormone receptor Ghr.
The few examples show n here illustrate the value of the approach in 
terms of revealing potential pathw ays and interactions that play a part in 
cancer metastasis, nevertheless further experim ental work will be needed 
to confirm the validity of these predictions.
5.3.3 Network view  of gene expression
Extracting meaningful inform ation from m icroarray expression data is of­
ten difficult, especially w hen looking at a complex process involving a large 
num ber of genes and unknow n mechanisms. C lustering of genes may be of 
use when trying to find genes in a common pathw ay and genes with related
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function, but this often has lim itations, such as in identifying negative feed­
back loops (Armstrong and  van de Wiel, 2004). Furtherm ore, even if key 
proteins are highlighted through microarray analysis, the expression data 
rarely reveals all proteins involved in a particular pathw ay
Examining the distribution of up- and dow n-regulated proteins in the 
context of their neighbours shows that this is indeed the case for the pro­
tein netw orks shown in Figure 5.4. The metastatic expression data was 
m apped onto the netw orks and the frequency of pairs of interacting genes 
was examined, based on the pairw ise expression (up-up, dow n-dow n and 
up-/dow n-regulated  pairs). The results, in Table 5.6, indicate that if expres­
sion data from the netw ork w as random ly redistributed, the probability of 
observing two up-regulated proteins interacting w ith each other is about the 
same as the observed probability. That is, up-regulated proteins do not have 
a trend of directly interacting w ith each other, but are interlinked through 
either neutrally expressed or dow n-regulated proteins. Moreover, down- 
regulated proteins are m uch less likely to interact w ith each other than ex­
pected, dem onstrating the benefit of projecting the expression data onto al­
ready built networks, as clustering similarly expressed genes and assigning 
to the same pathw ay w ould not be effective.
Table 5.6: Observed and expected frequencies of pairwise protein interactions, cate­
gorised by their expression: N-N (non-expressed protein interacting with non-expressed 
protein), U-U (up-regulated protein interacting with up-regulated protein), D-D (down- 
regulated protein interacting with down-regulated protein) and U-D (up-regulated inter­
acting with down-regulated). For the purpose of the classification, up-regulated proteins 
are those up-regulated more than 20% and down-regulated proteins down-regulated 
more than 20%. Expected values were calculated based on a random distribution of the 
expression data on the network (p <  0.001 for a ,y2-test).
O bserved Expected n-fold difference
N-N 8 5 1.5
U-U 121 109 1.1
D-D 17 41 0.4
U-D 71 67 1.1
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5.4 Conclusions
Expression data has previously been p u t into a netw ork context, for exam­
ple by incorporating gene ontology data (Jansen et al., 2002a) and  protein 
interactions (Segal et a l, 2003), bu t here the netw orks were generated first 
and the expression data m erged w ith  the networks before being subjected 
to clustering analysis. This approach allows bypassing of some of the obsta­
cles involved in traditional m icroarray analysis, such as clustering of gene 
expression patterns; as dem onstrated here, interactions of up-up  and  down- 
dow n regulated genes are not necessarily co-localised.
Subnetworks around highly up- and dow n-regulated genes w ere ini­
tially selected to focus on the parts of the genom e-wide interaction netw ork 
relevant to metastasis. The clique m ethod was then used to further highlight 
hubs of highly interconnected protein com m unities w ithin the networks. 
This allows examination of the m ost complex parts of the netw ork but as 
a result simple linear pathw ays do not get included. A lthough this gen­
eral approach of combining gene expression w ith rat interactom e data has 
show n some useful results, there rem ain some shortcomings. M ost im por­
tantly, transient protein-protein interactions are unlikely to be captured by 
the approach. This is a direct consequence of transient not being as well 
docum ented as non-transient interactions. Moreover, the m ethod cannot 
distinguish between true positives and false positives for w hich there is 
limited experimental data. These problem s will be alleviated as m ore high- 
throughput proteomic studies are completed. The system-level approach 
taken here is a particularly appealing w ay to gain an understanding  of com­
plex biological processes, such as metastasis. A lthough not discussed here 
in great detail, several interesting groups of interactions have been high­
lighted as potentially im portant players in the metastatic process. Further 
dissection of these is the subject of ongoing studies and consequently to be 
confirmed experimentally.
Chapter 6 
Concluding remarks
The work presented in this thesis is a study of proteins and their inter­
actions, ranging from the m ost fundam ental aspects—protein structure— 
through to predicting individual interactions and assembling large net­
works of interactions in as complete a way as possible.
6.1 Intron-exon boundaries
We employed statistical analysis to investigate the locations of intron-exon 
boundaries in protein structures w ith the aim of discovering the structural 
aspect of IEB location. We also asked w hether know ing the location of IEBs 
may be used as one of the indicators for identifying interaction sites. The 
analysis revealed an enrichment of IEBs in coiled regions of protein struc­
ture as well as at the ends of ^-helices and /1-strands. This was also con­
firmed in an analysis of sequence conservation: IEBs were show n to appear 
with a higher frequency in areas of low sequence conservation, w hich is of­
ten a feature of the loosely structured coil regions. Looking more closely at 
this phenom enon from a protein-interaction perspective, one w ould expect 
the boundaries also to have a tendency to stay away from protein inter­
faces, which often show signs of increased conservation. This could not be 
dem onstrated for the boundaries of constitutively spliced exons; how ever 
we observed that alternatively spliced boundaries tend to steer clear of in­
terface areas. Nevertheless, in the case of the alternatively spliced exons, the 
observation is based on a very limited data set and it would be p ruden t to 
re-examine this issue once more IEB data becomes available. Until then, it
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is not possible to say w hether IEB inform ation is useful as a param eter for 
prediction of protein-protein interactions.
6.2 Predicting interactions
In order to predict protein-protein interactions we developed a structure- 
independent algorithm  that is suitable for large-scale predictions. The ap ­
proach is based on the idea of conservation of interactions through sequence 
conservation, and as such is suitable for predicting de novo interactions in an 
organism that has not been subject to extensive experim ental studies. We 
improved the previously described interolog-based m ethods by introduc­
ing a simple scoring function, which takes into account the level of hom ol­
ogy to the experimentally detected interactions. An additional feature of the 
scoring function is the evidence weighting: predictions based on repeatedly 
experimentally-confirmed interactions receive a higher score. Furtherm ore, 
the accuracy of the scoring function was confirm ed by a ROC-curve analy­
sis. In spite of this, there is scope for im provem ent. In particular, the scoring 
could take view of the data source and assign a higher score to predictions 
based on small core-data that is deem ed highly reliable. Furthermore, as­
signing different weights to the various experim ental m ethods may also im ­
prove the accuracy by aw arding higher confidence to data based on highly 
reliable experiments, such as X-ray crystallography, while giving less reli­
able high-throughput m ethods a lower rating. The w eight assigning, how ­
ever, raises the question of how to accurately rate the relative quality of one 
experiment against another.
The uses of a predicted interactome are m ainly threefold: firstly, it al­
lows further exploration of known pathways; secondly the predictions can 
be used as an aid for designing new experim ents by indicating likely in­
teractions based on orthologous interactions; and finally, the interactome 
information is well-suited for integration w ith additional datasets w ith the 
aim of discovering the mechanisms behind a particular disease. This ap ­
proach, however, is not w ithout its limitations. As the predictions are solely 
based on experimental data, any gaps in experim ental screening will leave 
gaps in the predicted interactomes and no attem pt was made here to esti­
mate the prediction coverage for the three species whose interactomes were
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constructed.
6.3 Interactome analysis
The study of interactomes is increasingly providing valuable inform ation on 
biological systems. We dem onstrated the usefulness of the predicted inter­
actomes by conducting two separate studies. We first exam ined the overall 
topology of the hum an interactom e and compared the netw ork properties 
of two groups of proteins: proteins related to cancer and those not doc­
um ented as being implicated in cancer. We revealed that cancer proteins 
show an increase in the num ber of proteins with which they interact. They 
also appeared to participate in central hubs rather than peripheral ones, m ir­
roring their greater centrality and participation in netw orks that form the 
backbone of the proteome. Moreover, we showed that cancer proteins con­
tain a high ratio of highly prom iscuous structural dom ains, that is, dom ains 
w ith a high propensity for m ediating protein interactions. These observa­
tions may indicate an underlying evolutionary distinction between the two 
groups of proteins, reflecting the central roles of proteins, whose m utations 
lead to cancer.
The second study identified key protein com m unities and potential in­
teractions of proteins likely to be implicated in cancer metastasis. This was 
done by m apping gene expression data from highly metastatic rat cell-lines 
onto the rat interactome and subjecting the data to cluster analysis. The 
cluster analysis revealed distinct, tightly interconnected protein com m uni­
ties that play a role in metastasis. The results indicate that the combination 
of microarray expression data w ith protein network inform ation is a pow er­
ful way to shed light on biological mechanisms. This is an approach that can 
be extended to other species in conjunction with expression data relating to 
different biological states or diseases, although any predicted interactions 
w ould have to be confirmed experimentally.
6.4 Future directions
In recent years a great deal of em phasis has been pu t on studying biological 
phenom ena as a system of complex molecular networks. The success of this
Chapter 6. Concluding remarks 146
approach has been driven by the developm ent of high-throughput m ethods 
that allow screening of a large portion, or even the entire set, of proteins in 
an organism. This trend will no doubt continue, w ith the possibility of the 
hum an interactome netw ork being studied on a proteome-scale. Large-scale 
data sets will need to be increasingly integrated w ith the aim  of im proving 
the quality of the data (Vidal, 2005). Additionally, interaction data sets will 
need to be supplem ented by orthogonal experimental and com putational 
approaches to increase the proportion of highly confident interactions (Ge 
et al., 2003). To this end, experim ental m ethods such as X-ray crystallogra­
phy, TAP and MS will, w ithout a doubt, provide valuable addition  to Y2H 
data. Improvements in com putational m ethods, such as hom ology-based 
m odelling and docking m ay also provide additional m eans to validate and 
extend the experimentally determ ined maps.
Another development, which we may see sooner, is the application of 
flux and systems approaches to investigate cellular pathw ays and disease 
states. This may be achieved by m aking use of tem poral expression data 
in an attem pt to distinguish betw een active and inactive paths in the net­
work (de Lichtenberg et al., 2005; Zhao et al., 2006), leading to a dynamic 
netw ork construction in contrast to the static approach taken in this the­
sis. Moreover, the relative expression levels of neighbouring proteins may 
prove an im portant consideration, w hen protein netw orks are to be subse­
quently m odulated in conjunction w ith disease analysis, for exam ple by tar­
geting the expression of a particular gene by short interfering RNA (siRNA) 
(Karagiannis and El-Osta, 2005). A dding these extra dim ensions to interac­
tome data inevitably increases the dep th  of the analysis, bringing us closer 
to the situation where we are able to use mathematical m odels to charac­
terise, simulate and elucidate the mechanisms underlying both norm al and 
abnorm al cellular function.
Appendix A 
Statistical methods
Much of the analysis in this work relies on statistical tests for interpretation 
of the significance of the observations. This appendix describes the statisti­
cal tests that were used in this work.
The distribution of data can either be parametric, i.e. norm ally- 
distributed, or non-parametric, in w hich case the data is not norm ally dis­
tributed. This needs to be taken into consideration w hen the statistical 
m ethod is selected, as some m ethods assum e normal distribution for a cor­
rect interpretation.
A .l Comparative statistics
An im portant task in data analysis is to compare two or more sets of data to 
determine w hether one set is significantly different from the others or if they 
are essentially the same, i.e. coming from the same population. The most 
common statistical tests are the t-test, which assumes normal distribution, 
and the Wilcoxon rank sum test, which does not require any assum ptions in 
regard to the data distribution.
Student's t-test
The most common comparative statistical test is the f-test, which is used 
when there are two sets of continuous and norm ally-distributed data to 
compare. Each data set is characterised by its mean, standard deviation 
and num ber of data points. The t-test is used to support or reject a null hy­
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pothesis (HO) that the means of the two norm ally distributed populations 
are equal, effectively indicating w hether the two sets of samples are equally 
distributed or not. The test can be either paired (e.g. w hen the same popu la­
tion is m easured twice to compare a m easurem ent of some sort of interven­
tion), or independent (for instance w hen individuals are random ly assigned 
into two groups).
The approach for the unpaired case is as follows (Armitage and Berry, 
1994). Suppose x\ and % 2 are the m eans of the two samples, whose size is n\ 
and ri2 , respectively. The variance, s2, of the two samples is first calculated 
by:
s 2 =  £ ( ! ) ( *  ~ * l ) 2 +  L ( 2 ) ( x  ~  * 2 ) 2 ^
Yi\ +  ri2 — 2
The standard error of the difference of the two means, is given by
S E ^ - x z H  +  (A.2)
and to test the null hypothesis that \i\ =  \i2 , the t-statistics is calculated by
t =  7 - ~ X2- v  (A -3)SE(x! -  x 2)
Using information on the degrees of freedom (n\ +  ni — 2), and com paring 
to a statistical table containing details of the f-distribution, the probability 
(p) of observing a greater t value can be obtained. This p-value represents 
the likelihood that the null-hypothesis is w rongly rejected, that is, assum ing 
that the distributions are different w hen they are not.
Wilcoxon rank sum test
The Wilcoxon rank sum, also known as the M ann-W hitney U test, is non- 
parametric and is used in place of a two sample t-test when the populations 
being compared are not normal. It requires independent random  sam ples 
of sizes n\ and ri2 . The test is simple and consists of combining the two 
samples into one sample of size ri\ +  112, sorting the result, assigning ranks 
to the sorted values and then letting U-[ and U2 be the sum of the ranks 
for the observations in the first and second samples, respectively. If the two
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populations have the sam e distribution then the sum  of the ranks of the first 
sample and those in the second sample should be close to the same value. 
Statistical p-values can then be obtained from Wilcoxon two-sample tables 
by comparison of the If-values.
A.2 Statistics for frequency data
Frequency data requires a different approach to m ost other data, as it is not 
possible to calculate the mean, standard deviation or do a t-test on this kind 
of data. A common test for this type of data is the ^ 2-test.
* 2-test
The ^ 2-test is used to investigate association betw een frequency data in two 
separate groups. Each group can have counts in two or more categories 
and the frequency data are set out in a contingency table. In this thesis it 
has mainly been used to compare categorical frequencies in a subset of data 
(the observed values), to the general frequencies in the complete set (the 
expected values). The test is calculated by
x 2 =  l ( o _ e I '  ( A 4 )
for all observed (O) and expected (E) categories. The null-hypothesis, that 
states that the observed and expected groups are the same, is then either 
accepted or rejected based on comparison w ith a ^ -d is trib u tio n  table that 
gives the p-value.
A.3 Association statistics
A common task in data analysis is to investigate the correlation betw een 
variables. Correlation indicates w hether the two variables vary together. 
A positive correlation indicates that both variables increase or decrease to­
gether, whereas negative correlation indicates that as one variable increases, 
so the other decreases, and vice versa. Unrelated variables would then get
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a value around zero. The m ost com m on tests for correlation are the Pear­
son's product-m om ent correlation for param etric data and Spearm an's rank 
correlation for non-param etric data.
Pearson's product-moment correlation
The Pearson product m om ent correlation coefficient is a dimensionless in­
dex that ranges from -1.0 to 1.0, inclusive, and reflects the extent of a linear 
relationship between two data sets, X and Y, that are represented by n m ea­
surem ents, (x,y) .  It is given by
r = , ( A .5 )
y/nEx2-(Lx) 2^ /nEy2-(Ly)2'
and generally speaking, the strength of correlation can be classified accord­
ing to the following levels:
0.9 to 1.0 very high correlation
0.7 to 0.9 high correlation
0.5 to 0.7 moderate correlation
0.3 to 0.5 weak correlation
0.0 to 0.3 little, if any no correlation
Spearman's rank correlation
The Spearman's rank correlation, ps is more suitable com pared to Pearson's 
if there is any uncertainty regarding the distribution of data, as it does not 
assum e normal distribution and is also suitable for ranked data. It gives as 
m uch information as the Pearson correlation coefficient and is valid under 
a w ider range of circumstances (Altman, 1991).
The Spearman's rank correlation coefficient is defined by
. (« ,
vE*2E«r
where x and y are the statistical rank num bers for the two groups of data 
being tested. Moreover, the significance of the correlation can be tested by
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the Spearman f-statistic
t , /  l _ p2 '  (A '7>
which alongside the degrees of freedom allows the estim ation of the p- 
value.
Appendix B 
A detailed view of the human 
cancer communities
A detailed graphical view of the cancer communities at ^-clustering value 
6. Each com m unity is coloured in a distinct colour as per the colour scheme 
in Figure 4.4. Cancer proteins are show n as triangles and non-cancer as 
circles. Proteins are labelled w ith gene nam e and RefSeq identifiers — in 
case of m ultiple isoforms, the gene nam e will appear more than once with 
each isoform showing a separate RefSeq identifier.
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Appendix C 
KEGG pathway information for 
human protein communities
KEGG pathw ay inform ation for the protein com m unities (k =  6) identified 
by netw ork clustering. The interaction m aps for these com m unities are de­
tailed in A ppendix B.
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Co m m u n i ty  0 ( k  =  6 )
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REGULATORY Im m une System T cell receptor signaling  pa thw ay
REGULATORY Im m une System B cell receptor signaling  pathw  ay
REGULATORY Signal T ransduction Insulin  signaling pathw ay
REGULATORY Signal T ransduction A dipocvtokine signaling  pa thw ay
REGULATORY M etabolic D isorders Type II diabetes m ellitus
N'P_002493 NFKB2
REGULATORY Signal Transduction MAPK signaling pa thw ay
REGULATORY Cell G row th  and Death A poptosis
REGULATORY Im m une System Toll-like receptor signaling  pa th w ay
REGULATORY Im m une System T cell receptor signaling  pa thw ay
REGULATORY Im m une Svstem B cell receptor signaling  pathw  ay
REGULATORY Signal Transduction Adipocvtokine signaling  pa thw ay
NP_003630 IKBKG
REGULATORY Signal Transduction MAPK signaling pa thw ay
REGULATORY Cell Grow th  and Death A poptosis
REGULATORY Im m une System Toll-like receptor signaling  pa thw ay
REGULATORY Im m une System T cell receptor signaling  pa th w ay
REGULATORY Im m une Svstem B cell receptor signaling  pa thw ay
NP_003943 MAP3K14
REGULATORY Signal Transduction MAPK signaling pa thw ay
REGULATORY Cell Grow th  and Death A poptosis
REGULATORY Im m une Svstem T cell receptor signaling  pathw ay
\'P_003989 \FK B 1
REGULATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Cell G row th  and Death A poptosis
REGULATORY Im m une Svstem Toll-like receptor signaling  pa thw ay
REGULATORY Im m une Svstem T cell receptor signaling  pathw ay
REGULATORY Im m une Svstem B cell receptor signaling  pathw ay
REGULATORY Signal Transduction A dipocvtokine signaling  pathw ay
NIM.104347 NFKBIE
REGULATORY Im m une Svstem T cell receptor signaling  pathw ay
REGULATORY Im m une System B cell receptor s ignaling  pathw ay
REGULATORY Signal Transduction Adipocvtokine signaling  pathw ay
N 'P JX K W MAP3KS
REGULATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Im m une Svstem T cell receptor signaling  pathw ay
\P_003339 HSPCA
REGULATORY Im m une Svstem A ntigen processing and  presen tation
\P_006390 NEATS
REGULATORY Signal Transduction VVnt signaling pathw ay
REGULATORY Developm ent Axon guidance
REGULATORY Im m une Svstem N atural killer cell m ed ia ted  cytotoxicity
REGULATORY' Im m une Svstem T cell receptor signaling  pa thw ay
REGULATORY Im m une Svstem B cell receptor signaling  pa thw ay
\P_037386 TBK1
REGULATORY Im m une Svstem Toll-like receptor s ignaling  pathw ay
\P_034721 IKBKE
REGULATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Im m une Svstem Toll-like receptor s ignaling  pa thw ay
\P_06S390 NFKBIA
REGULATORY Cell Grow th and Death A poptosis
REGULATORY Im m une Svstem Toll-like receptor s ignaling  pathw ay
REGULATORY Im m une Svstem I cell receptor signaling  pa thw ay
REGULATORY Im m une Svstem B cell receptor signaling  pathw ay
REGULATORY Signal Transduction A dipocvtokine s ignaling  pathw ay
C o m m u n i ty  1 ( k 6 )
\T _002107 HLA-A
REGULATORY Signaling M olecules and Interaction 
REGULATORY Im m une Svstem
Cell adhesion  m olecules (CAM s) 
A ntigen processing and  p resen tation
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REGULATORY Im m une Svstem N atural killer cell m ediated cvtotoxicitv
REGULATORY M etabolic Disorders Tvpe I diabetes m ellitus
\T_002110 HI.A-DO A
REGULATORY Signaling M olecules and  In teraction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem A ntigen processing and presentation
REGULATORY M etabolic Disorders Ivpe I d iabetes m ellitus
N T jX )2111 HLA-1XTB
REGULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGUI A lt 'K '. Im m une Svstem A ntigen processing and presentation
REG.ULATORY M etabolic D isorders Ivpe I diabetes m ellitus
\ I ’J '0 2 1 12 11LA-OPB1
REGULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem Antigen processing and presentation
REGULATORY M etabolic Disorders H pe I diabetes m ellitus
X T .0021 n H l.A -lX JA l
REGULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULAIORY Im m une S\ stem A ntigen p r.xessing  and presentation
REGULATORY M etabolic Disorders Ivpe I diabetes m ellitus
NT J>02114 HLA-IXTBI
RTX.ULATORY Signaling M olecules and  In teraction Gell adhesion molecules (GAMs)
REC.ULATORY Im m une Svstem A ntigen processing and presentation
REC.ULARTRY M etabolic Disorders Tvpe I diabetes m ellitus
XP_00211s ETLA-DRB1
REGULATORY Signaling M olecules and  Interaction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem A ntigen processing and presentation
REGULATORY M etabolic D isorders Tvpe I diabetes m ellitus
\'P _ 0 0 2 116 ETLA-DRBS
REGULATORY Signaling M olecules and  In teraction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem A ntigen processing and presentation
REGULATORY M etabolic Disorders T\pe I diabetes m ellitus
REGULATORY Im m une Svstem Antigen processing and  presentation
X P jlO ^ W HLA-B
REG.ULATORY Signaling M olecules and  In teraction Gell adhesion m olecules (GAMs)
REGULAIORY Im m une Svstem A ntigen processing and  presentation
REC.ULATORY Im m une Svstem N atural killer cell m ediated cvtotoxicitc
REGULATORY M etabolic Disorders IVpe I diabetes m ellitus
XT_0M4S4 Hl.A-DRA
REGULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem A ntigen processing and presentation
REC.ULATORY M etabolic D isorders Tvpe I diabetes m ellitus
XT_0M44l) HI.A-DQA2
REC.ULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULATORY Im m une Svstem A ntigen processing and  presentation
REC.ULATORY M etabolic Disorders R p e  I diabetes m ellitus
XT_Ot>SS IS HLA-DRB4
REGULATORY Signaling M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULAIORY Im m une Svstem A ntigen processing and  presentation
REGULATORY M etabolic Disorders Tvpe I diabetes m ellitus
\P_072044 HI.A-DRB3
REC.ULATORY signaling  M olecules and Interaction Gell adhesion m olecules (GAMs)
REGULAIORY Im m une Svstem A ntigen prixessing  and presentation
REGULATORY Metabolic D isorders Tvpe I diabetes m ellitus
\P_241P32 HLA-DPA1
REC.ULAR>RY Signaling M olecules and Interaction Gell adhesion molecules (GAMs)
REGULATORY Im m une Svstem Antigen pn x essin g  and presentation
REGULAIORY Metabolic Disorders Ivpe 1 diabetes m ellitus
NT_S72TSS HLATXJB2
REC.ULATORY Signaling M olecules and Interaction Cell adhesion molecules (GAMs)
REC.ULARTRY Im m une Svstem Antigen processing and presentation
REGULATORY M etabolic Disorders Tc pe 1 diabetes m ellitus
Com m unity  2 U h)
XTjKlOOl 1 AGYKI 1
REC.ULARTRY Signal Iransduction R.E  beta signaling patlncac
\PJKH)470 AMU
REC.ULARTRY Signaling M olecules and Interaction G \to k m e cs tokme receptor interaction
REGULATORY Signal Transduction I (. .1 beta signaling pathw av
NTjIOOMS GITES
REGULAR TRY Signaling M olecules and Interaction C vtokm e -c\tokine receptor interaction
REC.ULARTRY Signal Transduction IGE-beta signaling pathw av
NTJH)1001=A7 GDE6
REC.ULARTRY Signal Transduction R.E beta signaling pathw av
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NT_001096 ACVR1
REGULATORY Signaling  M olecules and Interaction C ytokine-cytokine receptor interaction
REGULATORY Signal T ransduction TC.F-beta signaling  pathw ay
\'P_001097 ACVR2B
REGULATORY Signaling  M olecules and  Interaction G ytokine-cvtokine receptor interaction
REGULATORY Signal Transduction TG F-beta signaling pathw ay
NPJ101191 B.MP2
REGULATORY Signaling  M olecules and Interaction C ytokine-cytokine receptor interaction
REGULATORY Signal Transduction H edgehog  signaling  pathw ay
REGULATORY Signal Transduction TGF-beta signaling  pathw ay
\P_001193 BMP4
REGULATORY Signal Transduction I ledgehog  signaling pa thw ay
REGULATORY Signal Transduction TGF-beta signaling  pathw ay
N'P_001194 BMPR1B
REGULATORY Signaling  M olecules and Interaction C vtokine-cytokine receptor interaction
REGULATORY Signal T ransduction TGF-beta signaling  pathw av
\T _001195 BMPR2
REGULATORY Signaling  M olecules and Interaction C vtokine-cytokine receptor interaction
REGULATORY Signal Transduction TGF-beta signaling pa thw ay
\P_001607 ACVR2
REGULATORY Signaling  M olecules and Interaction C ytokine-cytokine receptor interaction
REGULATORY Signal T ransduction TGF-beta signaling  pathw ay
\P_001709 BMP6
REGULATORY Signal T ransduction H edgehog  signaling pathw ay
REGULATORY Signal T ransduction TGF-beta signaling  pathw ay
N'P_001710 BMP7
REGULATORY Signaling M olecules and Interaction C ytokine-cvtokine receptor interaction
REGULATORY Signal T ransduction H edgehog  signaling pa thw ay
REGULATORY Signal T ransduction TGF-beta signaling pathw ay
N'P_00I711 BMP8B
REGULATORY Signal T ransduction H ed g eh o g  signaling pathw av
REGULATORY Signal Transduction TGF-beta signalm g pathw ay
\P J1 0 2 1 8 3 I.VHBA
REGULATORY S ignaling M olecules and Interaction C ytokine-cvtokine receptor interaction
REGULATORY Signal T ransduction TGF-beta signaling pathw ay
\T_002184 IN'HBB
REGULATORY Signaling M olecules and Interaction C vtokine-cvtokine receptor interaction
REC.ULATORY Signal Transduction TC.F-beta signaling pathw ay
\P_003229 IGFB2
REGULATORY Signal Transduction M APK signaling pathw ay
REGULATORY Signaling M olecules and Interaction C ytokine-cytokine receptor interaction
REGULATORY Cell G ro w th  and  Death Cell cycle
REGULATORY Signal Transduction TC.F-beta signaling pathw ay
\P _003230 TGFB3
r e g u l a t o r y Signal T ransduction M APK signaling  pathw ay
REGULATORY Signaling  M olecules and Interaction C vtokine-cvtokine receptor interaction
REGULATORY Cell G row th  and Death Cell cycle
REGULATORY Signal T ransduction TGF-beta signaling pathw ay
\P_003231 LEFTY2
REGULATORY Signal Transduction TGF-beta signaling pathw ay
\T_004293 ACVR1B
REGULATORY Signal Transduction V1APK signaling pathw ay
REGULATORY Signaling  M olecules and Interaction C vtokine-cytokine receptor interaction
REGULATORY Signal Transduction TC.F-beta signaling pathw av
REGULATORY Gell C om m unication A dherens junction
\P_004320 BMPR1A
REGULATORY Signaling  M olecules and Interaction C ytokine-cvtokine receptor interaction
REGULATORY Signal Transduction TGF-beta signaling pathw ay
\P_004603 TGFBR1
REGULATORY Signal Transduction M APK signaling pathw ay
REC.ULATORY Signaling  M olecules and Interaction C vtokine-cvtokine receptor interaction
REG.ULATORY Signal Transduction TGF-beta signaling pathw ay
REG.ULATORY Gell C om m unication A dherens junction
NP_005529 IN'HBG
REG.ULATORY Signaling  M olecules and Interaction C vtokine-cvtokine receptor interaction
REGULATORY Signal Transduction IC F-beta  signaling pathw av
\P_060525 \O D A l.
REGULATORY Signal Transduction TC.F-beta signaling pathw av
N'P_065434 AMHR2
REG.ULATORY Signaling  M olecules and Interaction C vtokine-cvtokine receptor interaction
REGULATORY Signal Transduction T C.F-beta signaling pathw ay
\P _066277 LEFTY 1
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REGULATORY Signal T ransduction TGF-beta signaling  pa thw ay
XP_066??1 BMP?
REGULATORY Signal T ransduction H edgehog  signaling  pa thw ay
REGULATORY Signal T ransduction TGF-beta signaling  pa th w ay
N'P_ 113667 IN'HBE
REGULATORY Signaling  M olecules and Interaction C ytokine-cytokine receptor interaction
REGULATORY Signal T ransduction TGF-beta signaling  pa thw ay
XP_660302 ACVR1C
REGULATORY Signal T ransduction MAPK signaling pa thw ay
REGULATORY Signal Transduction TGF-beta signaling  pa thw ay
REGULATORY Cell C om m unication A dherens junction
XT_861?2? BMP8A
REGULATORY Signal T ransduction H edgehog signaling  pa thw ay
REGULATORY Signal Transduction TGF-beta signaling pathw ay
XP_208S4? LOC2831??
REGULATORY Signal Transduction TGF-beta signaling  pa thw av
C o m m u n ity  3 ( k  -  6)
\P_000205 JAG 1
REGULATORY Signal Transduction X otch signaling pathw ay
\P_002217 JAG 2
REGULATORY Signal Transduction X otch signaling pa thw ay
XP_00?609 DLL1
REGULATORY Signal Transduction X otch signaling pa thw av
XP_0S8637 DLL3
REGULATORY Signal Transduction X otch signaling p a thw ay
XP_077719 XOTCH2
REGULATORY Signal T ransduction X otch signaling pa thw ay
C o m m u n ity  4 ( k  =  6)
NP_002070 GOT 1
METABOLIC A m m o Acid M etabolism G lutam ate  m etabolism
METABOLIC A m ino Acid M etabolism A lanine and  asp arta te  m etabolism
METABOLIC A m ino Acid M etabolism Cysteine m etabolism
METABOLIC A m ino Acid M etabolism Arginine and pro ltne m etabolism
METABOLIC A m ino Acid M etabolism Tyrosine m etabolism
METABOLIC A m ino Acid M etabolism P henylalanine m etabolism
METABOLIC A m ino Acid M etabolism Phenylalanine, tyrosine and  try p to p h an  b iosynthesis
METABOLIC Biosynthesis of Secondary M etabolites X ovobiocin b iosynthesis
METABOLIC Energy M etabolism C arbon fixation
METABOLIC B iosynthesis of Secondary M etabolites A lkaloid b iosynthesis  I
C om m u n ity  5 ( k  = 6)
XP_000810 GART
METABOLIC X ucleo tide M etabolism Purine m etabolism
METABOLIC M etabolism  of Cofactors and  V itam ins O ne carbon pool by folate
XP_002S83 PCX A
REGULATORY Cell G row th  and  Death Cell cycle
XP_031396 RFC?
METABOLIC X ucleotide  M etabolism P urine m etabolism
METABOLIC X ucleo tide  M etabolism Pyrim idine m etabolism
C o m m unity  6 ( k =  6)
\P_002701 PPP1CC
REGULATORY Cell C om m unication Focal adhesion
REGULATORY X erv o u s svstem Long-term  potentiation
REGULATORY Cell M otility Regulation of actin  cytoskeleton
REGULATORY Signal Transduction insulin  signaling pathw ay
\P_004810 SYMPK
REGULATORY Cell C om m unication Tight junction
C o m m unity  8 i k  -■ 6)
XP_000391 ERCC2
METABOLIC C arb o h y d ra te  M etabolism Starch and sucrose m etabolism
METABOLIC M etabolism  of Cofactors and  Vitamins Folate biosynthesis
XT_002?83 PCX A
REGULATORY Cell G row th  and  Death Cell cycle
C o m m unity  9 ( k  -  6)
\T_037466 GMPPB
METABOLIC C arb o h y d ra te  M etabolism Fructose and m annose m etabolism
\P_037467 GMPPA
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C o m m u n ity  10
METABOLIC 
( k  =  6)
C arb o h y d ra te  M etabolism Fructose and  m annose  m etabolism
NP_000312 RBI
REGULATORY Cell G ro w th  an d  D eath Cell cycle
\T _000448 HXF4A
REGULATORY M etabolic D isorders M aturity  onset d iabetes of the young
NPJX H169 ARXTL
REGULATORY Behavior C ircadian rhythm
XP_002509 NPAS2
REGULATORY Behavior Circadian rhythm
XP_002607 PERI
REGULATORY Behavior C ircadian rhythm
XP_004889 CLOCK
REGULATORY Behavior C ircadian rhythm
\P _ 005339 HSPCA
REGULATORY Im m une System A ntigen processing and  p resentation
\P_0S8515 PER3
REGULATORY Behavior C ircadian rhythm
NP_064368 ARXTL2
REGULATORY Behavior Circadian rhythm
X P _ 6 12482 SP1
REGULATORY Signal Transduction TGF-beta signaling p a th w ay
C o m m u n ity  11 ( k  =  6)
C o m m u n ity  12 (.k  =  6)
XP_001245 CDC6
REGULATORY Cell G row th  and  D eath Cell cycle
.\P_002379 MCM3
REGULATORY Cell G row th  and  Death Cell cvcle
XP_002?43 ORC4L
REGULATORY Cell G row th  and  Death Cell cycle
\P_002544 ORC5L
REGULATORY Cell G row th  and  Death Cell cycle
N‘P_003494 CDC7
REGULATORY Cell G row th  and  Death Cell cvcle
XP_003495 CDC43L
REGULATORY Cell G row th  and  Death Cell cycle
XP_004144 ORC1L
REGULATORY Cell G row th  and Death Cell cvcle
XP_004517 MCM2
REGULATORY Cell G row th  and  Death Cell cycle
XP_005905 MCM4
REGULATORY Cell G row th  and  Death Cell cycle
XP_005906 MCM6
REGULATORY Cell G row th  and Death Cell cycle
XP_005907 MCM7
REGULATORY Cell G row th  and Death Cell cy cle
XP_006181 ORC2L
REGULATORY Cell G row th  and  D eath Cell cycle
XP_006730 MCM?
REGULATORY Cell G row th  and  Death Cell cycle
XP_0??136 ORC6L
REGULATORY Cell G row th  and Death Cell cycle
C om m u n ity  13 ( k  ---- 6)
\P_001830 IL12RB2
REGULATORY Signaling M olecules and  Interaction Cy tokine-cy tokine receptor interaction
REGULATORY Signal Transduction lak-STAT signaling pa thw av
XT_001833 CXTFR
REGUL.ArORY Signaling M olecules and  Interaction Cvtokine-cvtokine receptor interaction
REGULATORY Signal Transduction lak-STAT signaling pa thw av
XP_(H)2173 IL6ST
REGULATORY Signaling M olecules and  Interaction Cvtokine-cvtokine receptor interaction
REGULATORY Signal Transduction lak-STAT signaling pa thw ay
X P 002218 JAK1
REC.ULATORY Signal Transduction ]ak-STAT' signaling pa th w ay
REGULATORY Signal Transduction Adipocvtokine signaling  pathw ay
XP_002825 PTPX11
REGULATORY Signal Transduction lak-STAT signaling p a thw av
REGULATORY Im m une System N atural killer cell m ed ia ted  cvtotoxicitv
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REGULATORY Im m une System Leukocyte transendothelial m igration
REGULATORY Signal Transduction A dipocvtokine signaling pa thw ay
NP_004503 IL11RA
REGULATORY Signaling M olecules an d  In teraction C ytokine-cytokine receptor interaction
REGULATORY Signal Transduction Jak-STAT signaling pathw ay
\T_004963 IAK2
REGULATORY Signal Transduction Jak-STAT signaling pathw ay
REGULATORY Signal T ransduction A dipocvtokine signaling pathw ay
C o m m u n ity  14 (A =  6)
NP_001009552 PPP2CB
REGULATORY Signal Transduction VVnt signaling pathw ay
REGULATORY Signal Transduction TGF-beta signaling pathw ay
REGULATORY Cell C om m unication Tight junction
REGULATORY N ervous svstem Long-term  depression
C o m m u n ity  15 (A =  6)
\T_001009552 PPP2CB
REGULATORY Signal T ransduction W nt signaling pathw ay
REGULATORY Signal T ransduction TGF-beta signaling pathw ay
REGULATORY Cell C om m unication Tight junction
REGULATORY N ervous system Long-term  depression
C om m u n ity  18 (A =  6)
NP_005709 ARPC4
REGULATORY Cell M otilitv Regulation of actin cvtoskeleton
N'P_0057U ARPC1B
REGULATORY Cell M otilitv Regulation of actin cytoskeleton
N'P_006400 ARPC1A
REGULATORY Cell Motility- Regulation of actin cytoskeleton
C om m unity  19 (A = 6 )
NPJXXU67 NR3C1
REGULATORY Signaling M olecules and  In teraction N euroactive ligand-receptor in teraction
N’P_000448 HNF4A
REGULATORY M etabolic D isorders Maturity- onset d iabetes of the young
\'P_000452 THRB
REGULATORY Signaling M olecules and  Interaction Neuroactive ligand-receptor interaction
\P _002126 NR4A1
REGULATORY Signal T ransduction MAPK signaling pathw ay
\P _002948 RXRA
REGULATORY Signal T ransduction A dipocvtokine signaling pathw av
\P_004124 HNF4G
REGULATORY M etabolic D isorders M aturity  onset d iabetes of the young
NP_068811 RXRB
REGULATORY Signal Transduction Adipocvtokine signaling pathw ay
NP_612482 SP1
REGULATORY Signal T ransduction TGF-beta signaling pathw ay
C o m m unity  20 (A 6)
NP_001887 CSNK2A2
REGULATORY Signal T ransduction VVnt signaling pathw ay
REGULATORY Cell C om m unication A dherens junction
REGULATORY Cell C om m unication Tight junction
\P_006764 DDX18
METABOLIC C arbohydra te  M etabolism Starch and sucrose m etabolism
METABOLIC M etabolism  of Cofactors and  V itam ins Folate biosynthesis
\P _076977 DDX54
METABOLIC Carbohy d rate  M etabolism Starch and sucrose m etabolism
METABOLIC M etabolism  of Cofactors and  Vitam ins Folate biosynthesis
C om m unity  23 (A - 6)
\T_001310 CSNK1G2
REGULATORY Signal T ransduction Phosphatidvlinositol signaling system
METABOLIC Carbohy d rate  M etabolism Inositol phosphate m etabolism
METABOLIC Xenobiotics B iodegradation and  M etabolism Benzoate degradation  via CoA ligation
METABOLIC M etabolism  of Cofactors and  Vitam ins N icotinate and n icotinam ide m etabolism
\ ’P_002721 PRKACA
REGULATORY Signal T ransduction MAPK signaling pathw ay
REGULATORY Signal Transduction Calcium  signaling pathw av
REGULATORY Cell G row th  and Death A poptosis
REGULATORY Signal Transduction VVnt signaling pathw ay
Appendices 165
\ ’P_002722
NP_002723
NP_0027?1
NT_004148 
NP_00503S
\P_006249 
\P_0062W  
XP_4%112
C om m unity  24
NP_000134
\P_002173
NP_002823
NP_002823
NT_002828
\P _002829
NP_002831
REGULATORY Signal Transduction H edgehog  signaling pathw ay
REGULATORY Cell C om m unication G ap  junction
REGULATORY N erv o u s system l.ong-term  potentiation
REGULATORY Signal Transduction Insulin  signaling pathw ay
PRKACB
REGULATORY Signal T ransduction MAPK signaling pathw ay
REGULATORY S ignal Transduction Calcium  signaling pathw ay
REGULATORY Cell G row th  and  Death A poptosis
REGULATORY Signal Transduction VVnt signaling pathw ay
REGULATORY Signal T ransduction I ledgehog signaling pathw ay
REGULATORY Cell C om m unication G ap junction
REGULATORY N erv o u s system Long-term  potentiation
REGULATORY Signal Transduction Insulin  signaling pathw ay
PRKACG
REGUL.ATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Signal Transduction Calcium  signaling pathw ay
REGULATORY Cell G row th  and Death A poptosis
REGULATORY Signal Transduction VVnt signaling pathw ay
REGULATORY Signal Transduction I ledgehog signaling pathw ay
REGULATORY Cell Com m unication G ap junction
REGULATORY N ervous system Long-term  potentiation
REGULATORY Signal Transduction Insulin  signaling pathw av
PRKY
REGULATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Signal Transduction Calcium  signaling pathw ay
REGULATORY Signal Transduction VVnt signaling pathw ay
REGULATORY Signal Transduction H edgehog signaling pathw ay
REGULATORY Cell Com m unication Gap junction
REGULATORY N ervous svstem Long-term  potentiation
REGULATORY Signal Transduction Insulin  signaling pathw ay
PRKAR2A
REGULATORY Cell G row th  and  Death A poptosis
REGULATORY Signal Transduction Insulin  signaling pathw av
PRKX
REGULATORY Signal Transduction MAPK signaling pathw ay
REGULATORY Signal Transduction Calcium  signaling pathw ay
REGULATORY Signal Transduction VVnt signaling pathw av
REGULATORY Signal Transduction H edgehog signaling pathw av
REGULATORY Cell Com m unication G ap junction
REGULATORY N ervous system Long-term  potentiation
REGULATORY Signal Transduction Insulin signaling pathw ay
PRKG1
REC.ULATORY Cell Com m unication G ap junction
REGULATORY N ervous svstem Long-term  depression
PRKG2
REGULATORY Cell Com m unication G ap junction
REGULATORY N ervous svstem Long-term  depression
LOC440332
REGULATORY Cell Com m unication Focal adhesion
REGUL.ATORY 
k  — 6)
Signal Transduction Insulin  signaling pathw av
GHR
REGULATORY Signaling M olecules and Interaction Cvtokine-cvtokine receptor interaction
REGULATORY Signaling M olecules and Interaction N euroactive ligand-receptor interaction
REGULATORY Signal Transduction lak-STAT signaling pathw av
IL6ST
REGULATORY Signaling Molecules and  Interaction Cvtokine-cvtokine receptor interaction
REGULATORY Signal Transduction lak-STAT signaling pathw av
P T P \7
REGUL.ATORY Signal Transduction MAPK signaling pathw av
P T P M l
REGULATORY Signal Transduction lak-STAT signaling pathw av
r e g u l a t o r y Im m une Svstem N atural killer cell m ediated cvtotovicitv
Rl GIT AIORY Im m une System I.eukocvte transendothelial m igration
REGULATORY Signal Transduction Adipocvtokine signaling pathwav
PI PRB
REGULATORY Cell Com m unication A dherens junction
PTPRC
REGULATORY Signaling Molecules and Interaction Cell adhesion  m olecules (CAMs)
REGUL.ATORY Im m une Svstem I cell receptor signaling pathw ay
PTPRF
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REGULATORY S ignaling  M olecules and  In teraction Cell adhesion  m olecules (CAMs)
REGULATORY Cell C o m m unica tion A d h eren s  junction
REGULATORY Signal T ransduction Insu lin  signaling pathw ay
NT_002834 PTPRJ
REGULATORY Cell C om m unica tion A d h eren s  junction
NP_002836 PTPRM
REGULATORY S ignaling  M olecules and  In teraction Cell adhesion  m olecules (CAMs)
REGULATORY Cell C om m unica tion A dherens junction
NP_002838 PTPRN2
REGULATORY M etabolic D isorders Type I diabetes m ellitus
NP_004%3 JAK2
REGULATORY Signal Transduction Jak-STAT signaling pathw ay
REGULATORY Signal T ransduction A dipocvtokine signaling pathw ay
C om m unity  25 (* =  6)
NP_000199 INSR
REGULATORY Cell C om m unication A dherens junction
REGULATORY Signal Transduction Insulin  signaling pathw ay
REGULATORY M etabolic Disorders Type II d iabetes m ellitus
REGULATORY N 'eurodegenerative Disorders D entatorubropallidoluysian  a trophy (DRPLA)
\P_000866 IGF1R
REGULATORY Cell C om m unication Focal adhesion
REGULATORY Cell C om m unication A dherens junction
REGULATORY N erv o u s system Long-term  depression
\P _002823 PTPN7
REGULATORY Signal Transduction M APK signaling pathw ay
\'P_002825 PT P M 1
REGULATORY Signal Transduction Jak-STAT signaling pathw ay
REGULATORY Im m une System N atura l killer cell m ediated  cytotoxicity
REGULATORY Im m u n e System Leukocyte transendothelial m igration
REGULATORY Signal Transduction A dipocvtokine signaling pathw ay
\T_002828 PTPRB
REGULATORY Cell C om m unication A dherens junction
XP_002829 PTPRC
REGULATORY Signaling  M olecules and  Interaction Cell adhesion  m olecules (CAMs)
REGULATORY Im m une System T cell receptor signaling pathw ay
NP_002831 PTPRF
REGULATORY Signaling  M olecules and Interaction Cell adhesion  m olecules (CAMs)
REGULATORY Cell C om m unication A dherens junction
REGULATORY Signal Transduction Insulin  signaling pathw ay
\P_002834 PTPRJ
REGULATORY Cell C om m unication A dherens junction
\P _002836 PTPRM
REGULATORY- Signaling  M olecules and Interaction Cell adhesion  m olecules (CAMs)
REGULATORY Cell C om m unication A dherens junction
\P_002838 PTPRN2
REGULATORY M etabolic D isorders Tvpe I d iabetes m ellitus
C om m unity  26 ( k  =  6)
\P_002823 PTPN'7
REGULATORY Signal Transduction M APK signaling pathw ay
\P_002825 PTPXU
REGULATORY Signal Transduction Jak-STAT signaling pathw ay
REGULATORY Im m une Svstem N atu ra l killer cell m ediated  cytotoxicitv
REGULATORY Im m une System Leukocyte transendothelial m igration
REGULATORY Signal Transduction A dipocvtokine signaling pathw ay
XP_002828 PTPRB
REGULATORY Cell C om m unication A dherens junction
XPJ102829 PTPRC
REGULATORY Signaling  M olecules and Interaction Cell adhesion  molecules (CAMs)
REGULATORY Im m une System T cell receptor signaling pathw ay
\P_002831 PTPRF
REGULATORY Signaling M olecules and Interaction Cell adhesion  m olecules (CAMs)
REC.ULATORY Cell C om m unication A dherens junction
REGULATORY Signal T ransduction Insulin  signaling pathw av
\P_002834 PTPRJ
REGULATORY Cell Com m unication A dherens junction
\P_002836 PTPRM
REGULATORY Signaling M olecules and Interaction Cell adhesion  m olecules (CAMs)
REGULATORY Cell C om m unication A dherens junction
\P_002838 PTPRN2
REGULATORY M etabolic Disorders Type I diabetes m ellitus
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C om m unity  27 ( k  =  6)
NP_000391 ERCC2
METABOLIC C a rb o h y d ra te  M etabolism Starch and  sucrose m etabolism
METABOLIC M etabolism  of C ofactors and  Vitam ins Folate biosynthesis
N:P_002740 MAPK7
REGULATORY Signal T ransduction M APK signaling p a thw ay
REGULATORY Cell C om m unica tion Gap junction
NP_004126 IDH3G
METABOLIC C a rb o h y d ra te  M etabolism C itrate cycle (TCA cycle)
NP_00S521 IDH3A
METABOLIC C a rb o h y d ra te  M etabolism C itrate cycle (TCA cycle)
NP_006494 PSMC4
NP_008S30 IDH3B
METABOLIC C arb o h y d ra te  M etabolism C itrate cycle (TCA cvcle)
C o m m u n ity  28 ( k  =  6)
N P_000134 GHR
REGULATORY Signaling  M olecules and  Interaction Cytokine-cytokine receptor interaction
REGULATORY Signaling  M olecules and  Interaction N euroactive ligand-receptor interaction
REGULATORY Signal T ransduction Jak-STAT signaling  pathw ay
\'P_000940 PRLR
REGULATORY Signaling  M olecules and  Interaction C ytokine-cvtokine receptor interaction
REGULATORY Signaling  M olecules and  Interaction N euroactive ligand-receptor interaction
REGULATORY Signal Transduction Jak-STAT signaling pa thw ay
\T _00217? IL6ST
REGULATORY Signaling  M olecules and  Interaction C ytokine-cytokine receptor interaction
REGULATORY Signal Transduction Jak-STAT signaling  pathw ay
NP_0022I8 JAKi
REGULATORY Signal T ransduction Jak-STAT signaling  pa thw ay
REGULATORY Signal Transduction A dipocvtokine signaling  pathw ay
NP_002825 PTPN11
REGULATORY Signal Transduction Jak-STAT signaling  pathw ay
REGULATORY Im m une Sv stem N atura l killer cell m ed iated  cytotoxicity
REGULATORY Im m une System Leukocyte transendothelia l m igration
REGULATORY Signal Transduction A dipocvtokine s ignaling  pathw ay
\P_004963 JAK2
REGULATORY Signal Transduction Jak-STAT signaling  pa thw ay
REGULATORY Signal T ransduction A dipocvtokine signaling  pathw ay
C om m unity  29 ( k  =  6)
XP_000199 INSR
REGULATORY Cell C om m unication A dherens junction
REGULATORY Signal Transduction Insulin signaling pathw ay
REGULAIORY M etabolic D isorders Type II diabetes m ellitus
REGULATORY N eurodegenera tive  Disorders D en ta torubropallidoluvsian  atrophy (DRPLA)
\P_000866 IGF1R
REGULATORY Cell C om m unication Focal adhesion
REGULATORY Cell C om m unication A dherens junction
REGULATORY N erv o u s svstem Long-term  depression
.\P_001007793 NTRK1
REGULATORY Signal Transduction MAPK signaling pathw av
REGULATORY Cell G ro w th  and  Death A poptosis
.\P_001700 B D \F
REGULATORY Signal T ransduction MAPK signaling pa thw av
REGULATORY N eurodegenera tive  Disorders H u n ting ton 's  d isease
\P_002497 NGFB
REGULATORY Signal Transduction MAPK signaling pa thw av
REGULATORY Cell G row th  and  Death A poptosis
\P _002498 N’GFR
REGULATORY Signaling M olecules and  Interaction C ytokine-cvtokine receptor interaction
\P _002318 N’TF3
REGULATORY Signal Transduction MAPK signaling pathw av
C om m unity  30 ( k - 6)
\P_003061 SMARCA2
METABOLIC C arb o h y d ra te  M etabolism Starch and  sucrose m etabolism
METABOLIC M etabolism  of Cofactors and Vitamins Folate biosynthesis
\P _003392 SMARCA5
METABOLIC C arbohydra te  M etabolism Starch and  sucrose m etabolism
METABOLIC M etabolism  of Cofactors and Vitamins Folate biosynthesis
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C o m m unity  33 ( k  =  6)
\P_006297 SMC 1L 1
REGULATORY Cell G ro w th  and  D eath Cell cycle
NP_683?15 SMC1L2
REGULATORY Cell G ro w th  and  D eath Cell cycle
C o m m u n ity  34 ( k  ----- 6)
\P _006764 DDX18
METABOLIC C arb o h y d ra te  M etabolism Starch and  sucrose m etabolism
METABOLIC M etabolism  of C ofactors and  Vitam ins Folate biosynthesis
C o m m u n ity  33 U -  6)
NTJXH896 CTPS
METABOLIC N ucleotide  M etabolism Pyrim idine m etabolism
\P_062831 CTPS2
METABOLIC N ucleotide M etabolism Pyrim idine m etabolism
C o m m u n ity  36 ( k  = 6 )
NP_002493 XFKB2
REGULATORY Signal T ransduction MAPK signaling p a thw ay
REGULATORY Cell G row th  and  D eath Apoptosis
REGULATORY Im m une System Toll-like receptor signaling  pathw av
REGULATORY Im m une System T cell receptor signaling  pathw ay
REGULATORY Im m une Svstem B cell receptor signaling  pa thw av
REGULATORY Signal T ransduction A dipocvtokine signaling  pathw ay
N'P_003989 XFKBl
REGULATORY Signal Transduction MAPK signaling p a thw av
REGULATORY Cell G row th  and  D eath A poptosis
REGULATORY Im m une System Toll-like receptor signaling  pa thw av
REGULATORY Im m une System T cell receptor signaling  pathw av
REGULATORY Im m une System B cell receptor signaling  pathw av
REGULATORY Signal Transduction A dipocvtokine signaling  pathw ay
\P_004547 NFKBIE
REGULATORY Im m une System T cell receptor s ignaling  pathw ay
REGULATORY Im m une System B cell receptor signaling  pathw av
REGULATORY Signal T ransduction A dipocvtokine signaling  pathw av
\T_065390 NFKBIA
REGULATORY Cell G row th  and  D eath A poptosis
REGULATORY Im m une System Toll-like receptor signaling  pathw ay
REGULATORY Im m une Svstem T cell receptor signaling  pathw av
REGULATORY Im m une Svstem B cell receptor signaling  pathw av
REGULATORY Signal Transduction A dipocvtokine signaling  pathw av
Appendix D 
A closer view of the 
metastasis-related communities
A detailed description of the metastasis-related protein netw orks identified 
by cluster analysis. The protein nodes are labelled with RefSeq identifiers. 
The weakest links (blue and green) were removed from the last graph to 
improve legibility. A nnotations relating to these proteins are given in A p­
pendix E and the approxim ate location of the corresponding com munities 
is indicated.
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C o m m u n i t y  13
NP_036686
C o m m u n i t y  21
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Appendix E
Annotations for the 
metastasis-related proteins
An annotated list of the rat proteins identified by the clique analysis.
Sequence ID Gene name Description
Community 0: TGF-beta
NP_036722 Inha inhibin alpha
NP_036907 Tgfbrl transform ing grow th factor, beta receptor 1
NP_036959 Bmp4 bone m orphogenetic protein 4
NP_037234 Fkbpla FK506-binding protein la
NP_037239 Bmp6 bone m orphogenetic protein 6
NP_037306 Tgfb3 transform ing grow th factor, beta 3
NP_058824 Inhba inhibin beta A
NP_058874 Bmp2 bone m orphogenetic protein 2
NPJJ58952 Tgfbr3 transform ing grow th factor, beta receptor 3
NP_058973 A p lb l ad ap to r protein complex AP-1, beta 1 subunit
NP_059052 Hpcall neural visinin-like Ca2+-binding protein type 3
NP_067589 Tgfbl transform ing grow th factor, beta 1
NP_071886 Acreq activin A receptor type Il-like 1
NP_077342 Freq neuronal calcium sensor-1
NP_077812 Acvrl activin type I receptor
NP_110476 Bm prla bone m orphogenetic protein receptor, type 1A
NP_112393 Tgfb2 transform ing grow th factor, beta 2
NP_112394 Tgfbr2 transform ing grow th factor-b type II receptor
NP_954700 A cvrlb activin A receptor, type IB
XP_217147 sim ilar to mmDj4
XP_217297 activin receptor IIB
XP_217409 sim ilar to Bone m orphogenetic protein type II receptor
XP_227759 sim ilar to CFK-43a=bone m orphogenetic protein b inding s e r / th r  ki­
nase receptor
XP_232168 sim ilar to DNA replication licensing factor MCM2
XP 342432 activin receptor IIA
XP_342592 bone m orphogenetic protein 7
XP_345647 sim ilar to grow th /d ifferen tiation  factor 7
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Community 1: Proteasome
NP_001005875 Psm dl2 proteasom e 26S non-ATPase subunit 12
NP_001008218 Psma7 proteasom e (prosom e, macropain) subunit, alpha type 7
NP_001008282 Psmd3 proteasom e 26S non-ATPase subunit 3
NP_001008302 U spl4 ubiqu itin  specific protease 14
NP_058736 Ppp2cb pro te in  phosphatase  2a, catalytic subunit, beta isoform
NP_058796 Plkl polo-like kinase 1
NP_058974 Psm al proteasom e (prosom e, macropain) subunit, alpha type 1
NP_058975 Psma2 proteasom e (prosom e, macropain) subunit, alpha type 2
NP_058976 Psma3 proteasom e (prosome, macropain) subunit, alpha type 3
NP_038977 Psma4 proteasom e (prosome, macropain) subunit, alpha type 4
NP_058979 Psma6 proteasom e (prosome, macropain) subunit, alpha type 6
NP_058980 Psmb2 proteasom e (prosome, macropain) subunit, beta type 2
NP_058981 Psmb3 proteasom e (prosome, macropain) subunit, beta type 3
NP_112411 Sugl proteasom al ATPase (SUG1)
NP_112621 Psmd4 proteasom e (prosome, macropain) 26S subunit, non-ATPase, 4
NP_113817 Psmb4 proteasom e (prosome, macropain) subunit, beta type 4
NP_150239 Psmc2 proteasom e (prosome, macropain) 26S subunit, ATPase 2
NP_476440 Psmb6 proteasom e (prosome, macropain) subunit, beta type 6
NP_476463 Psmc4 proteasom e 26S ATPase subunit 4
NP_942025 MGC72968 proteasom e, 26S, non-ATPase regulatory subunit 6
XP_213456 sim ilar to Protein translation factor SUI1 hom olog
XP_215745 sim ilar to 26S proteasom e-associated p a d l hom olog
XP_218424 sim ilar to nucleotide excision repair protein
XP_220754 sim ilar to 26S proteasom e non-ATPase regulatory subunit 11
XP.224534 sim ilar to karvopherin beta 3; Ran_GTP b ind ing  protein 5; im portin 
beta-3 subunit
XP.226439 sim ilar to 26S proteasom e non-ATPase regulatory subunit 7
XP_233467 sim ilar to cytidine 5-triphosphate synthase
XP_341315 proteasom e (prosome, macropain) subunit, beta type 5
XP_342114 sim ilar to Periodic tryptophan protein 2 hom olog
XP_344650 sim ilar to Proteasom e subunit alpha type 7-like
XP_344977 sim ilar to 26S proteasom e subunit p40.5
Community 2: Mitotic sp indle checkpoint
NP_001008331 Polrlc RNA polym erase I subunit
NP_036942 Sycpl svnaptonem al complex protein 1
NP_071582 Rad50 RAD50 hom olog
NPJ371790 Pmpcb m itochondrial processing peptidase beta
NP_113771 Cspg6 chondroitin  sulfate proteoglycan 6
NP_113871 Sm clll SMC1 structural m aintenance of chrom osom es 1-like 1
NP_114009 Plk2 polo-like kinase 2
NP_703201 Rnf40 ring finger protein 40
NP_955795 Cdk2 cyclin-dependent kinase 2
XP.215573 sim ilar to SMG4 protein
XP.218574 sim ilar to BC013491 protein
XP_222860 sim ilar to NUF2R protein
XP_233108 sim ilar to strom al antigen 2
XP_233337 sim ilar to epiderm al growth factor receptor pathw ay substrate 15
XP_235267 sim ilar to pokew eed agglutinin-binding protein
XP 342838 sim ilar to SMC2 protein
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Com m unity 3: M yosin
NP_001009268 Actr2 actin-related protein  2
NP_058936 Myh7 m yosin heavy chain, polypeptide 7
NP_068640 Cttn cortactin isoform  B
NP_112406 Actb cytoplasm  beta-actin
NP_112408 A rpcla suppressor of profilin /p41 of actin-related com plex 2 /3
NP_446372 TriplO thyroid horm one receptor interactor 10
NP_446438 M yolb m yosin lb
NP_476540 W aspip W iskott-Aldrich syndrom e protein interacting protein
NP_775124 M yole m yosin IE
NP_955795 Cdk2 cyclin-dependent kinase 2
XP_217432 sim ilar to actin related protein 2 /3  complex subunit 2; A R P2/3  cc
plex subunit 34
XP_218617 sim ilar to nonm uscle myosin heavy chain
XP_228784 sim ilar to W iskott-Aldrich Syndrom e Protein
XP_233945 sim ilar to mKIAA1256 protein
XP_238365 sim ilar to actin related protein 2 /3  complex, subunit 4
XP_239604 sim ilar to G luR-delta2 philic-protein
XP_340818 myosin, heavy polypeptide 4
XP_341113 actin-related protein  3 hom olog
XP_343046 sim ilar to Sh3yll
C om m unity  4: In tracellu lar s igna ling  cascade
NP_001002289 Fut8 fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
NP_001004081 Mpi m annose phosphate  isomerase
NP_001008725 I16st interleukin 6 signal transducer
NP_036645 Bdnf brain derived neurotrophic factor
NP_036742 Ngfr nerve grow th factor receptor, fast
NP_036863 Ntrk2 neurotrophic tyrosine kinase, receptor, type 2
NP_036887 Fyn fyn proto-oncogene
NP_036921 Dpp4 d ipep tidy lpep tidase  4
NP_036978 Fgfl fibroblast grow th factor 1
NP_037101 Irsl insulin receptor substrate  1
NP_037137 Pik3r phosphatidylinositol 3-kinase, regulatory subunit, po lypeptide  1
NP_037194 Kdr kinase insert dom ain  protein receptor
NP.037213 Ptk2 PTK2 protein tyrosine kinase 2
NP_037220 P tp n ll protein tyrosine phosphatase, non-receptor type 11
NP_037319 Plcgl phospholipase C, gam m a 1
NP_058762 Ptn pleiotrophin
NP_058767 Insr insulin receptor
NP_038790 Ghr grow th horm one receptor
NP_038864 Plcg2 phospholipase C, gam m a 2
NP_059037 Lipf lipase, gastric
NP_062121 Ntrk3 neural receptor protein-tyrosine kinase
NP_062178 Fgf2 fibroblast grow th factor 2
NP_067600 N trkl trk precursor
NP_071549 Pik3r3 phosphatidylinositol 3-kinase p55 subunit
NP_071963 Arfl ADI’-ribosylation factor 1
NP_110483 I.rrn3 leucine rich repeat protein 3, neuronal
N IM 10486 Mdk m idkine
NP_112335 Ntf3 neurotrophin 3
NP_112624 C dhl cadherin 1
z
 
1 w 3^ ro Jak2 Janus kinase 2
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NP_113811 G rb l4 grow th factor receptor bound  protein 14
NP_434694 Ig flr insulin-like grow th  factor 1 receptor
NP_445775 Degs degenerative sperm atocyte hom olog
NP_445809 C atnb beta-catenin
NP_445835 Grb7 grow th factor receptor b inding protein GRB7
NP_476547 N crl lym phocyte antigen 94 (mouse) hom olog (activating NK-receptor;
NK-p46)
NP_542419 Plcd4 phospholipase C, delta 4
NP_604451 Sh2bpsm l SH2-B PH dom ain containing signaling m ediator 1
NP_612516 Ptprc protein tyrosine phosphatase, receptor type, C
NPJ>65725 C yp3al8 cytochrome P450, 3a 18
NP_665886 Socsl suppressor of cytokine signaling 1
NP_849197 Igfl insulin-like grow th factor 1
XP_213997 P tp n l3 sim ilar to protein Tyr phosphatase, non-receptor type 13
XP_214050 Lap3_pred leucine am inopeptidase 3 (predicted)
XP_217246 N ckl_pred sim ilar to non-catalytic region of tyrosine kinase adap tor protein 1
XP_217250 E phbl PREDICTED: Eph receptor B1
XP_218346 Axl_pred now NP_001013165. AXL receptor tyrosine kinase (predicted)
XP_221036 LOC303606 now NP_001013996.hypothetical protein
XP_224344 Dok2_pred sim ilar to docking protein Dok-R
XP_226503 LOC307845 sim ilar to hypothetical protein BC002770
XP_227525 Ngfb sim ilar to nerve grow th factor beta chain precursor - m ultim am m ate 
rat
XP_231137 A bll sim ilar to A bll protein Proto-oncogene tyrosine-protein kinase ABL1
XP_232763 Lck lymphocyte-specific protein tyrosine kinase
XP_233522 E(DC298528 sim ilar to Ephrin type-A receptor 10
XP_235164 Frs2_pred sim ilar to fibroblast grow th factor receptor substrate 2
XP_236628 M stlr_pred sim ilar to hepatocyte grow th factor-like protein receptor
XP_341110 Ptpn4 sim ilar to testis-enriched protein tyrosine phosphatase
XP_342283 Shcl now NP_445969 SHC (Src hom ology 2 dom ain-containing) tran s­
forming protein 1
XP_342864 Tek sim ilar to TIE-2=receptor-like tyrosine kinase
XP_343062 LOC362737 sim ilar to RIKEN cDNA D930036F22 gene
XP_347256 sim ilar to met proto-onco
Community 5: EGF-like domain containing proteins
NP_058928 Ptgs2 prostaglandin-endoperoxide synthase 2
NP_062020 Jag1 jagged 1
NP_077334 Notch2 notch gene hom olog 2
NP_446196 Dlkl delta-like 1 hom olog
NP_620192 Pou3f3 POU dom ain, class 3, transcription factor 3
NP_942048 Rpl3 ribosomal protein L3
XP_232595 sim ilar to Rbpsuh protein
XP_241375 sim ilar to N-term inal aceyltransferase 1
XP_343120 jagged 2
Community 6: Endo/exonuclease
NP_001008383 Cnot8 sim ilar to CCR4-NOT transcription complex, subunit 8 (CAEl-like
protein)
NP_001009357 Rqcdl RCD1 required for cell differentiation! homolog
XP_216889 sim ilar to CCR4-NOT transcription complex, subunit 2; NOT2 (neg.
reg. of transcr)
XP_218062 similar to LATS hom olog 1
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XP_218187 
XP_224583 
XP_226233 
XP_231603 
XP 341192
sim ilar to CCR4-NOT transcrip tion  complex, subunit 3 
sim ilar to CG31759-PA en do /exonuclease  activity 
sim ilar to KIAA1007 protein; adrenal gland protein AD-003 
sim ilar to potential transcriptional repressor Not4hp 
sim ilar to Hypothetical protein 4932442K20Rik
Community 7: Nucleocytoplasm  transport
NP_058759 K pnbl karyopherin (im portin) beta 1
NP_059057 Nup54 nucleoporin 54kDa
NP_445891 Ran RAN, m em ber RAS oncogene family
NP_446074 Pom l21 nucleus pore m em brane glycoprotein 121 kD
NP_703206 Krtl-9 keratin complex 1, acidic, gene 9
NP_942021 K pnal karyopherin alpha 1 (im portin alpha 5)
XP_214639 sim ilar to RIKEN cDNA 2410008G02
XP_218620 sim ilar to nucleus pore glycoprotein p62 (62 kDa nucleoporin)
XP_224534 sim ilar to karyopherin beta 3; Ran_GTP binding protein 5; im portin 
beta-3 subunit
XP_341509 nucleoporin 153kD
Community 8: Cell cycle/cytokinesis
NP.037027 Adk adenosine kinase
NP_037309 Got2 glutam ate oxaloacetate transam inase 2
NP_072138 Sept7 CDC10 (cell division cycle 10, S.cerevisiae, homolog)
NP_076481 Prkaa2 AM P-activated protein kinase a lpha 2 catalytic subunit
NP_114025 Sept9 septin  9
NP_446023 Rgpr regucalcin gene prom otor region related protein
NP_446383 G plbb glycoprotein lb (platelet), beta polypeptide
NP_476489 Sept2 septin  2
NP_620184 Gorasp2 golgi reassembly stacking protein 2
NP_787032 E eflal eukaryotic translation elongation factor 1 alpha 1
XP_213393 sim ilar to CGI-125 protein
XP_213413 sim ilar to H5
XP_213922 sim ilar to Brain protein 44 (0-44 protein)
XP_216170 sim ilar to Hypothetical protein MGC59076
XP_217147 sim ilar to mmDj4
XP_219498 sim ilar to serine/th reonine  kinase 29
XP_223227 sim ilar to hypothetical protein FI J1 0849
XP_231118 sim ilar to kynurenine am inotransferase/g lu tam ine transam inase K
XP_234516 sim ilar to Cyclin K
XP_340794 sim ilar to TBC1 dom ain, m em ber 8; BUB2-like protein 1; vase. Rab- 
GA P/TBC-containing
XP_343156 sim ilar to protein inhibitor of activated STAT gamm a
XP_343275 sim ilar to myosin phosphatase targeting subunit 3 MYPT3
Community 9: Nuclear hormone receptors
NP_036787 Spl sp l transcription factor
NP_036804 Thrb thyroid horm one receptor beta
NP_036937 Rxra retinoid X receptor alpha
NP_071516 Hnf4a hepatocyte nucleus factor 4 alpha
NP_077335 H ifla hypoxia inducible factor 1, alpha subunit
NP_077364 Nr4al nucleus receptor subfam ily 4, g roup  A, m em ber 1
NP_112392 Nr2fl nucleus receptor subfam ily 2, g roup  F, m em ber 1
NP_113815 N rlh3 nucleus receptor subfam ily 1, g roup  H, m em ber 3
Appendices 179
NP_446294 M apkl m itogen activated protein kinase 1
NP_695209 Cops2 COP9 (constitutive photom orphogenic) hom olog, subunit 2
XP_216720 sim ilar to Thyroid transcription factor 1 (Thyroid nucleus factor 1)
(TTF-1)
XP_226076 sim ilar to pu tative  WDC146
XP_233944 sim ilar to nucleus receptor co-activator
Community 10: Sarcoglycans
NP_001006994 Sgcg gam m a sarcoglycan
NP_036830 Dmd dystroph in  isoform Dp71a
XP_213891 sim ilar to abnorm al spindle
XP_220884 sim ilar to alpha-sarcoglycan
XP_223355 sim ilar to beta-sarcoglycan
Community 11: Karyopherins
NP_037347 Akr7a3 aldo-keto reductase family 7, m em ber A3 (aflatoxin aldehyde reduc­
tase)
NP_058759 K pnbl karyopherin  (importin) beta 1
NP_058999 Kcnabl potassium  voltage-gated channel, shaker-related subfamily, beta
m em ber 1
NP_039000 Kcnab2 potassium  voltage-gated channel, shaker-related subfamily, beta
m em ber 2
NP_942021 K pnal karyopherin  alpha 1 (importin alpha 3)
Community 12: Hypoxia inducable factor
NP_077335 H ifla hypoxia inducible factor 1, alpha subunit
NP_077338 A m tl aryl hydrocarbon receptor nucleus translocator-like
XP_234728 sim ilar to Hspca protein
XP_234791 sim ilar to heat shock protein 84 - m ouse
Community 13: Peroxisomal proteins
NP_742060 Pexl4 peroxisom al m em brane anchor protein
XP_218778 sim ilar to peroxisomal PTS2 receptor
XP_223684 sim ilar to Peroxisomal m em brane protein PEX13 (Peroxin-13)
XP.232343 sim ilar to Pex5 protein
Community 14: Cell cycle regulation
NP_001009470 MGC108931 sim ilar to cyclin B2
NP_741990 Cdc20 cell division cycle 20 homolog
NP_935795 Cdk2 cyclin-dependent kinase 2
XP_213222 sim ilar to m em brane-associated tyrosine-and threonine-spec. cdc2-
inhibitory kinase
XP.214152 sim ilar to cyclin-dependent kinase inhibitor 3; CDK2-assoc. dual
spec, phosphatase
XP_235722 sim ilar to cell division cycle 2 hom olog 2; cell division cycle 2-like 2
Community 15: VEGF
NP_037194 Kdr kinase insert dom ain protein receptor
NP_113949 Figf c-fos induced grow th factor
NP_ 114024 Vegfa vascular endothelial growth factor
NP_446047 Pgf placental grow th factor
NP_446105 Vegfc vascular endothelial growth factor C
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Com m unity 16: JAK/STAT cascade
NP_058790 Cihr grow th horm one receptor
NP_071775 Stat5b signal transducer and activator of transcription 5B
NP_ 113702 Jak2 jan u s  kinase 2
NP_116001 Statl signal transducer and activator of transcrip tion  1
Com m unity 17: Karyopherin docking com plex
NP_942021 K pnal karyopherin  a lpha 1 (im portin alpha 5)
XP_215550 sim ilar to polym yositis scleroderm a overlap  syndrom e (PM-SCI.)
antigen 1 a
XP_216949 sim ilar to putativ e exosome complex exonuclease RRP41
XP.218343 sim ilar to DNA segm ent, Chr 7, W ayne State University 180, ex­
pressed
XI’_233673 sim ilar to P100 polvm yositis-scleroderm a overlap  syndrom e assoc.
autoantigen hom olog
Com m unity 18: NF-kappaB regulation
NP_445807 I kb kb inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase
beta
NP_954534 Ikbkg inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase
gam m a
XP_219857 sim ilar to conserved helix-loop-helix ubiquitous kinase
XP_234728 sim ilar to Hspca protein
XP_234791 sim ilar to heat shock protein 84 - m ouse
XP_340919 sim ilar to NF-kappaB inducing kinase
Com m unity 19: Calmodulin
NP_036650 Calm 3 
NP_037220 P tp n ll 
XP_213368
XP_214050 
XP_341110
Com m unity 20: Actinins
calm odulin 3
protein tyrosine phosphatase, non-receptor type 11
sim ilar to F’ukarvotic translation initiation factor 5A (elF-5A) (ell -
4D) (Rev-binding)
sim ilar to leucine am inopeptidase
sim ilar to testis-enriched protein tyrosine phosphatase
NP_112267 Actnl actinin, alpha 1
NP_ 113863 Actn4 alpha actinin 4
NP_653346 C psm l Cl-protein signalling m odulator 1 (ACiS3-like, C. elegans)
XP_214499 sim ilar to actinin, alpha 2
XP_216586 sim ilar to Msx-2 interacting nucleus target protein
Com m unity 21: ATP transporter proteins
NP_036686 F'nol enolase 1, alpha
NP_445954 Abcgl ATP-binding cassette, sub-fam ily C> (WI UTF), m em ber 1
XP_214583 sim ilar to grp75
XP_341267 sim ilar to polvnucleotide phosphorylase-like protein
Com m unity 22: Tubulin proteins
NP_036942 Sycpl svnaptonem al complex protein 1
NIC 112286 Dbnl drebrin 1
NP_665721 Tubgl tubulin , gam m a 1
NP_954534 Ikbkg inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase 
gam m a
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XP_215080 sim ilar to RIKKN cDNA 3230401013
XP„219470 sim ilar to tubu lin , gam m a complex associated protein 2
XP_225013 sim ilar to G am m a-tubulin  complex 3 (GCP-3) (Spindle pole body
Spc98 hom ol.)
Com m unity 23: Actinin/calm odulin
NP 036630 Calm3 calm odulin  3
NP 059013 G rp 58 glucose regulated  protein, 58 kDa
N IM 12267 A ctnl actinin, a lpha 1
NIM 13863 Actn4 alpha actinin 4
XP_213891 sim ilar to abnorm al spindle
XP_214499 sim ilar to actinin, alpha 2
XP.343034 sim ilar to dystrobrevin  B (mDTN-B)
Com m unity 24: Proteasome
NP_001005875 Psm dl2 proteasom e 26S non-ATPase subunit 12
XP.226439 sim ilar to 26S proteasom e non-ATPase regulatory subunit 7 (26S p ro­
teasom e reg. subunit)
XP_230377 sim ilar to TRAF6
XP_343114 sim ilar to CD40 receptor associated factor 1
XP_344977 sim ilar to 26S proteasom e subunit p40.5
Com m unity 25: Serine protease inhibitors
NP_001007619 Rchyl ring finger and  CHY zinc finger dom ain containing 1
NP_001007733 MGC94010 sim ilar to SPI6
NP_036630 A ldrl a ldehyde reductase 1 (low Km aldose reductase) (5.8 kb PstI frag­
ment)
NP_037215 Hspa5 heat shock 70kD protein 5
NP_059036 Acoxl acyl-Coenzym e A oxidase 1, palm itoyl
NP_067728 Serpinb2 serine (or cysteine) proteinase inhibitor, clade B, m em ber 2
NP.075218 Kcnipl potassium  channel interacting protein 1
NP_113815 N rlh3 nucleus receptor subfam ily 1, group 11, m em ber 3
NP.446231 Serpinil serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), m em ­
ber 1
NP.476449 SerpinbS serine (or cysteine) proteinase inhibitor, clade B, m em ber 5
NP_543169 P d e lla phosphodiesterase  11A
NP_596897 Agpat4 l-acylglycerol-3-phosphate O-acyltransferase 4
NP.741984 Spna2 alpha-spectrin  2
NP.742005 Canx calnexin
NP.742026 Hif2bl eukaryotic translation  initiation factor 2B, subunit 1 alpha
NP.954888 Rela v-rel reticuloendotheliosis viral oncogene hom olog A
XP_213076 sim ilar to G TP-binding protein NGB
XP_233568 sim ilar to Zinc finger protein 436
XP 341644 sim ilar to Polym erase (RNA) II (I)NA directed) polypeptide C
Community 26: Myosin
NPJ)36650 Calm 3
NIM158936 Myh7
XP„218617
XIG340818 Myh4_pred
XPJU3512
calm odulin 3
m yosin heavy chain, polypeptide 7 
sim ilar to nonm uscle m yosin heavy chain
m yosin, heavy po lypeptide  4; now: XP_340819, sim ilar to Myh4 
sim ilar to leucyl-tRNA synthetase
Com m unity 27: Nucleoporin
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NP_036922 Dspp den tin  sialophosphoprotein
XP_218620 sim ilar to nucleus pore glycoprotein p62 (62 kDa nucleoporin)
XP_219263 sim ilar to im portin  7
XP_341309 nucleoporin 133kD
Com m unity 28: Laminin
NP_112406 Actb cytoplasm  beta-actin
N P„113708 MyhlO myosin heavy chain 10, non-m uscle
XP_218617 sim ilar to nonm uscle m yosin heavy chain
XP_223330 sim ilar to RIKKN cDNA 2310068022
XP_228209 sim ilar to Lama4 protein
Com m unity 29: Matrix m etalloproteases
NP_037213 Hspa3 heat shock 70kD protein 3
NP_077376 A dam tsl a disintegrin and m etalloproteinase with throm bospondin  m otifs 1
NP_446301 Krp70 protein d isulfide isom erase related protein (calcium -binding,
intestinal-rel.)
XP_343193 Now NP_001012197 Tral_predicted  tum or rejection antigen gp96
(predicted)
Community 30: Casein kinase
N P. 0366.34 Cbs cystathionine beta synthase
NP_074046 C snklg3  casein kinase 1, gam m a 3
XP_213368 sim ilar to Kukaryotic translation initiation factor 3A (ell -3A, ell -4D)
(Rey-binding)
XP_343107 sim ilar to Vrkl protein
Community 31: Zinc finger protein
NP_062366 Znf386 /in c  finger protein 386 (Kruppel-like)
NP_663887 Khxl LIM homeobox protein 1
NP_934323 MGC73008 Unknown (protein for MC'.C:73(X)8)
XP_342746 hypothetical protein XP_342743
Community 32: Actinin
NP_112267 A ctnl
NP_113863 Actn4
NP_773148 Pdlim7
XP_214499 
XP_233710
actinin, alpha 1 
alpha actinin 4 
PDZ and LIM dom ain 7 
sim ilar to actinin, alpha 2 
sim ilar to T en d  protein
Community 33: Breast cancer anti-estrogen resistance
NT_037063 Bcarl
NP_037213 Ptk2
XP_217230 Ilphbl
XI’_223781
XP_ 233322
XI’_341933
XP 343143
breast cancer anti-estrogen resistance 1 
ITK2 protein tyrosine kinase 2
PRKDICTK1): Kph receptor 111 (Tyrosine-protein kinase receptor 
KPH-2)
sim ilar to Vinculin (M etayinculin) 
sim ilar to 1.ph-like receptor tyrosine kinase 
transform ing grow th factor beta 1 induced transcript 1 
sim ilar to ring finger protein 41; hypothetical SBBI03 protein
Community 34: Breast cancer anti-estrogen resistance
NP 036890 Syk spleen tyrosine kinase
Appendices 183
NP_037063 Bcarl breast cancer anti-estrogen resistance 1
NP_067719 Erbb4 v-erb-a erythroblastic leukem ia viral oncogene homolog 4
XP_223781 sim ilar to Vinculin (M etavinculin)
XP_341935 transform ing grow th  factor beta 1 induced transcript 1
Community 35: Protein-tyrosine kinases
\T 0 3 6 8 8 7  fyn fyn proto-oncogene
NP_037137 Pik3rl phosphatidylinosito l 3-kinase, regulatory subunit, polypeptide 1
NIM137213 Ptk2 PTK2 protein tyrosine kinase 2
XP_217250 sim ilar to f’phrin  type-B receptor 1 precursor (Tyrosine-protein ki­
nase receptor I-PI 1-2)
XP_342283 SI 1C (Src hom ology 2 dom ain-containing) transform ing protein 1
Community 36: Fyn proto-oncogene
NT_036887 fyn fyn proto-oncogene
NP_569089 K hdrbsl src associated in m itosis, 68 kDa
XP_232763 Lck lymphocyte-specific protein tyrosine kinase
XP_343333 sim ilar to SMARCD1 protein
Appendix F 
Internet resources
URLs for some Internet resources m entioned or used in this work.
3D-JIGSAW Homology Modelling
Affymetrix
ASTRAL
BIND
BioGRID
Biomolecular Modelling at CR-UK 
BLAST and PSI-BLAST servers 
CATH 
DIP
DomainFishing
EBI
Ensembl Genome Browser
Google search tools
HPRD
IntAct
NACCESS
MINT
MIPS CYGT
MIPS Mammalian Protein Database
MySql
NCBI
OPHID
PFAM
PIP
POINT 
PostgreSQL 
Protein Data Bank 
SCOP 
STRING
Swiss-Prot Protein knowledgebase
bmm.cancerresearchuk.org/~3djigsaw
www. affymetrix. com
astral.stanford.edu
www.bind.ca
www.thebiogrid.org
bmm.cancerresearchuk.org
www.ncbi.nlm.nih.gov/BLAST
www.biochem.ucl.ac.uk/bsm/cath
dip.doe-mbi.ucla.edu
bmm.cancerresearchuk.org/~3djigsaw/d o m _ f i s h
www.ebi.ac.uk
www.ensembl.org
www.google.com
www.hprd.org
www.ebi.ac.uk/intact
wolf.bms.umist.ac.uk/naccess
cbm.bio.uniroma2.it/mint
mips.gsf.de/proj/yeast
mips.gsf.de/proj/ppi
www.mysql.com
www.ncbi.nlm.nih.gov
ophid.utoronto.ca
www.sanger.ac.uk/Software/Pfam
bmm.cancerresearchuk.org/servers/pip/
point.bioinformatics.tw
www.postgresql.org
www.rcsb.org
scop.mrc-lmb.cam.ac.uk/scop 
string.embl.de 
expasy.org/ sprot
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